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1.1. Transcellular Ca2+ transport 
Intestinal and renal epithelia absorb Ca2* via a paracellular and transcellular 
route. The paracellular or junctional route has a variable permeability for Ca2+ along 
the entire small intestine (1,2), the proximal tubule and loop of Henle of the nephron 
(3-6). Passive movements of Ca2* can occur in both directions and are driven by 
favourable electrochemical gradients or by solvent drag. Transcellular Ca2* transport 
occurs mainly in the duodenum (2,7,8) and the distal tubule of the nephron (9,10). 
The transcellular route consists of a passive influx at the luminal side, diffusion 
through the cytosolic compartment and finally extrusion of Ca2* out of the cell into 
the circulation. Active Ca2* extrusion in intestinal and renal epithelia is mediated by 
an ATP-dependent Ca2* pump and by a Na*/Ca2* exchange mechanism, both located 
in the basolateral membrane (11,12). 
Vitamin D-dependency of transcellular Ca2* absorption of intestinal epithelial 
cells has been studied for decades (13-15). The most active metabolite of vitamin D, 
l,25(OH)2D3, binds to a cytosolic receptor protein and then moves to the nucleus 
leading to the novo protein synthesis (16-18). Actions of 1,25(ОН)2оз on the 
transcellular Ca2* absorption without gene activation have also been demonstrated 
(19,20). The active vitamin Dj metabolite, 1,25(ОН)2Оз, rules the rate of transcellular 
Ca2* transport in the intestine and the kidney (21-23). It has been shown that the 
synthesis of Ca2*-binding proteins (calbindin-D* and calbindin-D^) in Ca2* 
transporting cells is governed by l,25(OH)2D, (24). Large amounts of Ca2*-binding 
proteins, up to 170 μΜ, have been demonstrated in intestinal and renal epithelial cells 
(25,26). In all likelihood their function is enhancement of Ca2* diffusion from the 
luminal side towards the serosal side, were it is pumped out of the cell. Feher (27) 
anticipated that a Ъискеі brigade' transport of Ca2 is unlikely and that the 
enhancement of Ca2* diffusion by Ca2*-binding proteins is due to an overall increase 
in cytosolic Ca2*. For comparison, at resting level the Ca2* concentration is about IO"7 
M. In the presence of 100 μΜ calbindin-D» which is occupied for 50% with Ca2*, the 
total cytosolic Ca2* increases 1000-fold without affecting free Ca2* concentration at 
resting level. A direct effect of 1,25(ОН)2оз on transcellular Ca2* transport has been 
demonstrated as well (19,20,28). The metabolite stimulates the influx of Ca2* at the 
luminal side by a mechanism not yet understood. Some investigators found that 
l,25(OH)2Dj also increases the number of Ca2*-ATPases at the basolateral side of the 
cell (29). This active component of Ca2* absorption is most striking during periods of 
increased Ca2* needs such as growth, pregnancy, lactation or when the diet is low in 
Ca2* (2,8,20). Studies on the vitamin D-dependency of Ca2* absorption in the kidney 
have been hampered due to a lack of techniques for measuring transcellular Ca2* 
transport and to a complex interaction between the calciotrophic hormones. A direct 
stimulation of renal Ca2* absorption by l,25(OH)2D, has been demonstrated by 
Yamanoto et al. (30). 
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Fig. 1. Schematic drawing of Ca2* translocating mechanisms in intestinal cells. 
1.2. Cellular Ca2+ homeostasis 
In all cells the cytosolic Ca2+ concentration is maintained at low resting levels 
around IO-7 M. A wide variety of cellular functions are regulated by fluctuations in 
cytosolic Ca2*, mainly brought about by receptor activation on the cell surface (31,32). 
Cells are surrounded by a ~ 10,000 fold higher Ca2+ concentration. To compensate 
for leak and to restore the basic level after transient rises in cytosolic Ca2*, specialized 
cellular mechanisms are needed. As mentioned before, cells extrude Ca2+ by an 
ATP-dependent Ca2* pump and a Na*/Ca2* exchange mechanism. Intracellular storage 
of Ca2* occurs as well. The mitochondria accumulate Ca2* in large amounts providing 
that cytosolic Ca2* reaches values of about 0.3 μΜ or higher. Restoration of cytosolic 
Ca2* back to resting levels around Ifr7 M is achieved by a non-mitochondrial, 
ATP-dependent Ca2* pool. The latter is probably located in the endoplasmic reticulum 
(33-38). The intracellular Ca2* homeostasis of intestinal and renal epithelial cells is 
continuously challenged by large and variable rates of transcellular Ca2* transport. 
Recently, parts of this intricate mechanism have been clarified. The presence of high 
concentrations of cytosolic Ca2*-binding proteins and a large Ca2* extrusion capacity 
seems to be of great importance. 
Abnormal membrane handling of Ca2* has been described for red blood cells 
(39,40), platelet membranes (41-43), adipocytes and nerve cells (44) from persons 
with essential hypertension. However, there is no agreement about the nature of the 
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abnormality, whether Ca2*-ATPase activities are increased or decreased. 
1.3. Ca2+-bmding proteins 
U . l . Tissue and species distribution of Ca2*-bmding proteins 
The vitamin D-dependent Ca2+-binding proteins, calbindins, are members of 
the troponin-C superfamiiy of proteins that occur in Ca2* transporting tissues such as 
the intestine, the distal tubule of the kidney and the placenta. Smaller, but significant 
amounts of calbindins, are present in other tissues such as the brain, the central 
nervous system, the pancreas, the parathyroid glands and bone (24). Vitamin 
D-dependency of Ca2*-binding proteins has been demonstrated in the intestine and 
kidney (24). In brain and the central nervous system the concentration of Ca2*-binding 
proteins is probably not vitamin D-dependent (24,45). The chicken intestine contains 
calbindin-D^, while the mammalian species contain an intestinal calbindin with a 
molecular mass of 9 kDa. In the distal tubule of mammalian kidney, calbindin-D^ is 
present. Although the mammalian calbindin-Dj^ represents a different protein, it 
resembles structurally and immunologically to chicken intestinal calbindin-D^ (46-52). 
In placental tissue, calbindin-D* has been demonstrated (24). Other members of the 
troponin-C superfamiiy, i.e. calmodulin and parvalbumin, are present in a wide variety 
of tissues. Calmodulin is present in all eukaryotic cells and is involved in many cellular 
functions. Parvalbumin was first demonstrated in skeletal muscle but more recently it 
is found in many other tissues as well (53). Parvalbumin often colocalizes with 
calbindin-Daa and/or calbindin-D,, (54-56). Unlike calbindins, calmodulin and 
parvalbumin are not vitamin D-dependent. 
1.3.2. Structural characteristics of Ca2+-bindmg proteins 
All Ca2*-binding proteins are relative small and heat stable (up to 60°C) 
proteins that possess two or more ,Ca2+-binding domains'. An important feature is the 
EF-hand Ca2*-binding site that is characterized by its helix-loop-helix configuration 
that enables Ca1*-binding with high affinity (Κ^<1 μΜ), and with a much lower affinity 
for other cations such as Mg2*, Mn2*and K* (57). The primary structures of bovine, 
porcine and murine intestinal calbindins have been obtained by amino acid sequencing 
techniques or have been detected from sequences of appropriate cDNA clones (58-
65). Bovine calbindin-D* consists of 78 amino acids with a molecular mass of 8,788. It 
is 87% and 81% homologous with porcine and murine proteins. The protein contains 
two helix-loop-helix structures of 29 amino acids and each mole of the protein binds 
two mole Ca2*. The amino acid sequence of chicken intestinal calbindin-Da, has been 
determined (46,47,66,67). The protein contains 261 amino acids, six putative Ca2*-
binding sites and has a molecular mass of 30,167. The protein binds 4 moles 
Ca2*/mole protein. Presumably, two of the six putative Ca2*-binding sites do not bind 
Ca2* or do so with a very low affinity. The amino acid sequence of rat, human and 
bovine brain calbindin-Da» has been determined (48-52). The sequence of these 
proteins is 79% homologous to the chicken intestinal calbindin-D^. These proteins 
also contain six putative Ca2*-binding sites but actually bind only 4 moles Ca2*/mole 
protein. Parvalbumin has a molecular mass of 12 kDa and binds two mole Ca27mole 
protein. The multifunctional calmodulin with a molecular mass of 17 kDa can bind 4 
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moles Ca2*/ mole protein. When three of its four metal binding sites are occupied the 
protein undergoes a conformational change that leads to an increased hydrophobic 
surface. Only in this shape the protein can associate with, and activate the plasma 
membrane Ca2+-ATPase (68). Although there is no evidence for hydrophobic surface 
patches on calbindins (69), some investigators found that Ca2* -binding proteins 
activate the plasma membrane Ca2*-ATPase (70-72). In contrast, others found no 
direct effect of calbindins (73-75). 
1.3.3. Physiological role of Ca2*-binding proteins 
Positive correlations between the concentration of calbindin and the rate of 
transcellular transport of Ca2*, strongly suggest a role for calbindins in the Ca2* 
absorption in intestinal and renal cells. It has been shown that in the absence of 
calbindin-D* the intestinal Ca2* absorption would only be 1/70 compared to a vitamin 
D-stimulated cell were the protein is present (76). Enhancement of Ca2* absorption 
has also been demonstrated for the distal tubule (77). The concentration of intestinal 
calbindin-Dja in laying hens is approximately three times that found in immature 
chicks (78). Presumably, Ca2* absorption is positively correlated with the presence of 
calbindins. Kretsinger et al. (79) performed a theoretical analysis of 
calbindin-facilitated diffusion and resolved the 'too slow' free diffusion paradox. Feher 
demonstrated that the overall Ca2* flux in an aqueous compartment increased 
proportionally with the concentrations of calbindin-D« (80) and parvalbumin (27). The 
facilitated diffusion of Ca2* by calbindins is most probably an important mechanism in 
vitamin D-dependent Ca2* transport. The presence of calbindins in various other 
tissues other than the intestine, kidney and placenta, and its evolutionary conservation 
suggests an important role in Ca2* homeostasis of numerous cell types. 
1.3.4. Evolution of CaI*-bmding proteins 
The 'EF-hand' Ca2*-binding family can be divided into two groups: 
- group 1 comprises proteins having four or less EF-hand domains such as calmodulin, 
parvalbumin and calbindin-D* 
- group 2 is made up of proteins with six EF-hand domains such as calbindin-D». 
Several authors have proposed that the proteins from the first group are all derived 
from a four domain ancestor resulting from two successive duplications of a single 
EF-domain (81). Perret et al. (82) analyzed the position of the introns in relation to 
the 'EF-hand' domain and the phases of the intron to detect if any conservation 
revealed any symmetry that might exist. They proposed that the two groups of Ca2*-
binding proteins, the group with four or less 'EF-hand' domains, and the proteins with 
six domains, are all derived from a single domain ancestral gene. Two successive 
duplications of this single domain, in agreement with the exon shuffling theory (83) 
would have giving rise to the first group. A duplication, followed by a triplication, 
which is also in agreement with the exon shuffling theory, would have produced the 
second group. In rat and human brain, two calbindins of slightly different molecular 
weight 28 kDa (27 kDa in rat) and 29 kDa, have been detected (45,84). Pochet (84) 
showed that the two proteins from rat brain cross-reacted with antibodies against 
chicken intestinal calbindin-D^. These two proteins were shown to derive from 
different messenger RNA populations. However, it was unknown if there respective 
mRNA were derived from a single gene by a brain specific alternative splicing, or if a 
second gene was specifically expressed in the nervous system. In a recent study 
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Parmentier (85) used antibodies against chicken intestinal calbindin-DÄ 
to screen complementary DNA libraries (human brain stem and human cerebellum). 
The 27 kDa protein turned out to be human calbindin-D^. The second protein, 
homologous to calbindin was compared to the partial sequence of chicken retinal 
protein described by Rogers (86) and named calretinine. Analysis of the sequences 
showed that the two proteins shared 58% identical residues. They both contain six 
'EF-hand' domains. Parmentier et al. (87) performed a phylogenetic study of 
calbindin-D» in lower vertebrates. They showed that only one band was present in 
the fish brain while two bands were detected in the brain of amphibians, reptiles, 
birds and mammals. Calbindin-D^ was not detected in the intestine and kidney of fish 
species. It was concluded that from an evolutionary point of view, calbindin-D^ was 
primarily a neuronal protein. When amphibian ancestors became terrestrial, the need 
for a Ca2*-binding protein somehow appeared in cells were Ca2* exchange with the 
environment was taking place, namely the intestinal tract and the kidney tubules. One 
of the existing brain calbindins was selected for this purpose. It is interesting to note 
that in mammals, a smaller and completely different protein, calbindin-DÄ has 
functionally replaced calbindin-D^ in the intestine. 
1.4. Ca2+-ATPases 
1.4.1. Two types of Ca^-ATPases 
At resting level, the intracellular free Ca2* concentration varies between 50-100 
nM. Cells are surrounded by a — 10,000 fold higher Ca2* concentration. Because of 
this impressive gradient, cells are continuously challenged to maintain the desired 
resting level. Specialized Ca2* selective systems are needed to extrude Ca2* from the 
cytosol. In many cell types a plasma membrane Ca2*-ATPase has been demonstrated. 
There is considerable evidence that the plasma membrane Ca2*-ATPases are similar 
in all cells of vertebrates and invertebrates, with perhaps the exception of the 
hepatocyte (88,89). The plasma membrane Ca2*-ATPase comprises only a minor 
fraction of the plasma membrane proteins, 0.1-0.2% (90-92). In polarized cells, such 
as the enterocyte, the distal tubule cell of the kidney and the placental trophoblast, 
the Ca2*-ATPases are located exclusively at the basolateral membrane (93-95). The 
sarcoplasmic reticulum of skeletal muscles contains large amounts of Ca2*-ATPase. A 
very efficient Ca2* translocation system in muscle cells is a necessity for a very fast 
reduction of the cytosolic Ca2* concentration after excitation. Sarcoplasmic reticulum-
like Ca2*-ATPases have been demonstrated in non-muscle cells as well (96-100). The 
endoplasmic reticulum of these cells contain, albeit in much lower densities, a 
Ca2*-ATPase that shares many characteristics with the sarcoplasmic reticulum 
Ca2*-ATPase. Recently, sarcoplasmic reticulum like Ca2*-ATPases have been 
demonstrated in a specific structure that might be a discrete organelle distributed 
throughout the cytoplasm, so called calciosomes (101,102). 
In conclusion, two types of Ca2*-ATPases are present in many mammalian cell 
types, a plasma membrane type- and a sarcoplasmic reticulum type Ca2*-ATPase 
(Table 1). 
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Table 1. Properties of plasma membrane (PM) and sarcoplasmic reticulum (SR) Ca'*-ATPases 
Property PM SR References 
Molecular weight: 
Calmodulin binding: 
Effect La3* on phosphoprotein: 
Vanadate sensitivity: 
Ca27ATP ratio: 
Coumenon: 
Reaction cycle: 
Binding siles for ATP: 
In situ form of the enzyme: 
-135 kDa 
yes 
accumulation 
К
и
 0.5-1.0 μΜ 
1 
probably Η* 
E1,E2 
2 
homodimer 
100-115 kDa 
no 
inhibition 
K
w
 -10 μΜ 
2 
probably H* 
ЕІ.Ег 
2 
homodimer 
(109,116-118) 
(68,44,14«) 
(136) 
(149-153) 
(136,154,155) 
(156.157) 
(134,135) 
(126-12S) 
(107,108) 
1.4.2. Structural and functional characteristics 
Ca+-ATPases are members of the P-type ion motive ATP-ases, to which class 
also the (Na\K*)-ATPase and the (H\K+)-ATPase belong (103,104). During the 
reaction cycle of these types, an acylphosphate intermediate is formed via reaction of 
a gamma-phosphate group of ATP with an aspartic acid group of the enzyme 
(105,106). Both types of Ca2*-ATPases consists of a single polypeptide chain that 
forms a homodimer (107,108). Hydrophobicity plots of CaI+-ATPases, 
(Na*,K*)-ATPase and (H\K*)-ATPase show a similar pattern of ten hydrophobic 
regions (109). It is still uncertain whether all the hydrophobic regions span the 
membrane. Sequence analysis of the ATP-binding site show that this part of the 
enzyme is highly conserved in all P-type ATPases (Fig. 2) (110). Although the two 
types of Ca2*-ATPases share many characteristics, there are also some striking 
differences between them. (Table 1). An important feature of the plasma membrane 
Ca2*-ATPase is its ability to bind calmodulin. As mentioned before, calmodulin 
associates with Ca2*-ATPase when three of its four metal binding sites are occupied. 
After binding of calmodulin, the affinity of red blood cell Ca2*-ATPase for ATP 
increases 100 fold (111) and the affinity for Ca2+ increases 30 fold (112-114) This 
mechanism probably plays an important role in selective activation of the Ca2*-
ATPase (115). 
ATPase 
Frythrocvie . 
Sarcopl ret . 
Rat stomach. 
Sheep kidnev, 
Torpedo i.alit. 
Rat brain. 
Neurospora crassa. 
F coli Kdp. 
Strepi taecalib 
Ca2· 
Ca> 
HVK' 
Na*/K* 
Na*/K* 
Na*/K* 
H* 
K* 
κ· 
Sequence 
M G Ν A Τ Λ 
L G Τ С S V 
L G Τ С S V 
L G S Τ S Τ 
L G S Τ S Τ 
L G S Τ S Τ 
L A Ô V Ë 1 
A G DV DV 
N N D L D V 
I C S D K T G T L T 
I C S D K T G T L T 
I C S D K T G T L T 
M 
T N O 
0 NR 
I C S D K T G T L T Q N R 
I C S D K T G T L T Q N R 
I C S D K T G T L T O N R 
L|C S D Κ Τ G Τ L ΤΙΚ Ν К 
L L L D K T G T I I T L G N 
I M L D K T G T L T Q|G К 
(475) 
(348) 
(382) 
(371) 
(373) 
(373) 
(375) 
(307) 
(275) 
Fig.2. Amino acid sequence of various ion-transporting ATPases. 
The number between the brackets represents the position of the reactive asparagin acid (174). 
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In 1985 McLennan et al. (116) published the primary amino acid sequence of 
the sarcoplasmic reticulum Ca2*-ATPase. Between 1988 and 1989 the complete 
primaiy amino acid sequence of plasma membrane Ca2*-ATPase in respectively a 
human teratoma (109), rat brain (117), human erythrocyte (118,119) was determined. 
Surprisingly, peptide sequence analysis of rat brain and human erythrocytes revealed 
two isoforms of the Ca2*-ATPase. The plasma membrane Ca2*-ATPases showed a 
high degree of conservation. Some differences were noticed in the C-terminus of the 
enzyme, although the calmodulin binding site showed, in contrast to other calmodulin 
regulated enzymes, a high degree of similarity. A hypothetical scheme of the 
architecture of the human teratoma Ca2+-ATPase in the plasma membrane was made 
by Carafoli (Fig. 3). (109,120,121). The enzyme consists of 1220 amino acids 
corresponding to a molecular mass of 134,683. Aspartic acid 475 forms the 
acylphosphate during the reaction cycle and Lysine 601 binds the ATP antagonist 
fluorescein isothiocyanate (FITC). Aspartic acid 475 and lysine 601 are separated by a 
domain that is highly conserved in the ion motive ATPases of the P-types and may 
function as a hinge that permits the two regions to come close together during the 
reaction cycle. The calmodulin binding site has been identified next to the C-termmus. 
The calmodulin binding domain interacts with a sequence adjacent to it on the 
N-terminal site which is very rich in aspartate and glutamate and which may play a 
role in the binding of Ca2*. 
20 AA 10 AA 8AA 2ЭАА 8AA 
cAMP-dependent 
phosphorylation 
site 
Fig. 3. Architecture of Ca2*-ATPase in the plasma membrane. 
1.4.3. Influence of Ca1*, Mg1* and ATP 
The apparent affinity of sarcoplasmic reticulum Ca2*-ATPase and plasma 
membrane Ca2*-ATPase for Ca2* is high on the cytosolic site (K„ respectively 0.1 and 
1.0 μΜ) and low on the extracelluar site (K„ respectively 2 mM and ~10 Mm)(122-
125). In both systems the presence of free Mg2* ions on the cytosolic site is nearly a 
absolute requirement. High Mg2* concentrations on the other hand are inhibitory, 
which seems to be due to competition with Ca2* at the transport site (125). Both 
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systems contain two ATP-binding sites of different affinity (126-128). At the high 
affinity site, 1 μΜ range, the hydrolysis of ATP takes place. The low affinity site, 
100-300 μΜ range, accelerates the reaction by a factor of 10 in plasma membrane 
Ca2*-ATPase and even more in sarcoplasmic reticulum Ca2+-ATPase. It is not clear 
whether the two sites are separated domains or one site which changes affinity during 
the reaction cycle. At any rate the two sites cannot exist simultaneously on the same 
molecule (129). For the high affinity site Mg-ATP is believed to be the substrate in 
sarcoplasmic reticulum Ca2*-ATPase, but for the plasma membrane Ca2*-ATPase free 
ATP and perhaps even Ca-ATP probably serve as substrate as well (130-132). 
1.4.4. The reaction cycle 
Both systems belong to the P-types of ion transporting enzymes. During the 
reaction cycle an acid stable acylphosphate is formed by phosphorylation of aspartic 
acid, and the enzymes undergo a conformational change from the E, conformation to 
the E2 conformation and back again. The elementary steps of the reaction cycle are 
probably the same in both systems. As example the reaction cycle of human red blood 
cell Ca2+-ATPase is shown in Fig. 4 (133). The enzyme hydrolyses ATP during the 
conformational change E, to E, by which the high energetically Ε,-Ρ is formed. For 
this step Ca2* is necessary. For the change of Ε,-Ρ to the low energetically Ej-P Mg2* 
is required. Dephosphorylation requires a high ATP concentration, > 100 μΜ. The 
Ca2* binding site at the E, conformation is at the cytosolic site and for the Ej 
conformation at the extracelluar site (134,135). The conformational change from Ε,-Ρ 
to Ej-P is coupled with translocation of Ca2* from the cell interior out of the cell. La'* 
is known to inhibit translocation of Ca2* in both systems. However, the amount of 
phosphointermediate in plasma membrane Ca2*-ATPase increases in the presence of 
La3*, whereas it decreases in sarcoplasmic reticulum Ca2*-ATPase (136). This suggests 
a different action of La3* on the two types of Ca2*-ATPases. 
ι 
Ca2 
ATP + E, 
A 
-» Ca2+.Ei~P + ADP 
IV 
Ca> * 
Mg** * ? 
(low) 
Mg2* 
(low) 
P. +E2 
(Mg)ATP * 
(high) 
Ca2*. E-)-P 
Ca2* 
m 
Fig. 4. Reaction scheme of human erythrocyte Ca2*-ATPase. 
An asterix means that the substance is required for the respective reaction. 
1.4.5. Controlled proteolysis of erythrocyte Ca2*-ATPase. 
Like other calmodulin targets (137-139) the plasma membrane Ca2*-ATPase 
can be activated by a controlled proteolytic treatment applied either to the native 
10 
membranes or to the purified enzyme (140-144). Of interest is the observation that 
this activation can be abolished by so-called anti-calmodulin drugs, suggesting that 
there is some similarity in the mechanisms by which calmodulin and proteolysis 
activate the Ca2+-ATPase (145,146). Treatment of the enzyme with trypsin leads to the 
fragmentation of the enzyme into a number of products and to the accumulation of 
major limit polypeptides having molecular weights of 14,000 , 33,500 , 48,000 and 
76,000 (147). Tbe 33,500 fragment contains probably intramembrane regions of the 
enzyme. A number of minor fragmentation products are formed, among them a 
90,000 and a 25,000 fragment. The 90,000 fragment retains the functional properties 
of the intact enzyme. Further proteolysis of the 90,000 fragment leads to the 
fragmentation of polypeptides with molecular weights between 81,000-76,000 which 
form an acylphospbate intermediate but do not bind calmodulin. 
[,25I]iodoazidocalmodulin reacts only with the intact enzyme and with the fragments 
90,000 and 25,000. 
1.5. Outline of the study 
In chapter 2 we describe the isolation of calbindins, the two types of 
Ca2+-ATPases and the production and properties of antisera. The isolated proteins 
and the produced antisera were used in several studies described in this thesis. 
In chapter 3 the effect of the vitamin D metabolite, l,25(OH)2Dj, on the 
Ca2*-ATPase activities and the number of pump sites in pig intestinal membranes was 
tested. Normal piglets and piglets suffering from an inherited inability to produce 
l,25(OH)2D, leading to severe rickets, were used as animal model. 
In chapter 4 the Ca2* homeostasis of intestinal and renal cells was described. 
ATP-dependent Ca2* uptake was measured in permeabilized cells, microsomes and 
isolated mitochondria from intestinal villus and renal cortex cells. 
In chapter 5 the effect of l,25(OH)2Dj on the transepithelial Ca2* flux of 
cultured Caco-2 cells was tested. 
In chapter 6 the effect of various Ca2*-binding proteins on the ATP-dependent 
Ca2*-uptake in red blood cell vesicles and in enterocyte basolateral membrane vesicles 
was tested. 
Chapter 7 is an immunocytochemical study of the localization of calbindin-Dja, 
calbindin-DÄ and parvalbumin in rat kidney. 
In chapter 8 we describe Ca2*-ATPase activities in red blood cells from healthy 
subjects, patients suffering from essential hypertension and patients suffering from 
Raynaud's phenomenon. We determined the number of Ca2* pumps in erythrocytes of 
these three groups. Antiserum against purified human erythrocyte Ca2*-ATPase was 
produced and a ELISA technique was developed. 
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Chapter 2 
Isolation and characterization of Ca2+-bmding 
proteins and Ca2+-ATPases 
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2.1. Summary 
Calbindin-Dja, calbindin-DÄ, parvalbumin and calmodulin were isolated using 
various techniques. It was demonstrated that all the isolated Ca:*-binding proteins 
showed high affinity for Ca2+. Polyclonal antibodies against the purified Ca2+-binding 
proteins were raised in rabbits. Each antiserum was specific towards its antigen, as 
was demonstrated by ELISA and western blotting. It turned out that anti-chicken-
calbindin-Dja cross-reacted with calbindin-D» from bovine and rabbit origin. Anti-
rabbit-parvalbumin cross-reacted with parvalbumin from chicken. In contrast, we 
found that anti-bovine-calbindin» showed a very weak cross-reactivity with porcine 
calbindin-D,,. 
Ca2+-ATPases from erythrocytes, sarcoplasmic reticulum and intestinal 
enterocytes were characterized by "P-phosphorylation on acidic gels and by 125I-
calmodulin binding after the proteins had been separated on SDS-PAGE and 
transferred to nitrocellulose sheets. It turned out that intestinal enterocytes contained 
a plasma membrane- as well as a sarcoplasmic reticulum-like Ca2*-ATPase, which 
were clearly distinguishable. 
Ca2*-ATPases from erythrocytes and sarcoplasmic reticulum were isolated with 
respectively a calmodulin-affinity column and a DEAE-column. Polyclonal antibodies 
against the purified Ca2*-ATPases were raised in rabbits. The antisera were specific as 
was demonstrated by ELISA and by western blotting. Antiserum against porcine 
erythrocyte Ca2+-ATPase showed a very weak cross-reactivity with other species. In 
contrast, antiserum against rat sarcoplasmic reticulum-Ca2*-ATPase showed a high 
cross-reactivity with other species. "'Ca-uptake experiments were carried out with 
reconstituted porcine erythrocyte Ca2+-ATPase. 
The isolated Ca2+-binding proteins, Ca2t-ATPases and the produced antisera 
were used in several studies described in this thesis. 
2.2. Introduction 
Intestinal and renal Ca2* absorption can follow a paracellular and a transcellu-
lar route. The paracellular or junctional route is driven mainly by favourable electro-
chemical gradients or by solvent drag. Transcellular transport consists of passive entry 
at the luminal site, diffusion through the cytosol and finally active extrusion of Ca2* 
out of the cell into the circulation. Circulating levels of the vitamin D metabolite, 
1,25(ОН)
г
Оз, control the rate of transcellular Ca2* transport in the intestine and the 
kidney (1-7). Low levels of 1,25(ОН)2Оз result in a decreased Ca2* absorption, and 
consequently to insufficient Ca2* supply in times of increased need such as during 
growth, pregnancy and lactation (3,4,8). Vitamin D-dependent Ca2*-binding proteins 
(calbindins) are typically found in intestinal and renal epithelial cells (9). 
The vitamin D-dependent Ca2*-binding proteins are members of the troponin-C 
superfamily of proteins. An important feature of these proteins is the presence of two 
ore more 'EF-hand' domains which are characterized by its loop-helix-loop 
configuration that enables binding of Ca2* with high affinity and with a much lower 
affinity other cations such as Mg2*, Mn2* and К* (9). The synthesis of calbindins in 
intestinal and renal cells is dependent upon 1,25(ОН)2Оз (10). The physiological role 
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of calbindins in these cells is most probably enhancement of Ca2* diffusion through 
the cytosol, that enables increased Ca2* absorption (11-13). The presence of Ca2*-
binding proteins in a wide variety of cell types which are not specialized in 
transcellular Ca2* transport, suggests an important role in other biological processes 
(10). This suggestion is consolidated by the evolutionary conservation of calbindins. 
Calbindin-Dja has an evolutionary rate that is comparable with cytochrome-C which 
is considered as a highly conserved protein (14). Since for Ca2* binding alone a high 
degree of variation is allowed, calbindins are likely to be involved in more specialized 
functions (15). 
Extrusion of Ca2* is accomplished by an ATP-dependent Ca2* transport and 
particularly in excitable cells by a Na*/Ca2* exchange mechanism, both located in the 
plasma membrane (18-22). In the intestine the Na*/Ca2* exchanger is of less 
importance than the Ca2*-ATPase (23,24). Two types of Ca2*-ATPases can be 
distinguished in several cell types; the plasma membrane contains a Ca2*-ATPase of 
138 kDa which is activated by calmodulin (25-28). Intracellular compartments, such as 
the endoplasmic reticulum and calciosomes, contain a Ca2*-ATPase of about 115 kDa 
that shares many characteristics with the sarcoplasmic reticulum Ca2*-ATPase of fast 
twitch muscle cells (29-35). It is unknown whether 1,25(ОН)2Оз effects the final step 
of transcellular Ca2* transport, i.e. extrusion of Ca2* out of the cell into the circulation. 
Some investigators found a decreased ATP-dependent Ca2* extrusion in duodenal 
enterocytes of vitamin D depleted rats (36-38). Their findings however, were due to 
inactivation of the basolateral Ca2*-ATPase during cell isolation in vitamin D-deficient 
animals (39,40). Therefore, at the present time it is still not clear whether 
1,25(ОН)2оз affects the ATP-dependent Ca2* extrusion. It is believed by other 
investigators that calbindins stimulate the plasma membrane Ca2*-ATPase of rat 
duodenal enterocytes and human erythrocytes (41,42). At first sight a stimulation of 
the active Ca2* extrusion by calbindins would cooperate with a high Ca2* supply near 
the basolateral membrane. However, other investigators found no stimulation of the 
plasma membrane Ca2*-ATPase by calbindins (43,44). 
In this chapter we describe the isolation of various Ca2*-binding proteins and 
the isolation of Ca2*-ATPases from respectively erythrocytes and sarcoplasmic 
reticulum of fast twitch muscle cells. Specific antisera were raised in rabbits and used 
for immunological characterization of the isolated proteins. Antisera and proteins 
were further used in the studies described in this thesis. 
2.3. Materials and methods 
2.3.1. Isolation of Ca2*-binding proteins 
Renal Ca2*-binding protein, calbindin-D^, was isolated from bovine and rabbit 
kidneys according to the method of Maruyama et al. (45). Briefly, bovine kidney 
cortex (50 g) was homogenized in 6 vol 10 mM Tris-HQ, 1 mM ß-mercaptoethanol, 
0.01% (w/v) NaN, , 0.1 mM PMSF (pH 8.0) in a Waring blender three times for 30 s 
at its maximum speed. The homogenate was filtered through Whatman No. 41 filter 
paper. To the clear filtered solution a saturated ammonium sulphate solution was 
added to a final concentration of 70% (w/v). After centrifugation at 30.000 χ g for 30 
min ammonium sulphate was added to the supernatant until 100% saturation was 
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reached. After centrifugation at 30.000 χ g for 30 min the pellet was dissolved in a 
minimum volume of a solution containing 10 mM Tris-HCl, 1 mM B-mercaptoethanol, 
0.01% (w/v) NaNj , 120 mM NaCl, 0.1 mM EGTA (pH 8.0). This was dialyzed 
overnight against the same solution. After centrifugation of the solution at 100.000 χ g 
for 30 min the supernatant was applied to an DEAE-cellulose column (1.5 χ 10 cm) 
that was equilibrated with the same buffer. After eluting the unbound proteins the 
NaCl concentration in the solution was reduced to 90 mM and next EGTA was 
replaced by 0.2 mM CaCI2. Pure calbindin-D^ was eluted at this step. 
The isolation of chicken calbindin-Da» was performed as follows; chicken 
duodena were cut open and rinsed with saline. The mucosa was scraped with a glass 
slide and 4 vol 10 mM Tris-HCl, 0.2 mM PMSF and 1 mM DTT (pH 8.0) were 
added. After homogenation with a polytron for 2 min the homogenate was centrifuged 
at 27,000 χ g for 30 min. The supernatant was heated to 60 0C and kept at this 
temperature for 20 min followed by cooling on ice. After centrifugation at 35,000 χ g 
for 40 min the supernatant was applied to a DEAE-cellulose column (1 χ 10 cm) that 
was equilibrated with the same buffer. After eluting the unbound proteins the column 
was eluted with a linear gradient (50-200 mM) KCl in 10 mM Tris-HCl (pH 8.0). Pure 
calbindin-Dja eluted at 100 mM KCl. 
Calbindin-D* was isolated essentially according to the method of Gleason and 
Lankford (46). Briefly, mucosal scrapings of duodena were homogenized in 4 vol of 
homogenizing buffer containing 13.7 mM Tris-HQ, 120 mM NaCl, 3 mM KCl, 1 mM 
ß-mercaptoethanol (pH 7.4) with a Potter-Elvehjem homogenizer using a loose-fitting 
Teflon pestle in a 40 ml glass tube. The resulting homogenate was centrifuged at 
30,000 χ g for 30 min at 4°C. The supernatant was heated to 65 °C in a shaking 
incubator for 10 min and then cooled in an ice bath for 30 min, at which time a 
chalky white precipitate formed. The heated mucosal supernatant was decanted, 
dialyzed against 10 mM ammonium acetate and lyophilized. The lyophilized powder 
was resuspended in homogenizing buffer at a concentration of approximately 5 mg/ml, 
applied to a Sephadex G-75 column (1.5 χ 100 cm) and eluted with homogenizing 
buffer. The peak containing the low molecular weight proteins were collected, pooled, 
dialyzed against 10 mM ammoniumacetate and lyophilized. For further purification 
the lyophilized powder from the gel-filtration column was redissolved in 5 mM 
Tris-HCl, 5 mM NaCl (pH 7.4) and passed through a small column (1 χ 10 cm) of 
Chelex-100 to remove divalent cations. Next, it was applied to a AG MP-1 column (1 
χ 10 cm). The column was washed until the eluate was free of protein, and eluted 
with a 100 ml salt gradient from 5 to 500 mM NaCl in 5 mM Tris-HCl (pH 7.4). 
Parvalbumin was isolated according to the method of Strehler et al. (47). 
Briefly, chick leg-muscle (500 g) was cut into small pieces and 2.5 vol 4 mM EDTA 
(pH 7.0) was added. The mixture was homogenized in a Braun mixer for 1 min at full 
speed and the homogenate was centrifuged at 14,000 χ g for 30 min The supernatant 
was then adjusted to pH 7.0 with 17% (v/v) ammonium hydroxide and heated to 70 "C 
for 30 min under constant stirring at which time a chalky white precipitate was 
formed. The suspension was immediately cooled to 10 "С and filtered through a 
sintered glasfunel. Proteins of the filtered clear solution were precipitated by addition 
of 1/6 vol cold 100% TCA to the solution, and centrifuged at 20,000 χ g for 30 min 
The pellet was redissolved in 50 ml 10 mM NaN, , containing additionally 1 mM 
ß-mercaptoethanol and 0.1 mM СаСІз (pH 5.7). The solution was dialyzed against the 
same buffer. The dialyzed solution was clarified by centrifugation, 20,000 χ g for 30 
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min and the supernatant was applied to a DEAE-cellulose column l.S χ 20 cm that 
was equilibrated with the same buffer. Unbound protein was collected dialyzed against 
distilled water and lyophilized. The powder was dissolved in 1.5 ml 10 mM imida-
zole-HQ pH 6.8 and passed through a Sephadex G-75 column (1.5 χ 100 cm) in the 
same buffer. Fractions containing parvalbumin were pooled, dialyzed extensively first 
against distilled water and then against 2 mM Tris-HCl pH 7.0 and finally applied to a 
second DEAE-cellulose column (1.5 χ 10 cm) that was equilibrated with the same 
buffer. Under these conditions parvalbumin was retained on the column. A linear 
salt-gradient (0-300 mM NaCl) was applied and homogenous parvalbumin was eluted 
at 20-30 mM salt concentration. 
Calmodulin was isolated according to the method of Gopalakrishna & Ander­
son (48). Briefly, about 500 g bovine brain was homogenized in 2 vol 50 mM 
Tris-HCl, 1 mM EDTA, 0.5 mM PMSF, 1 mM ß-mercaptoethanol (pH 7.5) in a 
Waring blender for 2 min at its maximum speed. The homogenate was centrifuged at 
15.000 χ g for 30 min. The supernatant was filtered through a fine gauze and the pH 
was adjusted to 4.3 with 6 M acetic acid. After incubation at 4 0C for 1 h it was 
centrifuged at 15.000 χ g for 30 min. The pellet was redissolved in 150 ml 
homogenizing buffer and the pH was adjusted to 7.5 with 1 M Tris-OH. The solution 
was boiled for 5 min. After cooling on ice it was centrifuged at 100.000 χ g for 30 min. 
To the supernatant 5 mM CaCli was added and the solution was applied to a 
phenylsepharose column (25 χ 1.5 cm) that was equilibrated with homogenizing buffer. 
After incubation for 1 h with the phenyl sepharose the column was washed with 50 
mM Tris-HCl, 0.1 mM CaCl2, 1 mM ß-mercaptoethanol (pH 7.5) and subsequently 
with 50 mM Tris-HCl , 0.1 mM CaCl,, 1 mM ß-mercaptoethanol, 500 mM NaCl (pH 
7.5). Finally, calmodulin was eluted with 50 mM Tris-HCl, 1 mM EGTA, 1 mM 
ß-mercaptoethanol (pH 7.5). 
2.3.2. bolation of Calt-ATPases 
For isolation of erythrocyte Ca2*-ATPase the method of Niggli et al. was 
followed (49). Briefly, calmodulin-deficient pig ghosts were solubilized at a protein 
concentration of approximately 4 mg/ml in an equal volume of 0.4% (v/v) Triton 
X-100, 20 mM Hepes-KOH, 130 mM KCl, 0.5 mM MgCl,, 50 μΜ CaCl» 2 mM DTT 
(pH 7.4) at 5 °C for 10 min. Nonsolubilized material was removed by centrifugation at 
100.000 χ g for 20 min. To the supernatant sucrose was added to a final concentration 
of 200 mM. The supernatant was then applied to a calmodulin-Sepharose 4B column 
(1.5 ml) that was equilibrated with 0.2% (v/v) Triton X-100, 20 Mm Hepes-KOH, 130 
Mm KCl, 1 Mm MgCl,, 100 μΜ CaCl,, 2 Mm DTT, 200 Mm sucrose (Ph 7.4). The 
column was washed with this buffer until no protein further eluted. Then the bound 
Ca^-ATPase was eluted with the same buffer containing 2 mM EDTA instead of 
CaCl,. The isolated Cal*-ATPase was stored in liquid N2 until further use. 
Sarcoplasmic reticulum from rat muscle was isolated essentially according to 
Heilmann et al. (50). The Ca2*-ATPase was isolated on DEAE-chromatography 
essentially according to Helmke & Howard (51). About 15 mg sarcoplasmic reticulum 
vesicles from rat was solubilized in medium containing 20 mM Tris-HCl, 1 mM MgCl2, 
50 μΜ CaCl2 , 200 mM mannitol, 1 mM DTT and 0.2% (v/v) Triton X-100 (pH 7.5) 
for 10 min. on ice. After centrifugation at 100.000 χ g for 30 min the supernatant was 
applied to an equilibrated 10 ml. DEAE-cellulose column and eluted with a linear 
gradient of 0-400 mM KCl in the same buffer. Ca2*-ATPase eluted at a KCl 
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concentration of 120 mM. 
2.33. Reconstitution of erythrocyte Ca2+-ATPase 
Reconstitution of erythrocyte Ca2+-ATPase was carried out essentially as 
described by Niggii et a (49). Briefly, purified Ca2+-ATPase (50 to 100 Mg) was 
suspended in 1 ml 450 mM KCl, 1 mM MgClj, 50 дМ CaCl,, 2% (v/v) Triton X-100 
and 10 mg/ml phosphatidylcholine. This mixture was applied to a 10 ml Biobeads 
SM-2 column, equilibrated with 10 mM HEPES-KOH, 500 mM KCl, 50 дМ MgCl» 2 
mM D I T (pH 7.4) and incubated for 30 min at 4 "C. Fractions containing the 
Ca2+-ATPase in essentially Triton-free form were collected. 
2.3.4. Preparation of basolateral membranes 
Basolateral membranes were isolated as described in chapter 4. 
The individual steps are outlined below. 
duodenal scrapings 
vortexed 
200 χ g,10 min 
pellet (H.) 
homogenized 
600 χ g, 10 min 
Ï 
pellet (Ρ,) κ supernatant (S,) 
100,000 χ g 20 min I 
pellet 
applied to 40% discontinuous 
sucrose gradient 200,000 χ g, 1.5 h 
upperlayer 
100,000 χ g, 20 min I 
pellet (Ρ,) 
2.3.5. Electrophoresis 
SDS-polyacrylamide gel electrophoresis was carried out according to the 
method of Laemmli (52). Samples were dissolved in 40 mM Tris-HCl, 4% (w/v) SOS, 
30% (v/v) glycerol, 5.5% (w/v) DTT and 0.01% (w/v) bromophenolblue (pH 6.8), 
followed by heating at 100 "C for 5 min prior to loading on gels (Protean II, 
Pharmacia). 
23.6. Detection of Ca2*-bmding proteins with *Ca autoradiography 
The method of Maruyama et al. (53) was followed. Briefly, proteins were 
separated on SDS-PAGE according to Laemmli (52) on 7.5-20% (w/v) Polyacrylamide 
gels. The proteins were transferred onto a nitrocellulose sheet. After the transfer, the 
sheet was soaked into a solution containing 60 mM KCl, 5 mM MgCl2 and 10 mM 
imidazole-HCI (pH 6.8), and the buffer was changed three times in one hour to wash 
away the electrode buffer. Then the sheet was incubated for 10 min in the same 
buffer containing additionally 1 mCi/liter ^СаС1
г
. The sheet was rinsed with distilled 
24 
water for 5 min. Excess water was absorbed between filter paper and the sheet was 
dried at room temperature. The sheet was then exposed to Kodak XAR-5 X-ray film 
for 12 to 24 h. 
23.7. Phosphorylation of membrane proteins 
Membrane protein was incubated in 200 μΐ of a medium containing 100 mM 
KQ, 30 mM imidazole-HCl , 2.5 μΜ (gamma "РЭАТР (pH 6.8) and either (1) 1 mM 
EGTA (2) 50 μΜ CaCl2 or (3) 50 μΜ CaCl2 + 25 μΜ LaCl, for 10 s on ice. The 
reaction was stopped by addition of 1 ml cold stop solution containing 50 mM НзР04 
and 10% (w/v) TCA. The precipitated proteins were centrifuged, washed two times 
with cold stop solution, and solubilized in a medium containing 10 mM Tris-HCl, 1 
mM EDTA, 40 mM DTE, 3% (w/v) SDS, 10% (w/v) sucrose, and 10 μg/ml 
pyronine-Y (pH 6.5), before it was applied to 7.5-15% linear gradient Polyacrylamide 
slab gels according to Fairbanks & Avruch (54). Gels were dried and exposed 
overnight to Kodak XAR-5 X-ray film at - 80 "C. 
23.8. шІ-са1тоаи1ш overlay 
Membrane proteins were separated on a 7.5-15% (w/v) gradient SDS-PAGE 
according to Laemmli (52). The proteins were transferred to a nitrocellulose sheet 
that was then blocked in excess bovine serum albumin. Subsequently the sheet was 
incubated for 45 min in a medium containing 20 mM Tris-HCl, 150 mM NaCl, 0.1 
mM CaClj, 0.5% (w/v) bovine serum albumin and about 0.15 nmole 125I-calmodulin 
(spec. ac. 0.74 MBq/nmole) (pH 7.4). After the sheet was washed three times with the 
same buffer (without 125I-calmodulin) it was dried and exposed overnight to Kodak 
XAR-5 X-ray film at -80 °C. 
13.9. ELISA 
The competitive ELISA was performed in the following way, (1) 100 ng 
purified antigen was coated to each well of a polystyrene plate in a total volume of 
100 μΐ coating buffer, containing 0.1 M Na2COJ, 5 mM NaN, (pH 9.6) for 2 h at 37 
°C. (2) to each well 50 μΐ standard amounts of purified antigen and 50 μΐ antiserum 
dilution was added. The plate was incubated overnight at 4 "C to reach equilibrium. 
(3) To each well 100 μΐ peroxidase-labelled goat anti rabbit conjugate (whole 
molecule, Sigma, 1:500) was added and incubated for 2 h at room temperature. (4) 
Color was developed by adding to each well 100 μΐ medium containing 0.5 mg/ml 
o-phenyldiamine in 23 mM citric acid 66 mM NaiHPO* 0.01% (w/v) H A (pH 5.5). 
The reaction was stopped by adding to each well 100 μΐ 2M H£0, and after 5 min 
the absorbance was read with an EIA-reader (Bio-rad). Antisera and antigen were 
diluted in 10 mM Tris-HCl, 0.9% (w/v) NaCl, 0.05% (v/v) Tween-20 and 0.5% (w/v) 
BSA (pH 7.4). After each step the ELISA plate was washed four times for two 
minutes with 10 mM Tris-HCl, 0.9% (w/v) NaCl and 0.05% (v/v) Tween-20 (pH 7.4). 
The non-competitive ELISA was performed in the following way; to each well 
100 μΐ test sample containing variable amounts of antigen was coated. Next diluted 
antiserum followed by conjugated peroxidase was applied as has been described for 
the competitive ELISA. 
2.3.10. Western blotting 
Membrane protein was applied to 10% (w/v) SDS-PAGE, according to 
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Laemmli (52), on a mini-gel equipment. Subsequently the proteins were transferred to 
nitrocellulose sheets and during the night at room temperature incubated in 10 
Tris-HCl, 0.9% (w/v) NaCl, 0.05% (v/v) Tween-20 and 1% (w/v) BS A (pH 7.4). The 
blot was incubated with antiserum in the same buffer for 2 h at 20 0C. Next the sheet 
was incubated with peroxidase-labelled goat anti rabbit conjugate (whole 
molecule.Sigma, 1:500) for 2 h at 20 "C in the same buffer. Color was developed by 
incubation with 0.5 mg/ml 4-chloronaphtol in 15% (v/v) methanol, 10 mM Tris-HCl, 
0.9% (w/v) NaCl and 0.01% (w/v) H A (pH 7.4). Following each step the sheet was 
washed intensively with 10 mM Tris-HCl, 0.9% (w/v) NaCl and 0.05% (v/v) Tween-20 
(pH 7.4). Prior to color development the sheet was washed once in the same buffer 
without Tween-20. 
2.3.11. Protein 
Protein was determined with the Coomassie Blue method (Bio rad). 
Membranes were solubilized with 0.1% (v/v) Triton X-100 for 5 min prior to the 
addition of dye reagent. After 5 min the absorbance was read at 595 nm. 
2.3.12. Statistical analysis 
Values were expressed as means ± SEM. Differences in mean values were 
tested using Student's t test for unpaired groups. 
2.3.13. Chemicals 
BSA, EDTA, EGTA, Tris, Hepes, PMSF, phenylsepharose, peroxidase-labelled 
conjugate goat anti rabbit (whole molecule), parvalbumin (from rabbit muscle) and 
anti-parvalbumin (monoclonal) was obtained from Sigma (St. Louis, USA). DTP and 
alkaline phosphatase (calf intestine) was from Boehringer (Mannheim, FRG). DE-
AE-cellulose was from Whatmann. Calbindin-D* (bovine) was a gift of Dr. Sture 
Forsén (Chemical Centre, University, Lund, Sweden). 
Purified (Na\K*)-ATPase from rabbit kidney was provided by H. Swarts (Dept. of 
Biochemistry, University of Nijmegen, The Netherlands). 
2.4. Results 
2.4.1. Isolation of Ca^-binding proteins 
Calbindin-Daa could be successfully isolated following the method of Maruyama 
et al. (45). From 100 g kidney cortex milligram quantities highly pure calbindin-D^ 
could be isolated. The same method proved to be successful for the isolation of 
calbindin-Dja from rabbit kidney. Calbindin-Dja from chicken intestine was isolated 
with DEAE-chromatography following heat precipitation. At 100 mM KCl highly pure 
protein eluted. The isolation of parvalbumin from chicken leg muscle with 
DEAE-chromatography gave milligram quantities parvalbumin. There was however a 
very small contamination with a protein of about 12,000 Da which is probably the 
parvalbumin-like protein (47). The isolation of calmodulin from bovine brain 
according to the method of Gopalakrishna & Anderson (48) was also very successful. 
The use of a phenylsepharose column turned out to be a very efficient and easy 
method to isolate milligram quantities highly pure calmodulin. Enrichment of 
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mammalian intestinal calbindin-DÄ 
could easily be achieved with 
Sephadex-G50 gel filtration. However, 
final purification of the protein was 
difficult. We used DEAE- an QAE-
chromatography at different pH and 
ionic strength in order to purify the 
protein. These methods were all 
unsuccessful. Finally, we used an AG 
MP-1 column described by Gleason & 
Lankford (46) for isolation of 
calbindin-D, k human in tes t ine . 
Calbindin-D* eluted from the AG MP-1 
column at 50 mM NaCl. Although the 
protein could be isolated in pure form 
the recovery was very low. The isolated 
Ca2+-binding proteins were applied to 
SDS-PAGE (Fig. 1). 
2.4.2. ^Ca-autoradiography 
Ca2* binding of the isolated Ca2+-
binding proteins was tested with 4'Ca 
autoradiography as described under 
math, and meth. Both calbindin-Da» 
from chicken intestine and from bovine 
kidney showed strong 45Ca binding after 
the proteins had been run on SDS-PA-
GE and transferred to a nitrocellulose 
sheet. However, parvalbumin and 
particular calmodulin showed weaker 
,5Ca binding. A possible explanation is 
that parvalbumin and calmodulin were 
not t ransferred effectively to 
nitrocellulose sheets. However,<5Ca 
autoradiography was not carried out in 
order to provide quantitative values, but 
mainly to demonstrate high affinity Ca2* 
binding of these proteins. All the 
isolated Ca2*-binding protein showed 
high affinity ^Ca binding (Fig. 2). 
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Fig. 1. SDS-PAGE of purified Ca2*-binding 
proteins according to Laemmli (52). (A): (1) 
mol. weight markers (2) 1 μg calbindin-D^, 
(3) 1 ßg calbindin-D* (B): (1) 1 ßg 
calbindin-Dja (2) 1 μg parvalbumin (3) 1 ßg 
calmodulin (4) mol. weigth markeis. 
i - i j · 
Fig. 2. '"Ca-autoradiography of purified Ca2*-
binding proteins according to Maruyama et 
al. (53). (1) 20 ßg bovine calbindin-D», (2) 
20 ßg chicken calbindin-D^, (3) 20 μg 
bovine calmodulin, (4) 20 μg chicken 
parvalbumin. 
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2.4.3. Mol. \Mh (kl)üi Isolation of Ca2*-ATPases 
I so l a t i on of e r y t h r o c y t e 
Ca2*-ATPase with calmodulin-affinity 
chromatography according to Niggli et 
al. (49) was a successful and easy 
method. With this method we isolated 
the Ca2+-ATPase from porcine, human 
and rabbit erythrocytes. Porcine and 
human erythrocyte Ca2+-ATPases 
consisted of a major polypeptide of 
about 138 kDa and a very minor 
polypeptide of a slightly lower molecular 
weight. However, rabbit erythrocyte 
C a 2 + - A T P a s e c o n t a i n e d b o t h 
polypeptides in more or less equal 
a m o u n t s ( F i g . 3 ) . T h e 
calmodulin-sepharose column could be 
used several times without any notable 
decrease in binding capacity. Attempts 
to isolate the plasma membrane 
Ca2+-ATPase from pig duodenal 
enterocytes with calmodulin-affinity 
chromatography failed, probably because of endogenous calmodulin that proved 
impossible to remove by EDTA. 
The sarcoplasmic reticulum Ca2+-ATPase 
with DEAE-chromatography in the presence of 
Ca2+-ATPase eluted at 120 mM KCl (Fig. 4) 
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Fig. 3. SDS-PAGE of purified eiythrocyte 
Ca2*-ATPases according to Laemmli (52). (1) 
2 μg porane Ca2+-ATPase, (2) 2 /ig human 
Ca2+-ATPase, (3) 2 μg rabbit Ca2*-ATPase. 
from rat skeletal muscle was isolated 
0.2 % (v/v) Triton X-100. Nearly pure 
Pfotaln (mq/ml) 
0.00 
МЫ. \Vlh. (kDa) ¡^¡i + 
97 4 —)Щ0 
66.2 —* 
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Fig 4. (A) Chromatography of solubihzed rat sarcoplasmic reticulum on DEAE-cellulose. Sarcoplasmic 
reticulum was solubihzed in 20 mM Tns-HCl, 1 MgCl^ 50 μΜ СаСІг, 200 mM manmtol, 1 mM DTT, 
0 2% (VA') Triton X-100 (pH 7.5) for 10 mm at 20 0C and centnfuged at 100,000 g for 30 mm. The 
supernatant was applied to the column. After the column was washed, a linear gradient (0-400 mM 
KCl) in the same buffer was applied. (B) SDS-PAGE on 10% (w/v) gels according to Laemmli (52). 
(1) 5 μg rat sarcoplasmic reticulum. (2) 5 μg pellet after solubilization and centnfugation of 
sarcoplasmic reticulum. (3) 5 μg purified Ca2*-ATPase. 
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2.4.4. Phosphorylation of membrane 
proteins 
The pattern of 32P incorporation 
into membrane proteins is shown in Fig. 
5. It is obvious that for both the 
erythrocyte and the sarcoplasmic 
reticulum Ca2*-ATPase, the presence of 
Ca2* is a necessity for phosphorylation. 
In the presence of 1 mM EGTA no or 
only a very weak phosphorylation 
occurred. Secondly it is shown that there 
is an opposite effect of La3* on the 
amount of phosphorylated intermediate 
between the two types of Ca2*-ATPases. 
The amount of phosphorylated 
intermediate is increased in erythrocyte 
membranes in the presence of 25 μΜ 
LaCl, whereas it is decreased under the 
same conditions in sarcoplasmic 
r e t i c u l u m m e m b r a n e s . " P 
phosphorylation of the H« fraction of rat 
duodenal enterocytes revealed the 
presence of two types of Ca2*-ATPases. 
Their molecular weights, the 
dependency of Ca2* for phosphorylation 
and the effect of La'* are all in 
agreement with the presence of both a 
plasma membrane- and a sarcoplasmic 
reticulum like Ca2*-ATPase. 
2.4.5. "'I-calmodulin binding 
125I-calmodulin overlay showed 
that only the erythrocyte Ca2*-ATPase 
and the plasma membrane Ca2*-ATPase 
of rat duodenal enterocytes bind 
calmodulin. It is shown that along the 
gradual purification of rat duodenal 
basolateral membranes the amount of 
125I-calmodulin binding and hence the 
amount of plasma membrane 
Ca;*-ATPase increased. Furthermore it 
is noteworthy to mention that in 
contrast to erythrocyte membranes, the 
rat duodenal membranes possessed 
more proteins other then the plasma 
membrane Ca2*-ATPase which bind 
calmodulin (Fig. 6). 
I 
L NVH( Kl I 
Fig. 5. Autoradiography of "P-labcllcd 
proteins. Phosphorylation in the presence of: 
1 mM EGTA (1),(4),(7) 50 μΜ C a a 2 (2),(5),(8) 50 μΜ СаС12 + 25 μΜ LaClj (3),(6),(9),(10). Rat intestinal duodenal 
protein: (1),(2),(3). Rat sarcoplasmic 
reticulum (7),(8),(9). Alkaline phosphatase 
(10). 
Ш 
IM Ml 
Fig. 6. Autoradiography of шІ-са1тск1и1іп 
labelled proteins. (1) rat erythrocytes (2) rat 
sarcoplasmic reticulum. Fractions obtained 
after isolation of rat duodenal basolateral 
membranes. See melhods.(3) Pt (4) S0 (5) P0 (6)HU 
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2.4.6. Reconstituted erythrocyte Ca^-ATPase 
Using the non-competitive ELISA for Ca2*-ATPase in which coated calmodulin 
served as the binding factor )r solubilized Ca2*-ATPase, it was possible to measure 
ng amounts of the enzyme (Fig. 7). This method could be used in our study since 
purified Ca2+-ATPase and the phosphatidylcholine/Ca2*-ATPase proteoliposomes were 
calmodulin free. In the reconstitution experiments the amount of incorporated 
Ca2+-ATPase ranged from 10 to 27 μg/ml proteoliposome mixture (Table 1). In all 
reconstitution experiments the "Ca uptake is low with respect to the amount of 
incorporated Ca2*-ATPase. The apparent turnover number is 0.8 ± 0.2 mole 
Ca2Vmole enzyme, mm in the absence and 2.2 ± 0.6 mole Ca27mole enzyme, min in 
the presence of 1 μΜ calmodulin. This low turnover is most likely due to instability of 
the enzyme and a low number of correctly orientated Ca2*-ATPase in closed 
liposomes. 
0.32 
Absorbance 492 nm Absorbance 492 nm 
10 20 30 40 50 
no Purified Ca'^ATPase 
6 10 15 
μΙ Vesicle suspension 
Fig. 7. Typical example of a non-competitive ELISA for calmodulin depleted Ca2*-ATPase. 100 ng 
calmodulin was coated to each well of an ELISA plate, followed by incubation with purified 
erythrocyte Ca2*-ATPase or solubilized test sample. Next the wells were incubated with anti-Ca2*-
ATPase, followed by incubation with peroxidase-labelled conjugate. Color was developed with 0-
phenyldiamine.(A) Calibration curve with purified porcine erythrocyte Ca2*-ATPase. (B) Amount of 
punfied porcine erythrocyte Ca!*-ATPase incorporated into phosphatidylcholine vesicles after 
reconstitution. 
Table 1. Reconstitution of erythrocyte C^-ATPase. 
Expenment no. 1 2 3 
A) μg Ca2+-ATPase/ml lyposome mixture: 10.0 26.7 22.4 
B) "Ca uptake (nmol/min. ml lyposome mixture) 
control: 0 08 009 0.14 
+ 1 μΜ calmodulin: 018 0.23 0.47 
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2.4.7. Immunology of Ca2*-binding proteins 
Antisera raised against the 
various Ca2*-binding proteins were 
tested for their specificity. See chapter 7 
and Fig. 8. All the antisera proved to be 
specific to their respective antigen. 
Against the Ca2+-binding proteins a 
competitive ELISA was developed. 
Typical examples are shown in Fig. 9 
A-Ε. In Table 2A the variation in the 
calibration curve and the detection limit 
for each competitive ELISA is listed. 
The detection limit was determined as 
the smallest amount of competitive 
antigen producing a statistically 
significant (P<0.05) reduction of the 
absorbance at 492 nM when compared 
to the absorbance value obtained 
without competing antigen. 
Immunological resemblance of 
Ca2*-binding proteins was tested with a 
non-competitive ELISA. In Table ЗА 
the obtained values are listed. Calbindin-D^ from respectively bovine, rabbit and 
chicken origin showed a high degree of immunological similarity. Also parvalbumin 
from rabbit muscle showed a high degree of similarity with parvalbumin from chicken 
muscle. In striking contrast we found that antiserum against bovine calbindin-D* 
cross-reacted only to a very minor extent with porcine calbindin-D,». We measured the 
amount of calbindin-DA in duodenal enterocytes from pigs suffering from an inherited 
disease in producing the active vitamin D metabolite l,25(OH)2D3 and healthy pigs. 
See also chapter 3. It turned out that enterocytes from rachitic pigs contained only 
42% of the amount of calbindin-D» found in healthy pigs. However, the absolute 
amounts were far below the values obtained by other investigators (Table 4). In all 
likelihood the antibodies raised against bovine calbindin-D« recognize porcine 
calbindin-D* to a minor extent. From these results we calculate a cross-reactivity 
between 0.1-0.4%. 
2.4.8. Immunology of Ca^-ATPases 
Antisera raised against porcine erythrocyte Ca2+-ATPase and rat sarcoplasmic 
reticulum Ca2*-ATPase were tested for their specificity. See chapter 3. All the antisera 
proved to be specific for their respective antigen. Competitive ELISA's were carried 
out in the presence of 0.1% Triton X-100 to prevent precipitation of the 
Ca2*-ATPases in solution. In chapter 3 and 8 competitive ELISA's are shown of 
respectively porcine and human erythrocyte Ca2*-ATPase and porcine sarcoplasmic 
reticulum Ca2*-ATPase. Detection limits and variations about the calibration curves 
are listed in Table 2B. With a non-competitive ELISA the immunological resemblance 
of the various Ca2*-ATPases were tested (Table 3B). Antiserum raised against porcine 
erythrocyte Ca2*-ATPase showed a very weak cross-reactivity with Ca2*-ATPases 
derived from human and rabbit erythrocytes. In contrast we found that antiserum 
Ы>.! - » 
t 
-12.7-* 
21.5 -• 
IJ.4-» 
Fig. 8. Western blot of calbindin-D^. 
Proteins were separated on SDS-PAGE 
according to Laemmli (52) and subsequently 
transferred to a nitrocellulose sheet. The 
sheet was incubated with anti-calbindin-D^ 
(1:400) as described in detail under Methods. 
(1) iMg purified rabbit calbindin-D^ (2) 25 
ßg rabbit kidney cortex cytosol. 
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against rat sarcoplasmic reticulum Ca2+-ATPase cross-reacted to a high degree with 
rabbit and porcine sarcoplasmic reticulum Ca2*-ATPases. 
Table 2. Competitive ELISA 's for Ca1*-binding proteins and C^-ATPases. 
Detection limit (ng/ml) Variation in the calibration curve (%) 
A) Ca2*-binding proteins 
Calbindin-Dja .bovine 88 7 6 
Calbindm-DÄ, bovine 18 6.0 
Calbmdin-D*, bovine " 5 10.3 
Calmodulin, bovine 29 13 4 
Parvalbumm, rabbitь n.d. 39.2 
B) Ca2*-ATPases 
Erythrocyte, human 226 9 0 
Sarc ret, porcinee 159 6 7 
' Following incubation with goat-anti-rabbit peroxidase-labelled conjugate, a second 
incubation was performed with rabbit peroxidase-anti-peroxidase (1:500) for two hours 
at 20 "С. 
" The variation in the calibration curve was detected along the straight part of the 
curve Commercial monoclonal antibodies against rabbit parvalbumm were used 
' As competitive antigen solubilized porcine sarcoplasmic reticulum was used. 
η d., not detectable. 
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Table 3. Immunological comparison among Ca2*-bindingproteins and among Ca2*-ATPases. 
A) Ca2*-binding proteins 
Calbindin-Dgt, bovine 
Calbindin-Dat, bovine 
Calbindin-Dja, chick 
Calbindin-D^, chick 
Calbindin-Dgt, bovine 
Calbindin-D^, rabbit 
Calbindin-DA, bovine 
Calbindin-D
№
 porcine 
Parvalbumin, rabbit 
Parvalbumin, chick 
antiserum 
anti-calbindin-D^, bovine 
anti-calbindin-Dja, chick 
anti-calbindin-D*, bovine 
anti-parvalbumin, rabbit 
cross-reacti 
100 
52 ±7 (4) 
36 ± 3 (4) 
100 
58 + 7 (3) 
68 ± 4 (3) 
100 
0.1-0.4 ' 
100 
54 ± 7 (4) 
B) Ca2+-ATPases 
Erythrocyte, porcine 
Erythrocyte, human 
Erythrocyte, rabbit 
Sarc. ret., rat 
Sarc. ret., rabbit 
sarc ret., porcine 
anti-erythrocyte, porcine 
anti-sarc, ret, rat 
100 
3.8 + 0.2 (3) 
1.2 ± 0.5 (3) 
100 
73 ± 7 (3) 
97 ± 22 (3) 
1
 See also table 4. 
Number of determinations in parenthesis. 
Table 4. Calbindin-D^ concentration in porcine enterocytes. 
μg calbindin-D%/g mucosa 
our results * cross-reactivity (%) 
Healthy pigs 
Rachitic pigs 
644-1902 
460-770 
2.1-2.6 
0.7-1.3 
0.11-0.40 
0.10-0.27 
' Calbindin-D% concentrations in pig enterocytes was measured with 
anti-bovine calbindin-D* 
* Measured by Dr. T.M. Murray, Dept. of Med., University of Toronto, Canada 
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1.50 
Absorbance 492 nm 
100 1000 
ng Calblndln-DjM 
Absorbance 492 nm 
0.70 
10 20 30 40 50 60 
ng Calblndln-D„ 
Absorbance 492 nm Absorbance 492 nm 
0.4 
2 3 
ng Calblndln-DM 
100 1000 
ng Calmodulin 
1.40 Absorbance 492nm 
500 1000 1500 2000 
ng Parvalbumln 
Fig. 9. Competitive ELISA's for Ca2*-binding proteins. 
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2.5. Discussion 
Calbindin-Dat from rabbit kidney was isolated following the same procedure as 
has been described for bovine kidney. The method is based upon Ca2*-dependent 
elution of the protein from an anion exchanger. The absence of Ca2* in the elution 
buffer decreases binding of calbindin-D» to DEAE-cellulose and hence elution of 
pure protein. We did not apply this method for the isolation of chicken intestinal 
calbindin-Da» since the method that we used proved to be successful. However, at 
relative low calbindin concentration the Ca2*-dependent elution is probably more 
suitable. 
Several efforts were done to isolate intestinal calbindin-D^ by means of anion 
exchange chromatography. Changing the pH and ionic strength of the buffer and 
using QAE instead of DEAE were all not successful in retaining the protein to the 
column. Finally, the use of an AG MP-1 column as described by Gleason & Lankford 
(46) seemed promising. The use of the macroporous ion exchanger AG MP-1 was 
suggested by the work of Wasserman (55), which demonstrated an interaction 
between lysolecithin and the intestinal calbindin-Da» of the chick. AG MP-1 possesses 
a similar quaternary ammonium functional group , and its highly cross-linked divinyl 
benzene matrix contains pores large enough to admit proteins. 
The isolation of calmodulin is based upon a decrease in hydrophobicity of the 
protein when Ca2+ is withdrawn from the medium. Bound calmodulin elutes from 
phenyl sepharose when EDTA is added. Pure calmodulin could be isolated in large 
quantities using the described hydrophobic interaction chromatography. 
Parvalbumin from chicken muscle could easily be isolated using the procedure 
described by Strehler et al. (47). The isolated Ca2*-binding protein were all pure and 
showed high affinity Ca2* binding. 
The isolation of erythrocyte Ca2*-ATPase by means of affinity chromatography 
with a calmodulin-sepharose-4B column was very successful. Pure erythrocyte 
Ca2*-ATPase could be isolated using a small column of about 1.5 ml. The column was 
used several times over a period of two years without a notable decrease in its 
capacity. It was possible to reconstitute the purified erythrocyte Ca2*-ATPase into 
phosphatidylcholine liposomes. However, the Ca2* transport capacity of reconstituted 
Ca2*-ATPase was very low compared to the native enzyme. A key factor here is the 
instability of the pump and its peculiar sensitivity to environmental factors (56) 
An affinity chromatography technique for sarcoplasmic reticulum Ca2*-ATPase is not 
available. However, the abundance of large amounts Ca2*-ATPase in sarcoplasmic 
reticulum and the binding to DEAE-cellulose in the presence of 0.2% Triton X-100 
enabled us to isolate this type of Ca2*-ATPase as well. The Ca2*-ATPases from 
erythrocyte and sarcoplasmic reticulum were characterized by SDS-PAGE, 32P 
phosphorylation and '"I-calmodulin binding. 
We found that the purified Ca2*-ATPases from porcine and human erythrocyte 
consisted of two polypeptides; a major band of about 138 kDa and a very minor band 
of a slightly lower molecular weight. However, rabbit erythrocyte Ca2*-ATPase 
contained both polypeptides in more or less equal amounts. This observation was 
confirmed at another laboratory (F. Wuytack, Dept. of Physiology, Univ. of Leuven, 
Belgium, personal communication). It is unlikely that the smaller polypeptide 
represents a proteolytic breakdown product of the Ca2*-ATPase since addition of 
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various protease inhibitors had no effect. The "'I-calmodulin overlay in Fig. 6 revealed 
also two bands of the Ca2*-ATPase in the same relative abundance as was found with 
SDS-PAGE in Fig. 3. It seems as if the rat intestinal Ca2+-ATPase (H0,S0 and P() has a 
slightly higher molecular weight compared to the erythrocyte Ca2*-ATPase and 
consists like the erythrocyte Ca2*-ATPase, of more than one polypeptide. In 1989 
Strehler et al. (57) demonstrated that the human erythrocyte contained two Ca2*-
ATPase isoforms; one with a molecular weight of 138 kDa and the other with a 
molecular weight of 134 kDa. Already in 1988 Shull & Greeb (58) demonstrated two 
isoforms of the plasma membrane CaI*-ATPase in rat brain. The polypeptides we 
demonstrated may represent the two isoforms . It might be possible that the presence 
of the Ca2*-ATPase isoforms is a common feature in the plasma membrane of several 
cell types. 
The developed competitive ELISA's were all reproducible and sensitive, 
perhaps with exception for parvalbumin. Further improvement of the detection limit 
could be achieved by a second incubation with peroxidase-anti-peroxidase, as was 
shown for calbindin-D*. A competitive ELISA for parvalbumin using polyclonal 
antibodies was for unknown reason impossible. However, a non-competitive ELISA 
could be carried out without problems. The competitive ELISA for parvalbumin in 
Table 10 E was performed with commercially available monoclonal antibodies. The 
calibration curve shows a non-competitive behaviour at concentrations below 100 ng 
competitive antigen (applied in 50 μΐ). 
We demonstrated the possibility to perform a competitive ELISA for 
membrane-bound proteins. It was necessary that the proteins were solubilized prior to 
application on ELISA plates. The presence of 0.1% Triton X-100 had no effect on the 
ELISA. 
Calbindin-D» from bovine, rabbit and chicken origin possessed a high degree 
of immunological similarity. In contrast, anti-bovine calbindin-D« cross-reacted to a 
very minor extent with porcine calbindin-D* as was already mentioned by Gross & 
Kumar (10). It has been demonstrated that calbindin-D
a
 from different species 
possessed a high degree of similarity in the primary amino acid composition. However, 
the primary structures of calbindin-D* from bovine, porcine and murine intestine 
show the same degree of similarity as was found for calbindin-Da, (10). Apparently, a 
high similarity in the primary amino acid composition of different proteins is not a 
guarantee for immunological cross-reaction. The same phenomenon was observed 
with erythrocyte Ca2*-ATPases. Anti-porcine erythrocyte CaI*-ATPase cross-reacted to 
a minor extent with Ca2+-ATPases from human and rabbit erythrocytes, in spite of 
highly conserved functional groups such as the ATP-binding site, the phosphorylation 
site and the calmodulin binding site (57-59). The lack of immunological cross-reactivity 
of erythrocyte Ca2*-ATPases was not surprising, since Verma et al. (60) already 
demonstrated a poor cross-reactivity of rat and rabbit erythrocyte Ca2*-ATPase with 
anti-human erythrocyte Ca2*-ATPase. In contrast, a high immunological cross-reaction 
between sarcoplasmic reticulum Ca2*-ATPases from different species was noticed. 
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Chapter 3 
Quantification of Ca2+-ATPases in porcine 
duodenum. 
Effects of 1,25(ОН)2Вз deficiency 
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3.1. Summary 
Previous studies have identified a calmodulin-stimulated ATP-dependent Ca2*-
pump as the major Ca2* efflux pathway in enterocytes. Here, we developed methods 
to quantify the number of Ca2* pumps in basolateral and intracellular membranes 
from porcine duodenum. By the use of a pig strain with a genetic defect in renal la-
hydroxylase, we were able to investigate the influence of l,25(OH)2D,-deficiency on 
the number of Ca2*-ATPases in porcine duodenum. The amount of Ca2*-ATPase in 
isolated basolateral membranes was 5.5 ± 0.7 Mg/mg protein, while the Y,,,, of ATP-
dependent Ca2* transport into inside-out resealed basolateral membrane vesicles was 
2.6 ± 0.4 nmole/mg protein, min. From these data we estimated roughly — 95 · 103 
plasma membrane Ca2* pump sites per enterocyte. In addition, the amount of 
intracellular Ca2*-ATPase in microsomal fractions was 0.41 ± 0.02 ßg/mg protein. 
Comparison of these parameters between control and rachitic animals showed that 
Ca2* pump capacities in both basolateral membranes and microsomal fractions of 
porcine duodenum are not influenced by 1,25(ОН)2Оз deficiency. In conclusion, 
stimulatory effects of 1,25(ОН)2Оз on intestinal Ca2* transport most likely result from 
specific effects on apical influx and facilitation of cytosolic Ca2* diffusion by Ca2*-
binding proteins and not from an increase in Ca2* pumping capacity in basolateral 
membranes. 
3.2. Introduction 
Net Ca2* absorption in the intestine is the result of passive and active transport 
mechanisms. Passive Ca2* absorption and/or secretion via the paracellular pathway 
occurs along the whole small intestine, while active transcellular absorption is 
restricted to the proximal small intestine (1). Active absorption is dependent on the 
level of circulating l,25(OH)2Dj and consists of Ca2* influx via the brush border, 
diffusion of Ca2* through the cytosol and active extrusion via the basolateral 
membrane. Studies of Ca2* uptake into inside-out-orientated basolateral membrane 
vesicles have demonstrated a calmodulin-stimulated ATP-dependent Ca2* pump as the 
predominant Ca2* transport system in mammalian small intestine (2-6). Since Ca2*-
ATPases comprise only a minor fraction of the plasma membrane proteins, the 
identification and quantification of Ca2* pumps in epithelial cells is difficult. For 
example, (i) Ca2*-dependent ATPase activities were markedly different from ATP-
driven Ca2* uptake rates in basolateral membrane vesicles (7,8,9), (ii) ATP-dependent 
Ca2* uptake activity is only present in resealed, inside-out vesicles which constitute a 
minor fraction of basolateral membrane preparations, (iii) ATP-driven Ca2* uptake 
activity in duodenal basolateral vesicles of vitamin D-deficient rats may be inactivated 
during isolation of enterocytes (10). 
Besides a calmodulin-dependent Ca2* pump in the basolateral membrane, 
enterocytes contain intracellular Ca2* pumps with similar properties as the one from 
sarcoplasmic reticulum (11,12,13). Quantification of intracellular Ca2*-ATPase in 
enterocytes proved difficult for similar reasons as given above (14). 
In the present study, we developed competitive ELISA's for both Ca2*-ATPases 
and were able to quantify the number of Ca2* pumps in porcine duodenal epithelium. 
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By the use of piglets with pseudo vitamin D-deficiency rickets type I, a pig strain with 
an inherited defect in renal la-hydroxylase (15), the influence of l,25(OH)2Dj-
deficiency on the number of Ca2* pumps was studied. 
3.3. Materials and methods 
3.3.1. Animals 
Eight homozygote piglets with pseudo vitamin D-deficiency rickets, type 1 
('Hannover Pig Strain') and 7 clinically normal heterozygote litter mates were used. 
The piglets belonged to four different litters, and were 50-60 days old, with body 
weights between 3.8 and 13.4 kg. The plasma calcium levels in control animals were 
between 2.68 and 3.27 mM, and in the rachitic piglets between 1.28 and 2.48 Mm. 
The activity of plasma alkaline phosphatase ranged from 159 to 334 U/1 (control) and 
from 893 to 1907 U/1 (rachitic). After a weaning period to an age of 30-40 days, the 
piglets were fed a diet containing 0.8% calcium, 0.6% phosphorus and 37.5 μg (1500 
U) vitamin D/kg. The animals were killed by stunning and bled from the dissected 
carotid arteries. Immediately after bleeding, the duodenum (proximal 20-30 cm of the 
small intestine) was removed, flushed with cold isotonic saline and frozen in liquid М
г
. 
The frozen intestine were stored at -80 "C. 
3.3.2. Preparation of basolateral membranes 
In each experiment, membranes were prepared simultaneously from a rachitic 
and from a control piglet. Basolateral membranes were prepared from mucosal 
scrapings, according to Ghijsen et al. (8). About 0.6-0.7 g wet weight of mucosal 
scrapings were vortexed with 30 ml saline and centrifuged at 200 χ g for 10 min. The 
pellet was homogenized for 1 min with a polytron (Braun) in 15 ml of 25 Mm NaCl, 1 
Mm Hepes-Tris (Ph 8.0), diluted with the same medium to 50 ml and centrifuged at 
600 χ g for 10 min. The supernatant was centrifuged at 100,000 χ g for 20 min. The 
resulting pellet was resuspended in about 6 ml medium containing 250 Mm sucrose, 5 
Mm MgClj and 10 Mm Hepes-Tris (Ph 7.4) in a Dounce apparatus by 100 strokes 
with a loose-fitting pestle. The suspension was brought to 40% sorbitol concentration 
by the addition of 60% (w/v) sorbitol solution (containing 10 Mm Hepes-Tris, Ph 7.4) 
and centrifuged at 200,000 χ g for 1.5 h in a swing-out rotor. The membranes 
positioned between the 40% sucrose layer and the overlay buffer were removed with 
a syringe, mixed with the final uptake medium (150 Mm KCl, 1 Mm MgClj, 20 Mm 
Hepes-Tris, Ph 7.4) and centrifuged at 100,000 χ g for 20 min. The final pellet was 
resuspended in uptake medium. All steps of the preparation were carried out at 0-4 
"C with 1 mM dithiothreitol and 0.4 Mm PMSF added to the homogenization and 
sorbitol buffers. 
333. Preparation of microsomal membranes 
To prepare a microsomal fraction, the scrapings were vortexed with saline and 
centrifuged as described above. The pellets were homogenized in a medium 
containing 250 Mm sucrose, 0.5 Mm EGTA, 3 Mm Hepes-KOH, 1 Mm dithiothreitol 
and 0.4 Mm PMSF (Ph 7.4). The suspension was homogenized in a Dounce 
apparatus, first with 4-6 strokes of a loose-fitting pestle, then with 10-15 strokes of a 
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tight-fitting pestle. After centrifugation at 10,000 χ g for 10 min, the supernatant was 
centrifuged at 100,000 χ g for 60 min and the pellet was resuspended in uptake 
medium. 
33.4. Determination of Ca1* uptake in the vesicles 
Ca2* uptake studies were done at 37 0C by a rapid filtration technique as 
described previously (4,12). The uptake medium for basolateral membranes contained 
150 Mm Kcl, 0.5 Mm EGTA, 0.5 Mm HEEDTA, 20 Mm Hepes-Tris adjusted to Ph 
7.2. The free Mg2* concentration was adjusted to 1.5 Mm by adding MgCl2 , and the 
free Ca2* between 0.01-5.0 μΜ by adding CaClj in amounts calculated according to a 
routine described by van Heeswijk et al. (16). ATP was added as Tris-ATP to a final 
concentration of 3 Mm. The uptake medium for microsomes contained 120 Mm Kcl, 
20 Mm Na oxalate when indicated, 1.2 Mm Kf^HPO«, 5 Mm pyruvate, 5 Mm 
succinate, 0.5 Mm EGTA, 0.5 Mm HEEDTA, 20 Mm Hepes-KOH, 0.05% (w/v) BSA, 
10 Mm creatinine phosphate and 10 U/ml creatinine kinase (Ph 7.2). The free Mg2* 
was adjusted to 1.5 Mm, the free Ca2* to 1 дМ, and ATP was added as Mg-ATP to a 
final concentration of 10 Mm. 
33.5. шІ-са1пнхііі1іп overlay 
Membrane protein was applied to a 7.5-15% (w/v) gradient Polyacrylamide gel 
according to Laemmli et al. (17). The proteins were transferred to nitrocellulose 
sheets and blocked with excess BSA. Subsequently, the sheets were incubated for 45 
min in a medium containing 20 mM Tris-Hcl, 150 Mm NaCl, 0.1 Mm CaCl
a
 0.5% 
(w/v) BSA (Ph 7.4) and about 0.15 nmole 125I-calmodulin (spec. act. 0.74 MBq/nmole). 
After washing three times, the blot was dried, marked with radioactive ink, and 
exposed to Kodak X-Omat film at -80 °C. The radioactive band corresponding to the 
Ca2* pump was cut out and counted in a multigamma counter (LKB). Calmodulin was 
isolated from bovine brain according to Gopalakrishna and Anderson (18). lodination 
of calmodulin was performed as described by Bolton and Hunter (19). 
33.6. Competitive ELISA's for Ca^-ATPases 
Ca2*-ATPase from pig erythrocytes was isolated according to Niggli et al. (20). 
Ca2*-ATPase from rat skeletal muscle sarcoplasmic reticulum was isolated with 
DEAE-chromatography after solubilization of membrane proteins, essentially as 
described by Heilman (21). See chapter 2. 
3.3.7. Western blotting 
See chapter 2. 
3.3.8. Enzyme assay's 
(Na*-K*)-ATPase, succinic acid dehydrogenase (SDH), alkaline phosphatase 
(AP) and NADPH-cytochrome-C-reductase activities were determined, as previously 
described (12). The orientation of the basolateral vesicles was determined by 
measuring the (Na*-K*)-ATPase activity in the absence and presence of 0.5 ßg 
digitonin per mg protein and 0.1 Mm ouabain for 15 min at 37 "С. Medium containing 
digitonin gives the total (Na*-K+)-ATPase activity. (Na*-K*)-ATPase in inside-out 
orientated vesicles is not ouabain-sensitive within short incubation periods (up to 15 
min), since ouabain penetration into the vesicle is slow. The basolateral membrane 
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preparation contains 15 ± 3% (n=4) inside-out resealed vesicles. Protein was 
determined with the Coomassie Blue method (Bio-Rad) in the presence of 0.1% (v/v) 
Triton X-lOO, using bovine gamma-globulin as standard. 
Data are presented as the mean ± S.E. and statistical significance was tested 
using Student's t-tests. 
3.3.9. Chemicals 
EGTA, NTA, HEEDTA, Tris-ATP, Mg-ATP, PMSF, ß-glycero-phosphate and 
peroxidase-labelled goat anti rabbit IgG (H&L) were obtained from Sigma (St.Louis). 
"CaClj and 125I were purchased from New England Nuclear (Dreieich, Germany), [32P-
-]ATP from Radiochemical Center (Amersham), ruthenium red from Merck 
(Darmstadt, Germany), and Na*-orthovanadate from ICN (Plain View, New York). 
Dithiothreitol, calcium ionophore A23187 and calf intestinal alkaline phosphatase 
were purchased from Boehringer (Mannheim, Germany). All other chemicals were of 
the purest grade. 
3.4. Results 
3.4.1. Immunology and calmodulin binding 
Basolateral membrane vesicles from pig enterocytes were purified 5-fold in 
(Na*-K*)-ATPase activity. The microsomal vesicles were purified 3-fold with respect 
to NADPH-cytochrome-C-reductase. No differences in purification factors between 
duodenal preparations from rachitic and control piglets were observed. (Table 1) 
Although Ca2+-ATPase in basolateral membranes is calmodulin-dependent, 
attempts to purify this Ca2+ pump using calmodulin-affinity chromatography were 
unsuccessful. Calmodulin depletion of the membrane fraction before solubilization is a 
prerequisite for calmodulin-affinity chromatography, but the abundantly-present, and 
tightly-bound calmodulin in intestinal membrane fractions could not be removed with 
methods used to deplete Ca2*-ATPase from erythrocytes or heart plasmalemma 
(5,20). Since purification of basolateral Ca2*-ATPase was not possible, an indirect 
method for quantifying this pump was developed. 
Firstly, polyclonal antibodies were raised against the purified Ca2*-ATPase from pig 
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Table 1. Enrichment factors for marker enzymes m basolateral and microsomal membranes from control 
and rachitic piglets 
Basolateral 
control 
rachitic 
Microsomal 
control 
rachitic 
Na\K+.ATPase 
4.9 ± 0.6 
5.7 ± 0.5 
1.5 ± 0.3 
1.3 ± 0.2 
Succinate 
dehydrogenase 
1.0 ± 0.1 
0.8 ± 0.2 
0.3 ± 0.1 
0.4 ± 0.1 
Alkaline 
phosphatase 
2.6 ± 0.4 
2.4 ± 0.4 
1.3 ± 0.3 
1.5 ± 0.4 
NADPH-cyt.-c 
reductase 
1.6 ± 0.3 
1.3 ± 0.2 
3.5 ± 0.6 
3.0 ± 0.5 
Values are the means ± S.E. for five animals. Control and rachitic animals preparations are not 
significantly different (all Ρ values >0.05). 
A В 
K D «MW·» kD 
97 — 97 ^ 
66 - ^ 66 -^ 
4 2 - ^ 42 -
31 ^ 
31 -*• 22 -^ 
2 2 — 1 2 3 4 5 
1 2 3 
Fig. 1. Western blots of antisera against porcine erythrocyte Caz*-ATPase (A) and rat sarcoplasmic 
reticulum Ca2+-ATPase (B). (A) Lane 1: 1 ^g purified porcine erythrocyte Ca2+-ATPase; lane 2: 25 ßg 
porcine erythrocyte ghost; lane 3: 1 ßg purified porcine sarcoplasmic reticulum Caz*-ATPase. The blots 
were incubated with 300x diluted antiserum against purified porcine erythrocyte Ca2*-ATPase. (B) 
Lane 1: 1 μg purified porcine erythrocyte Ca2*-ATPase; lane 2: 1 ßg purified porcine sarcoplasmic 
reticulum Ca2*-ATPase; lane 3: 1 μg purified rabbit sarcoplasmic reticulum Ca2*-ATPase; lane 4: 1 μg 
purified rat sarcoplasmic reticulum Ca2*-ATPase; lane 5: 2 μg purified rabbit renal (Na*,K*)-ATPase. 
The blots were incubated with 750x diluted antiserum against purified rat sarcoplasmic reticulum Ca2+-
ATPase. 
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erythrocyte membranes and from rat sarcoplasmic reticulum. Both antibodies were 
specific for their own antigen illustrated in Figs. 1 A & В by means of Western 
blotting. 
Using a competitive ELISA, it was shown that the antibodies against pig 
erythrocyte Ca2*-ATPase did not recognize the intestinal plasma membrane Ca2*-
ATPase (Figs. 2 Α,Β). In contrast, antibodies against rat sarcoplasmic reticulum Ca2*-
ATPase exhibited good cross-reactivity with intestinal microsomal Ca2*-ATPases (Figs. 
3A3). 
Absorbance 492nm Abeorbance 492nm 
0.20 
200 400 600 SO 80 
ng Protein M0 Protein 
Fig. 2. (A) Competitive ELISA for purified porcine erythrocyte Ca2*-ATPase. Each well was coated 
with 50 ng purified porcine erythrocyte Ca2*-ATPase (see Methods for further details). (B) 
Competitive ELISA: Competition between 50 ng punfied porane erythrocyte Ca2*-ATPase and varying 
amounts of erythrocyte ghost (open symbols) or basolateral membranes from porcine duodenum 
epithelium (closed symbols) (see Methods for further details). 
Abeorbance 492nm 1.00 Absorbance 492nm 
Fig. 3. (A) Competitive ELISA for purified rat sarcoplasmic reticulum Ca2*-ATPase. Each well was 
coated with 50 ng purified Ca2*-ATPase (see Methods for further details). (B) Competitive ELISA: 
competition between 50 ng purified rat sarcoplasmic reticulum Cau-ATPase and varying amounts of 
microsome membranes from porcine duodenum (see Methods for further details). 
Secondly, with the 125I-calmodulin overlay technique, a quantitative relationship 
between the amount of ghost protein or intestinal membrane protein and the 
47 
radioactivity on blots could be obtained. (Fig. 4) Hence, the amount of Ca2*-ATPase 
in pig intestinal basolateral membranes can be expressed in equivalent pig ghosts. 
Using the competitive ELISA for pig ghost Ca2*-ATPase, the equivalent pig ghost can 
then be converted into the actual amount of Ca2*-ATPase per mg basolateral 
membrane protein. The results of the 125I-calmoduIin overlay technique and the 
competitive ELISA for the basolateral Ca2*-ATPase for control and for rachitic piglets 
are presented in Table 2. No differences between rachitic and control duodena were 
observed. The results of the competitive ELISA for sarcoplasmic reticulum Ca2*-
ATPase in the microsomal preparation are given in Table 3, and again, there was no 
difference between control and rachitic animals. 
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Fig. 4. Calibration curve for the 125I-calmodulin overlay technique. Porcine red blood cell ghosts is 
subjected to SDS-PAGE in increasing amounts and subsequently blotted onto nitrocellulose paper (x-
axis). After incubation with '"i-calmodulin and after washing , bound '"(-calmodulin is counted (y-
axis). Linear regression yields y= 2.67x (r= 0.99). 
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Table 2. Quantification of Ca2*-ATPase m basolateral membranes from 
porcine duodenum 
Control Rachitic 
125I-calmo<lulm bound 
(cpin/50 Mg protein) 426 ± 56 (5) 422 ± 50 (5) 
Pig ghosts equivalents/mg protein 3 2 ± 0.4 3.2 ± 0.4 
ßg Ca2*-ATPase/mg protein 5.5 ± 0.7 5.5 ± 0.6 
ATP-dependent ^Ca uptake 
(nmol Ca2*/min. mg prot.) Z6 ± 0.4 (5) 3.2 ± 0.4 (6) 
100 ßg pig ghosts protein binds 267 cpm шІ-са1тск1иІіп (Fig. 4). Pig 
ghosts contains 1.73 ± 0.06 ßg Cau-ATPase/mg protein (Fig. 2, n=3). 
cpm 12SI-caImodulin bound to blois were determined in triplicate for 
each intestine. ATP-dependent "Ca uptake was measured for 1 min at 
1 μΜ free Ca2* (37 °C) and corrected for ATP-mdependent uptake. 
Values are the means ± S.E. with the number of experiments in 
parenthesis. Control and rachitic animals are not significantly 
different, Ρ values > 0.05. 
Table 3. Quantification of intracellular Cd**-ATPase in porcine duodenum 
Control Rachitic 
ßg Ca2*-ATPase/mg protein 0.41 ± 0 02 (5) 0.36 ± 0.04 (5) 
ATP-dependent "Ca uptake 
(nmol Ca2*/ min. mg prot.) 1.2 ± 0.2 (5) 1 4 ± 0.3 (4) 
ßg Ca2*-ATPase/ mg protein was measured as shown in Figs. 3 A and B. 
ATP-dependent "Ca uptake was measured over 10 mm at 37 °C in the 
presence of 20 mM oxalate and corrected for ATP-independent uptake. 
Values are the means ± S.E. with the number of experiments in 
Parenthesis. Ρ values >0.05. 
3.4.2. ATP-dependent CaI+ uptake 
The ATP-dependent Ca2* uptake in pig duodenal basolateral membrane 
vesicles is shown in Fig. 5. Addition of the Ca2*-ionophore A23187 to vesicles which 
had reached steady-state Ca2* uptake resulted in the release of accumulated "Ca. 
ATP-dependent Ca2* uptake in pig intestinal microsomal membranes is stimulated in 
the presence of 20 Mm oxalate (Fig. 6), which is typical for endoplasmic reticulum 
membranes (11,12,14). The kinetics of ATP-dependent Ca2* uptake in basolateral 
membranes were determined in 3 control and 3 rachitic duodena. The K„ values 
(mean ± S.E.) in control and rachitic preparations were 68 ± 15 and 55 ± 12 Nm 
Ca2*, respectively. The V,,^ , values are given in Table 2. In microsomal preparations, 
ATP-dependent Ca2+ uptake was measured in the presence of oxalate and the 
activities are given in Table 3. There were no statistically significant differences in 
Ca2* transport rates between control and rachitic preparations. 
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Ca2* uptake (nmol/mg protein) 
3 α 
20 30 
Time (min) 
Fig. S. ATP-dependent Ca2* uptake in basolateral membranes from porcine duodenum. Timer course 
of "Ca uptake in the absence (open circles) and presence of ATP (closed circles). ATP + A23187 after 
10 min (squares). "Ca uptake was measured at 1 μΜ free Ca2* and 37 °C. For further details see 
methods. 
Ca2* uptake (nmol/mg protein) 
6 8 10 12 
Time (min) 
Fig. 6. ATP-dependent Ca2* uptake in microsomes from porcine duodenum. Time course of "Ca 
uptake in the presence of ATP + 0.1 mM vanadate (open circles), in the presence of ATP (closed 
circles) and in the presence of ATP + 20 mM oxalate (squares). "Ca was measured at 1 μΜ free Ca2* 
and 37 "C. For further details see methods. 
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3.5. Discussion 
To study effects of 1,25(ОН)2оз on intestinal Ca2* absorption, vitamin D-
deficient animals are required. So far, this has been achieved with rats or chicks raised 
on vitamin D-deficient diets, while being housed in dark rooms. The advantage of 
using piglets with pseudo vitamin D-deficiency rickets type I is that no special 
conditions are required to obtain rachitic controls, since the low levels of 1,25(ОН)2Оз 
are caused by lack of renal 1 α-hydroxylase activity. Previously, Ghijsen and Van Os 
(22) showed that in vitamin D-deficient rats the activity of the plasma membrane Ca2+ 
pump was reduced. However, this reduction was not due to a lack of l,25(OH)2Dj, but 
was shown to be induced by inactivation of Ca2*-ATPase during enterocyte isolation 
procedures (23). Differences in fatty acid composition in the sphingomyelin fraction of 
basolaterai membranes, induced by vitamin D-deficient diets, were most likely 
responsible for this instability of the basolaterai membrane Ca2* pump (24). In the 
present study, porcine duodenum proved a more convenient model, since enterocyte 
isolation procedures did not reduce basolaterai membrane Ca2* pump activity in 
1,25(ОН)А- deficiency. 
The present study confirms that vitamin D-deficiency does not affect Ca2*-
ATPase activities in duodenum when this activity is measured as the ATP-dependent 
"Ca uptake in basolaterai membrane vesicles. However, using competitive ELISA's 
and шІ-са1тоаи1іп binding, our work has now allowed the determination of the 
number of pump sites and has been able to show that pump density was not 
influenced by vitamin D-deficiency. 
The present results imply that the efflux of Ca2* across the basolaterai 
membrane is not the rate-limiting step in transcellular Ca2* transport. It is known, 
however, that 1,25(ОН)2Оз increases Ca2*-influx across the brush border and the 
amount of са1Ьіпаіп-О
ж
 in the cytosol (25). Considering the high calbindin 
concentration in the duodenal enterocyte, it is anticipated that calbindin markedly 
enhances the diffusional flux of Ca2* through the cytosol (25,26). Consequently, in the 
presence of a sufficient pump capacity in the basolaterai membrane, there would be 
no need to increase the number of Ca2* pumps. 
The present study allows the calculation of several parameters relevant to 
transcellular Ca2* transport in the duodenum, such as the number of Ca2* pump 
molecules per enterocyte, the turnover number of intestinal Ca2*-ATPase and the 
maximum Ca2* absorption rate per cm2 of tissue. Assuming 10" cells/cm2 in pig as in 
rat duodenum (27), of which roughly 50% are involved in active Ca2* absorption since 
the lower villus and crypt regions do not absorb Ca2* (4,25,28), and assuming that 1 
cm
2
 of pig duodenum equals 2 mg cell protein as in the rat (25), we calculate — 95.103 
plasma membrane Ca2* pump sites/enterocyte. 
The turnover number for the basolaterai Ca2* pump can be calculated by 
combining the data in Table 2. A V,^ , value of 3 nmole Ca2*/min. mg in membrane 
vesicles of which only 15% are resealed inside-out leads to a turnover number of 
roughly —500 Ca2* ions/pump site per min at 37 °C. This is a factor of 2 lower than 
the turnover number reported for the erythrocyte Ca2*-ATPase (29). From the pump 
density and the turnover number, we estimate that under V,^ . conditions the 
basolaterai Ca2*-pump can remove Ca2* from the cells with a rate of roughly ~ 500 
nmole Ca2*/h.cm2 duodenum. Realizing that porcine duodenal transcellular Ca2*-
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transport does not exceed 70 nmole Ca2+/h.cm2 (Kaune, unpublished observation), 
there is ample Ca2* pump capacity to prevent the enterocyte from being flooded with 
Ca2* entering the cells via the brush border membrane, under the influence of 
l,25(OH)2Dj. Although the above calculations provide physiologically realistic values 
they are based on several assumptions, hence its uncertainty has to be acknowledged. 
The competitive ELISA developed in this study for porcine erythrocyte Ca2*-ATPase 
reached a similar sensitivity as the previously-reported competitive radioimmunoassay 
for purified human erythrocyte Ca2*-ATPase (30). We have shown that the 
combination of a competitive ELISA and the 125I-calmodulin overlay technique 
provides a sensitive assay for quantifying plasma membrane Ca2*-ATPase in epithelial 
tissues. Recently, Borke et al. (31,32) described a monoclonal antibody, 5F10, raised 
against the human erythrocyte Ca2* pump, which binds to a Ca2* pump epitope in rat 
kidney and intestine. We have produced 6 monoclonal antibodies against porcine 
erythrocyte Ca2*-ATPase, but no cross-reactivity with other tissues could be observed. 
The intracellular Ca2*-ATPase in porcine duodenum exhibited a good cross-reactivity 
with anti-rat skeletal muscle sarcoplasmic reticulum Ca2*-ATPase. This was 
anticipated since anti-rabbit SR Ca2*-ATPase sera have been shown to exhibit good 
cross-reactivity with other tissues, even among different species (33,34). The data in 
Table 3 demonstrate clearly that the Ca2*-ATPase activity in enterocyte endoplasmic 
reticulum is of several orders of magnitude less than that in skeletal muscle cells (35). 
There also appears to be more Ca2+-ATPase activity in the plasma membrane than in 
intracellular membranes in porcine duodenal enterocytes, which is similar to the 
situation in rat enterocytes and rat kidney cortex (14). 
In conclusion, we found that the vitamin D status of the animal is not reflected 
in Ca2* pump capacities in the enterocyte. Therefore, the stimulatory effect of 
1 ,25(OH)ID, on intestinal Ca2* transport must be due to specific effects on brush 
border entry and on facilitation of Ca2* diffusion, mediated by Ca2*-binding proteins, 
through the cytosol. 
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4.1 Summary 
Free cytosolic Ca2* concentration is an important regulator in many cellular 
processes. The cytosolic Ca2* concentration in intestinal and renal epithelial cells is 
regulated by a concerted action of Ca2* transport systems. These Ca2* transport 
systems were studied in intestinal and renal cortex cells with emphasis on their 
transport capacities and Ca2* affinities. ATP-dependent Ca2* transport was studied in 
isolated plasma membranes, microsomes and mitochondria. For both epithelial cell 
types it is clear that the Ca2* pumps in plasma membranes and in the non­
mitochondrial intracellular store have almost identical capacities. Since the affinities 
for Ca2* are also identical, Κ„~0.1 μΜ, both systems play an important role in 
maintaining cytosolic Ca2* around a resting value of 0.1 μΜ. From our analysis it is 
clear that mitochondria have no role in maintaining a low cytosolic Ca2* concentration 
since they start to accumulate Ca2* at 0.3 μΜ. The Ca2* transport systems were also 
studied in permeabilized cells and were found to be consistent with the values 
obtained with isolated organelles. Only in isolated renal microsomes the Ca2* 
transport capacity was higher than in permeabilized cells. Furthermore, the effect of 
pH and temperature on Ca2* transport capacities was studied. 
4.2 Introduction 
Intracellular Ca2* concentration is maintained at low resting values around 107 
M. Various cellular processes are triggered by fluctuations in cytosolic Ca2* 
concentrations, brought about by receptor-activation on the cell surface. 
Neurohumoral substances induce a rapid but transient rise in cytosolic Ca2* either by 
Ca2* influx via receptor-operated Ca2* channels in the basolateral membrane and/or 
via Ca2* release from intracellular stores whose pathway is activated by cleavage of 
phosphatidylinositol 4,5- bisphosphate (1,2). Restoration of intracellular Ca2* back to 
the resting level of 10'7 M, is achieved by intracellular storage of Ca2* and/or extrusion 
of Ca2* out of the cell (3). Like other cells, intestinal and renal cells maintain a low 
free Ca2* concentration and regulate cellular processes by fluctuations in the cytosolic 
Ca2* concentration. Unlike other cells, the proximal small intestine enterocytes and 
distal convoluted tubule cells are specialized in transporting large amounts of Ca2+ 
transcellular. High concentrations of calbindins, present in these cells, induce rapid 
diffusion of Ca2* through the cytosol without increasing the cytosolic free Ca2* 
concentration (4,5). In this study, the active Ca2* transport of plasma membrane 
vesicles, microsomes and mitochondria have been studied in small intestine and renal 
cortex. The relative importance of these Ca2* transport systems in Ca2* homeostasis 
will be discussed. 
4.3. Materials and methods 
4.3.1. Isolation and permeabflization of villus enterocytes 
Male Wistar rats (170-200 g) were killed by cervical dislocation. The small 
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intestine was removed and rinsed with ice-cold 150 mM NaCl (pH 7.4), containing 1 
mM DTT. Villus cells were isolated by vibration followed by incubation with 
hyaluronidase as described in detail (6). The plasma membranes of isolated enterocy-
tes were permeabilized with saponin (30 Mg/ml). A 10 min incubation at 25 °C yielded 
80% trypan blue leaky cells (6). 
4.3.2. Isolation and permeabflization of renal cortex cells 
Cells from rat renal cortex were isolated according to a method described by 
Thévenod et al. (7). We found that cell isolation was greatly improved when, in 
addition to 1600 U collagenase, 1 mg/ml hyaluronidase was added. Cells were 
permeabilized by saponin treatment (20 pg/ml) during 15 min at 30 "C. About 60% of 
the cells became leaky based upon trypan blue exclusion. 
4.3J. Basolateral membrane isolation from small intestine and kidney 
Basolateral membrane isolation procedures have been described in detail (8,9). 
The purification factors for the basolateral membrane marker (Na*,K*)-ATPase were 
approx. 10-fold and approx. 30-fold for BLM vesicles from small intestine and renal 
cortex, respectively. The percentages of inside-out resealed BLM vesicles were 25% 
and 10% respectively for intestinal and renal preparations (8,9). 
4.3.4. Isolation of mitochondria and microsomes 
Mitochondria from rat renal cortex were isolated according to Shaw et al. (10). 
Mitochondria from rat small intestine were isolated according to Vercesi et al. (11). 
The enrichment of succinic dehydrogenase in renal and intestinal mitochondrial 
preparations was 2.3 and 3.5 times compared to the homogenate. The supernatant of 
the mitochondrial sedimentation step was spun at 100,000 g for 60 min and in the 
microsomal pellet NADPH-cytochrome-c-reductase was enriched 3.2 and 2.4 times 
with respect to the homogenate of renal and intestinal cells, respectively. 
43 J . *Ca uptake experiments 
ATP-dependent ''Ca uptake by permeabilized cells or by mitochondria, 
microsomes and basolateral membrane vesicles was studied by a rapid filtration 
technique in media which have been described before in detail (6,9). The free Mg2* 
concentration was 1.45 mM and the free Ca2* concentration was varied between 0.025 
and 5.0 μΜ, using EGTA, HEEDTA and NTA as Ca2* ligands (9). 
4.4. Results and discussion 
4.4.1. Plasma membranes 
ATP-dependent Ca2* transport systems in renal and intestinal plasma 
membranes have been well characterized (3). They are similar to the erythrocyte Ca2* 
pump and exhibit the following characteristics: Ca2* transport and (Ca2*,Mg2*)-ATPase 
activity with high affinity for Ca2*, hydroxylamine sensitive phosphorylated 
intermediate around 140 kDa on SDS gels, vanadate sensitive and Ca2*-calmodulin 
regulated. In Table 1 the transport capacities of Ca2*-pumping ATP-ases are 
summarized. The transport data are uncorrected for membrane sidedness, while the 
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(Ca2*,Mg2*)-ATPase activities are determined in detergent treated membranes. After 
corrections for these factors an apparent stoichiometry of about 1 Ca2* pumped per 
ATP splitted is obtained. 
NaVCa2* exchange activity is also present in epithelial plasma membranes but 
the activity seems to be minor when the transport assay is performed with isolated 
membrane vesicles (Table 1). Recent evidence suggests that NaVCa2* exchange 
activity may be under control of cell volume regulatoiy processes. In view of the 
problem to maintain steep Ca2* gradients across the small membrane vesicles, the 
properties of NaVCa2* exchange should be studied in intact cells. 
Table 1. Cef* transport activities in isolated basolateral membranes (at °C) from small intestine and 
kidney cortex. 
Duod. villus 
Ileum villus 
Duod. crypt 
Kidney cortex 
ATP-dependent 
Ca2* transpon 
10.5 
5.8 
0.9 
7.4 
(Са2*+М^*)-АТРа5е 
(nmol Pi/min.mg prot) 
36.7 
30.7 
n.d. 
81.4 
NaVCa2* exchange 
Na*-grad. dependent 
Ca2* uptake 
0.19 
0.20 
0.22 
0.41 
References 
8 
8 
8 
9 
Ca2* transport rates in nmol Ca2*/min.mg prot. 
n.d. not detectable. 
4.4.2. ATP-dependent "Ca uptake by permeabilized cells 
In the presence of ATP, the permeabilized cells take up Ca2* into 
mitochondrial and non-mitochondrial stores (Fig. 1). The uptake into mitochondria is 
via the Ca2* uniporter system and is completely blocked by 10 μΜ ruthenium red. 
Uptake into non-mitochondrial compartment is via a vanadate sensitive Ca2*-ATPase 
(Fig. 2). The results in Fig. 1 suggest that the non-mitochondrial store has a very low 
capacity in renal cortex cells. From Fig. 2 it can be concluded that at normal cytosolic 
Ca2* concentration of 0.1 μΜ, all Ca2* uptake is into non-mitochondrial stores. A 
kinetic analysis indicated that mitochondria start to take up significant amounts of 
Ca2* between 0.2 and 0.3 μΜ free Ca2* and there seems to be no real VM value for 
the mitochondrial Ca2* uniporter (6). For enterocytes we studied the effect of several 
conditions during cell isolation on the Ca2* uptake capacity of the non-mitochondrial 
store. The results are summarized in Table 2. The factors that affected the transport 
capacities most were the temperature during hyaluronidase treatment and the pH of 
the uptake medium. 
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Ca3* uptake (nmol/mg protein) Ca1* uptake (nmol/mg protein) 
15 20 25 
Time (min) 
Fig. 1. Ca2+ uptake by renal cortex cells permeabilized with saponin. (A) Ca2* uptake in the presence 
of 10 μΜ ruthenium red. (B) Ca2* uptake in the presence of 0.5 mM vanadate. Medium free Ca2+ was 
1 μΜ. Closed symbols: + 10 mM ATP, open symbols: no ATP. 
4.4.3. ATP-dependent ^Ca uptake by isolated organelles 
In isolated mitochondria and microsomes ATP-dependent Ca2+ uptake is easily 
demonstrated. For intestinal and renal cells we have performed a complete kinetic 
analysis of Ca2+ uptake by microsomes and mitochondria. The results are summarized 
in Table 3. 
120 
100 
80 
60 
40 
20 
% Activity 
a b c 
0.1 μΜ Ca2* 
a b c 
1.0 μ M Ca2* 
Fig. 2. Inhibition of ATP-depcndent Ca2* uptake in permeabilized enterocytes by vanadate and 
ruthenium red at low (0.1 μΜ) and high (1.0 μΜ) free Ca2* concentrations. (A) Control, (B) + 0.5 
mM vanadate, (C) + 10 μΜ ruthenium red. 
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When the transport capacities in permeabilized enterocytes are compared 
to those measured in isolated organelles, then there is good agreement 
between the two values when purification factors are taken into account. 
The similarity between the transport capacities obtained by two 
independent methods adds extra confidence to these values. For renal 
cells the results obtained with permeabilized cells and isolated organelles 
deviate more from each other. Even when the purification of renal 
microsomes is taken into account, the Ca2+ transport capacity in 
microsomes is 3-fold higher than in the non-mitochondrial compartment 
of permeabilized renal cells. This difference is not due to the 
permeabilization procedure because microsomes prepared from 
permeabilized cells have similar Ca2+ transport capacities as microsomes 
prepared from whole renal cortex. The renal mitochondria seem to have 
an extremely high temperature sensitivity. Compared to intestinal 
mitochondria they accumulate almost two orders of magnitude less Ca2+ 
at 25 0C. However, at 37 0C the renal mitochondria Ca2+ uptake is almost 
equal to the intestinal mitochondrial capacity at 25 0C. 
In addition to the 
effect of temperature we 
investigated the effect of 
pH on Ca2+ uptake of 
isolated organelles from 
renal cells. The results are 
shown in Fig. 3. The 
microsomal Ca2+ transport 
system has a clear pH 
optimum around 7.2, which 
coincides with the expected 
c e l l p H v a l u e . 
Mitochondrial Ca2+ uptake 
is almost non-existent at 
pH 7.0 or below, while at 
more alkaline pH Ca2+ uptake becomes increasingly more manifest. 
4.4.4. Overview of Ca2+ transport systems in epithelial cells 
Since we now have Ca2+ transport data for plasma membranes, 
microsomes and mitochondria a table from which the relative importance 
of each system can be constructed. In Table 4 the transport capacities of 
the Ca2+ transporting elements in intestinal and renal cells are presented. 
The purification factors and percentage inside-out resealed have been 
Table 2. Kinetic parameters of non-mitochondrial Cef* store 
of saponin permeabilized enterocytes at 25 °C. 
Conditions of cell isolation 
Hyaluronidase treatment 37 °C 25 "C 25 "C 
ATP-dependent Ca2* uptake 
Temperature during Ca2+ uptake 37 "C 
pH during Ca2* uptake 7.4 
Km (дМ Ca2*) 0.14 
Vmax (nmol Ca2*/min.mg prot.) 0.38 
25 0 C 
7.4 
0.16 
1.65 
25-^ 
7.15 
0.19 
4.50 
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used to calculate the capacities which should occur in intact cells. For 
both epithelial cell types it is clear that the Ca2+ pumps in plasma 
membranes and the non-mitochondrial intracellular store have almost 
identical capacities. Since the affinities for Ca2+ are also identical, K
m
~ 
0.1 μΜ, both systems are of equal importance to maintain intracellular 
Ca2+ around a resting value of 0.1 μΜ. From our analysis it is clear that 
mitochondria have no role in maintaining a low intracellular Ca2+ 
concentration, which is consistent with the literature on mitochondrial 
transport (12,13). However, increases in cytosolic free Ca2+ between 0.3 
and 1.0 μΜ Ca2+, also increases mitochondrial Ca2+ uptake which then 
results in increased activities of Ca2+-dependent mitochondrial enzymes 
which are essential in the regulation of ATP production (13). 
1.5 
1.2 
0.9 
o.e 
0.3 
Ca2* uptake (nmol/mg prot. min) 
/ 
^ -
Τ 
i 
θ.θ 6.8 7.0 7.2 7.4 7.6 
PH 
Fig.3 Effect of pH on Ca2* uptake by renal microsomes and mitochondria. Ca2* uptake is determined 
as initial rate of uptake at 1.0 μΜ free Ca2+ in the presence of 3 mM ATP at 37 "C (A) Ca2* uptake 
by microsomes in the presence of 10 μΜ ruthenium red and in the absence of oxalate. (B) Ca2* uptake 
by mitochondria in the presence of 0.5 mM vanadate. 
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Table 3. Transport capacities of Ca2* stores in intestinal and renal cells at 1 μΜ free Ca2* 
intestine (25 "С) 
kidney (25 "С) 
(37 "С) 
ATP-depcndent Саг 
permeabilized cells 
non-mito. mito. 
1.65 52 
0.1 0.8 
n.d. n.d. 
transport (nmol Ca2*/min.mg prot.) 
isolated organelles 
microsomes mitochondria 
2.77 
1.1 
5.5 
(4x) 
(3.2x) 
(3.2x) 
1.64 (3.5x) 
2.4 (2.3x) 
49 (2.3x) 
Numbers in parenthesis indicate the enrichment factors for NAOPH-dependent cyt.C-
reductase and for succinic dehydrogenase. 
ATP-dependent Ca2* uptake into microsomes is measured in the presence of 20 mM 
oxalate and 10 μΜ ruthenium red. 
ATP-dependent Ca2* uptake into mitochondria is measured in the presence of 0.5 
mM vanadate. 
Table 4. Capacities of ATP-dependent Ce* transport systems in intestinal and renal epithelial cells at 1.0 
uMfree Co2*. 
Intestine duod. 
jej+ile 
jej+ile 
Renal cortex 
рн 
7.4 
7.4 
7.2 
7.4 
7.4 
7.2 
"C 
25 
25 
25 
25 
37 
37 
plas; ma membranes 
2.10 
1.16 
n.d. 
1.43 
2.47 
3.21 
non-mitochondrial 
1.65 
1.65 
4.50 
0.34 
1.72 
141 
mitochondrial 
52 
52 
n.d. 
1.04 
21.3 
5.22 
ATP-dependent Ca2* transport in nmol Ca2*/ min. mg.prot. 
n.d., not done. 
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Chapter 5 
Vitamin D-dependent Ca2+ transport in cultured 
Caco-2 cells 
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5.1. Summaiy 
Caco-2 cells were cultured on permeable membrane supports and used for ^Ca 
uptake and transepithelial "Ca transport studies. The presence of 10"" to ΙΟ-7 M of the 
active vitamin D-metabolite 1,25(ОН)
г
Оз for 24 to 48 h, significantly increased the 
"Ca influx in Caco-2 cells in a dose-dependent manner. Both mucosal-to-serosal and 
serosal-to-mucosal fluxes were significantly increased by incubation for 48 h with W7 
M l,25(OH)2Dj. However, there was no effect of the drug on the net flux. 
We could not demonstrate the presence of calbindin-D* in Caco-2 cells with 
monoclonal antibodies against human intestinal calbindin-D«. 
We conclude that l,25(OH)2Dj increases both the Ca2+ influx in Caco-2 cells and the 
Ca2* absorption of Caco-2 cells via the paracellular route. Caco-2 cells do not contain 
calbindin-D«, which presence is typical for mature small intestinal enterocytes and is 
likely to facilitate transcellular Ca2* transport. 
5.2. Introduction 
The human colon cancer cell line Caco-2 is the only intestinal cell line that 
differentiates spontaneously in culture, exhibiting the structural and functional 
differentiation patterns characteristic of mature small intestinal enterocytes (1). 
Caco-2 cells are the only established mammalian intestinal cell line that has been 
shown to possess а 1,25(ОН)2Оз receptor in the differentiated state (2). The 
mechanism by which 1,25(ОН)2Ьз increases saturable Ca2* transport in Caco-2 cells is 
presently unknown but may represent a l,25(OH)2Dj-dependent increase in the 
synthesis of Ca2*-binding proteins, leading to an enhancement of the intracellulair 
movement of Ca2*. An effect of vitamin D status on saturable Ca2* absorption has 
been frequently reported by other investigators using various in vivo and in vitro 
techniques to measure Ca2* absorption. Caco-2 cells may provide an important new in 
vitro model to investigate the molecular mechanisms of hormones in the small 
intestine. The aim of this study was to determine whether l,25(OH)2D, affected both 
the transepithelial Ca2* transport and the concentration of calbindin-D* in Caco-2 
cells. 
5.3. Materials and methods 
5.3.1. Cell culture 
The human colon cancer cell line Caco-2 was obtained from the American 
Type Tissue Collection (passage 15) and studied between the 16" and 30* passage. 
Caco-2 cells were routinely maintained at 37 "C in a humidified 5% C0 2 atmosphere 
in Dulbecco's modified Eagle's medium, supplemented with 5% fetal bovine serum, 
100 Mg/ml penicillin, 100 Mg/ml streptomycin and a mixture of non-essential amino 
acids. The cells were fed three times a week and were trypsinized weekly with PBS 
solution containing 0.1% (w/v) trypsin and 1 mM EDTA. 
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5.3.2. Caî+ influx experiments 
All experiments were performed with confluent monolayers, grown on 12-wells 
plates. Immediately before the Ca2* uptake experiments, the cells were washed with 
buffer containing 140 mM NaCl, 5.4 mM KCl, 1.2 mM MgSO« 0.1 or 0.7 mM CaClM 
10 mM HEPES-Tris (pH 7.4) (37 0C). "Ca2* uptake was initiated by adding the same 
buffer containing 2 дСі/тІ ^Са2*. The "Ca2* uptake was stopped by addition of 
ice-cold 150 mM NaCl, 2.5 mM CaCl» 20 mM HEPES-Tris (pH 7.40) buffer. After 
several washings with the same stop buffer, an aliquot of the cells was taken and 
counted for radioactivity. As Ca2* influx the difference between 10"4 M D600 
containing and D600 free medium was taken. 
5.3.3. Transepithelial Ca2* transport experiments 
All experiments were performed with confluent monolayers grown on Costar's 
cell culture chamber inserts. The filter bottom of the inserts was placed in an 
Ussing-type chamber and bathed in an aerated (95% 0^5% C0 2) Krebs buffer. The 
filter cups were first washed twice with culture medium containing 1 mM CaCli, and 4 
ßCiJml ^Са2* was added to either the mucosal or serosal compartment. After 30 min, 
5 μΐ samples were taken from the non-labelled side and counted for radioactivity. Net 
Ca2* flux (.!„„) was calculated as the difference between mucosal-to-serosal flux (J,,) 
and serosal-to-mucosal flux (1
Ю
) 
5.3.4. Immunological quantification of calbindin-D% 
Calbindin-D» was isolated from human small intestine according to the method 
of Gleason & Lankford (3)(see chapter 2). Purified human calbindin-D* was used for 
the production of monoclonal antibodies. A competitive ELISA was developed for 
quantification of calbindin-D* in Caco-2 cells (see chapter 2). 
53.5. Statistical analysis 
Values were expressed as means ± SEM. Differences in mean values were 
tested using Student' t-test for unpaired groups. 
5.3.6. Chemicals 
l,25(OH)2Dj was kindly provided by Duphar (Weesp, NL). "СаСІг was purchased 
from New England Nuclear ( Drieeich, FRG). D600 was kindly provided by Knoll AG 
(Ludwigshafen, FRG) 
5.4. Results 
5.4.1. Cell culture 
Caco-2 cells grown on 12-wells plates and on permeable membranes were 
confluent at day 14. The layers possessed many domes, characteristic of functionally 
polarized, transporting epithelial cells. The electrical resistance of the monolayers 
grown on permeable membranes ranged from 215 to 291 n. cm2. 
5.4.2. Ca1* influx experiments 
The Ca2* influx of Caco-2 cells monolayers was linear between 10 and 40 min 
(Fig. 1). Because the uptake was linear over this time period we used 30 min time 
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periods in subsequent experiments. The effect of l,25(OH)2Dj concentration on Ca2* 
influx was assessed by incubating cultures (day 14) for 24 h and for 48 h in the 
absence or presence of ία" to IO-7 M l,25(OH)2Dj· (Fig-2) With increasing 
concentrations of 1,25(ОН)20з there was an apparent dose-dependent increase in Ca2* 
influx. Incubation of the cells with l,25(OH)2Dj for 48 h instead of 24 h resulted in 
further augmentation of the Ca2* influx. 
Ca2* uptake (nmol/mg protein) 
10 20 30 40 50 
Time (min) 
Fig. 1. Time course of D600-<iependent "Ca uptake of Caco-2 cells grown on 12-wells plates for 14 
days in culture media containing 5% fetal bovine serum. "Ca2* uptake was performed at 0.1 mM Ca2* 
and was linear between 10 and 40 min. 
5.4.3. Transepithelial Ca2* transport 
The effect of l,25(OH)2Dj on the transepithelial Ca2* transport of confluent 
Caco-2 cells (day 14) grown on permeable membranes was assessed after 48 h 
incubation with ΙΟ"7 M 1,25(ОН)2Оз. The mucosal-to-serosal flux as well as the 
serosal-to-mucosal flux were both significantly increased by 1,25(ОН)2оз. However, 
there was no effect of the drug on the net flux. (Fig. 3) As a consequence, we 
conclude that l,25(OH)2D, stimulates Ca2* transport via the paracellular transport 
route. The electrical resistance of the Caco-2 cells monolayers was significantly higher 
in the presence than in the absence of 1,25(ОН)2Оз; respectively 274.0 ± 13 
n.cnr(n=5) and 225.7 ± 10 n.cm2(n=5)(P<0.001). 
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Ca2* uptake (nmol/mg prot. 30 min) 
•11 -10 -9 -8 -7 -6 
log [ 1 , 2 5 [ O H ] 2 D 3 ] 
Fig. 2. Effect of 1,25(ОН)2Оз concentration on ^Са2* uptake by Caco-2 cells. Caco-2 cells were grown 
for 14 days in culture media containing 5% fetal bovine serum on 12-wells plates in the absence or 
presence of 10"" to 1СГ7 M 1,23(01-1)20] for 24 hours (closed symbols) or 48 hours (open symbols) 
before the "Ca uptake was measured at 0 7 mM Ca2*. Values represent means ± SEM. 
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Fig. 3. Transepithelial 4SCa fluxes of Caco-2 cells grown on permeable membranes for 14 days in 
culture media containing 5% fetal calf scrum in the absence or presence of 10"7 M 1,25(ОН)20э for 48 
h before transport study was conducted at 1 mM Ca2*. Values represent means ± SEM. 
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5.5. Discussion 
We studied Ca1* influx and transepithelial Ca2* transport in Caco-2 cells at day 
14 in culture, a point in culture when Caco-2 cells form a tight epithelial sheet as 
marked by the presence of tight junctions and a high electrical resistance (4). At this 
stage of growth Caco-2 cells are morphologically and biochemically differentiated (1) 
and have increased levels of the vitamin D receptor (2). Our results indicate that the 
CaI+ influx in Caco-2 cells at day 14 in culture was increased by treatment with 
nanomolar concentrations of l,25(OH)2Dj for 24 h. Treatment of the cells with 
1,25(ОН)2оз for 48 h resulted in a further augmentation of the Ca2* influx. It can be 
anticipated that l,25(OH)2Dj affects the Ca2* channels in Caco-2 cells since other 
studies strongly suggest in vivo stimulation of intestinal Ca2* channels by the hormone 
(5,6). According to the 'liponomic control' hypothesis, l,25(OH)2Dj would unmask 
cryptic Ca2* channels in the luminal membrane by changing the lipid annulus 
surrounding the channel (7). In a previous study we showed that 1,25(ОН)2Оз affected 
the composition of fatty acids and the cholesterol content of rat intestinal basolateral 
membranes (8). The hormone might affect the lipid composition of Caco-2 cells as 
well. 
The effect of 1,25(ОН)2Оз on the transepithelial Ca2* transport of Caco-2 cells 
monolayers at day 14 in culture was investigated. There was a significant increase in 
both the mucosal-to-serosal and the serosal-to-mucosal flux after treatment with IO"7 
M l,25(OH)2Dj for 48h. However, there was no effect of the hormone on the net flux. 
This indicates, that l,25(OH)2Dj stimulates Ca2* transport via the paracellular route. 
In a recent study, stimulation of transcellular Ca2* transport in Caco-2 cells by 
1,25(ОН)2Оз has been reported (9). However, these authors did not measure serosal-
to-mucosal flux and could therefore not differentiate between the transcellular and the 
paracellular route. The apparent transepithelial Ca2* absorption of 1,25(ОН)2Оз 
treated Caco-2 cells is 50-fold lower than recently was determined in cultured rabbit 
connecting tubule cells (10). This might be due to the high concentration 
calbindin-Dja ,that was demonstrated in connecting tubule cells which might act as a 
soluble Ca2* shuttle between the luminal and the serosal site of the cell, thereby 
enhancing the transcellular transport rate. Calbindin-D* was not detectable in Caco-2 
cells with monoclonal antibodies raised against purified human intestinal calbindin-D* 
in a competitive ELISA The lack of calbindin-D» might be the reason for the low 
transcellular Ca2* flux of Caco-2 cells that was observed. In spite of increased Ca2* 
influx in Caco-2 cells by 1,25(ОН)2Оз that was found, the rate limiting step of 
transcellular transport is likely diffusion of Ca2* through the cytosol. 
The Ca2* influx in Caco-2 cells is stimulated after treatment with 1,25(ОН)2Оз. 
The transepithelial Ca2* flux is also increased by l,25(OH)2Dj but this is due to 
increasing Ca2* flux via the paracellular route and not via the transcellular route. 
Caco-2 cells do not possess the vitamin D, inducible calbindin-D» , which presence is 
characteristic for mature small intestinal enterocytes and is likely to facilitate 
transcellular Ca2* transport. The lack of calbindin-D^ might be the reason for the low 
transepithelial Ca2* flux of Caco-2 cells that was observed. 
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6.1. Summary 
We studied the effect of Ca2*-binding proteins (calbindin-Daa, parvalbumin and 
calmodulin) on Ca2* pump activity using erythrocyte vesicles as a model. Furthermore, 
studies were done with rat duodenal basolateral membrane vesicles. Since EGTA 
altered the effect of calbindins, Ca2* pump activities were also measured in EGTA-
free solutions. 
In EGTA-free solutions, 6-40 μΜ Ca2*-binding proteins significantly increased 
the ATP-dependent Ca:* uptake in erythrocyte- and in enterocyte basolateral 
membrane vesicles. In the presence of 0.2 μΜ calmodulin, ATP-dependent Ca2* 
uptake in erythrocyte- and enterocyte basolateral membrane vesicles could be further 
increased by 36 μΜ parvalbumin. This assumes different binding sites for calmodulin 
and Ca2*-binding proteins on the Ca2* pump. 
6.2. Introduction 
Transcellular Ca2* absorption consists in passive influx at the luminal side, 
diffusion through the cytosol and finally active extrusion out of the cell into the 
circulation. The rate limiting step in transcellular Ca2* absorption is believed to be 
diffusion through the cytosol. There is increasing experimental and theoretical 
evidence that high concentrations of vitamin D-dependent Ca2*-binding proteins 
(calbindins) in intestinal and renal epithelial cells facilitate the diffusion of Ca2* 
through the cytosol (1-4). Calbindins belong to the troponin-C superfamily of high 
affinity Ca2*-binding proteins to which also parvalbumin and calmodulin belong. 
The presence of calbindins in intestinal and renal epithelial cells has been positively 
correlated with the rate of Ca2* absorption (1,5). Morgan et al. (6) found a two-fold 
stimulation of the Ca2*-dependent ATP-hydrolysis of human ghosts in the presence of 
10 μΜ calbindins or parvalbumin. Walters (7) found a three-fold stimulation of ATP-
dependent ^Ca2* uptake in rat duodenal basolateral membrane vesicles in the 
presence of 30 μΜ calbindins or parvalbumin. According to Walters it was necessary 
that Ca2* chelators were omitted in the uptake medium since they mimic the effect of 
Ca2*-binding proteins. In other studies a stimulation of duodenal epithelium cells and 
renal distal tubule cell Ca2*-ATPase by calbindins could not be demonstrated (8,9). 
This study addresses the question whether calbindin-Da» or parvalbumin stimulate 
directly the plasma membrane Ca2* pump. We tested the effect of these proteins on 
the ATP-dependent ''Ca2* uptake rate of erythrocyte vesicles. Furthermore, the effect 
of calbindin-Da* and parvalbumin on the ATP-dependent "Ca2* uptake rate of rat 
duodenal basolateral membrane vesicles was measured. 
6.3. Materials and methods 
6.3.1. Preparation of erythrocyte vesicles 
Erythrocyte vesicles were prepared according to the method of Sarkadi et al. 
(10). See chapter 2. Briefly, porcine red blood cells were washed three times with 150 
mM NaCl, 10 mM Tris-HCl (pH 7.4) and then hemolyzed in 8 volumes hemolyzing 
buffer containing 150 mM KCl, 20 mM sucrose, 10 mM Tris-HCl (pH 7.4). After 
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centrifugation at 20,000 χ g for 20 min the pellet was washed 4 times with a 10-fold 
diluted hemolyzing buffer. The obtained membranes were immediately diluted in 40 
vol 0.5 mM Tris-HCl, 50 μΜ ß-mercaptoethanol, 20 μΜ EDTA (pH 8.5) and incuba­
ted for 30 min at 4 "С and for 15 min at 37 °C , sedimented and washed once with the 
same buffer. The vesicles were homogenized and washed twice with 10 vol 10 mM 
Tris-HCl, pH 7.4. Finally the vesicles were resuspended in 10 mM Tris-HCl, 130 mM 
KCl (pH 7.4) and stored in liquid N2. 
632. Isolation of basolateral membranes 
Duodenal cells were isolated from male rats of 5-6 weeks old and 
basolateral-enriched membrane fractions were prepared as described previously (11). 
Fractions enriched for basolateral membranes were immediately used for Ca2* uptake 
experiments. See chapter 2. 
6.3.3. Isolation of Ca2*-bmding proteins 
See chapter 2. 
6.3.4. eCa uptake determinations in EGTA containing solutions 
^Ca uptake was studied by means of rapid filtration. To 50 μΐ assay medium 10 
μΐ vesicle suspension was added to get a final concentration of 20 mM Hepes-Tris, 130 
mM KCl, 0.5 mM EGTA, 3 mM ATP and varying concentrations Caa+-binding 
proteins (pH 7.5). The free Mg2* concentration was adjusted to 2 mM and the free 
Ca2* concentration to 0.2 μΜ, calculated according to a routine described by van 
Heeswijk et al. (12). The reaction was initiated by addition of vesicle suspension and 
incubated for 1 min at 25 "C. To stop the reaction 1 ml icecold stop solution 
containing 20 mM Hepes-Tris, 130 mM KCl, 1 mM EGTA (pH 7.5) was added. This 
mixture was immediately filtered through ME-52 cellulose acetate filters (Whatmann, 
Kent) and washed three times with 1 ml stop solution. The radioactivity on the filter 
was counted. The difference between ATP-containing and ATP-free medium was 
taken as active Ca2* uptake 
6.3.5. *Ca uptake determinations in EGTA free solutions 
^Ca-uptake determinations in EGTA free solutions were performed essentially 
according to Walters (7). Briefly, preparations of calbindins in 135 mM KCl, 10 mM 
imidazole-acetate (pH 7.5) were dialyzed three times against the same buffer. The 
final solution also contained 1 mM MgCl2 and approximately 2 mCi "CaCli and was 
dialyzed at 25 "C. All dilutions were performed with the "Ca containing dialysate. 
Uptake experiments were performed with 20 μg membrane protein in 50 μΐ uptake 
medium containing 10 mM imidazole-acetate, 135 mM KCl, 1 mM MgC^ (pH 7.5) at 
25 "C. Membranes were preincubated for 10 min, ATP (final concentration 1 mM) 
was added when indicated, and Ca2* uptake rates were determined by filtration after 1 
min as has been described under " "Ca uptake determinations in EGTA containing 
solutions" The stop solution contained 10 mM imidazole-acetate, 135 mM KCl, 1 mM 
MgCl2 and 1 mM EGTA (pH 7.5). The difference between ATP-containing and 
ATP-free medium was taken as active Ca2* uptake. 
Free Ca2* activity in the dialysate was measured with 2 μΜ Fura-2. A 
calibration curve of free Ca2* activity and the corresponding fluorescence was 
obtained with solutions containing 10 mM imidazole-acetate, 135 mM KCl, 1 mM 
7 5 
MgCla 1 mM Mg-ATP, 0.5 mM EGTA (pH 7.5) and calculated amounts of CaCl2 
(12). 
6.3.8. Statistical analysis 
Values are expressed as means ± SEM. Differences in mean values were 
tested using Student' t-test for unpaired groups. All experiments were carried out in 
triplicate unless otherwise stated. 
6.3.9 Chemicals 
Mg-ATP and parvalbumin (rabbit muscle) were from Sigma (St. Louis,USA). 45CaCl2 
was from New England Nuclear (Dreieich,FRG). Fura-2 was purchased from 
Molecular Probes (Eugene,USA). 
All other chemicals were of the purest grade. 
6.4. Results 
The effect of 6-40 μΜ Ca2+-binding 
proteins on the Ca2* pump of erythrocytes 
was measured in EGTA-buffered solutions. 
There was no significant effect of Ca2+-
binding proteins on the Ca2* uptake rate in 
erythrocyte vesicles as is shown in Fig. 1. 
Only calmodulin stimulated the Ca2* pump 
of erythrocyte vesicles in this assay. 
In contrast, 45Ca uptake rates in 
erythrocyte- and duodenal basolateral 
membrane vesicles were significant 
increased by Ca2*-binding proteins when 
EGTA-free solutions were used (Fig. 2). 
Calbindin-Dat (18 μΜ) and parvalbumin 
(36 μΜ) increased both the ATP-
dependent "Ca uptake rate in erythrocyte 
vesicles 2-fold. In enterocyte basolateral 
membrane vesicles a 1.7-fold stimulation 
was observed in the presence of calbindin-
DHI (18 μΜ) or parvalbumin (36 μΜ). In 
the presence of 0.2 μΜ calmodulin, 
addition of calbindins resulted in a further 
augmentation of the uptake rate in 
erythrocyte vesicles 2.3-fold (P<0.01) and 
in enterocyte basolateral membranes 
vesicles 1.5-fold (P<0.05). In the EGTA 
free system, calmodulin (0.2 μΜ) increased 
the Ca2*-uptake rate of erythrocyte vesicles 
but not that of enterocyte basolateral 
. Ca2* uptake (nmol/mg prot. min) 9 
a b e d 
Fig. 1. ATP-dependent "Ca-uptake in 
erythrocyte vesicles in EGTA-containing 
solutions. Vesicles were incubated with 
<sCaCl2 at a free Ca
2
* activity of 0.2 μΜ for 1 
min at 25 °C in the absence or presence of 
Ca2*-binding proteins, (a) Control, (b) 10 
μΜ calbindin-Djm, (c) 10 μΜ parvalbumin, 
(d) 1,0 μΜ calmodulin/ P<0.01. Values 
represent means ± SEM of three 
experiments. Significance was determined by 
Student't test. 
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membrane vesicles. However, high concentrations of calmodulin (6 μΜ) increased ^Ca 
uptake rates in both cell preparations. The free Ca2* concentration in the EGTA-free 
assay was measured at 3 μΜ. 
Ca2* uptake (nmol/mg prot. min) Ca** uptake (nmol/mg prot. min) 
Fig. 2. ATP-dependent 4SCa-uptake in A: porcine erythrocyte vesicles and in B: rat enterocyte 
basolateral membrane vesicles in EGTA free solutions. Vesicles were incubated with ^CaCI? at a free 
Ca2* activity of 3 μΜ for 1 min at 25 0C in the absence or presence of Ca2*-binding proteins, (a) 
control (b) 18 μΜ calbindin-D^ (c) 36 μΜ parvalbumin (d) 0.2 μΜ calmodulin (e) 6 μΜ calmodulin 
(f) 0.2 μΜ calmodulin + 36 μΜ parvalbumin. 
A: (b) Ρ < 0.01 В: (b) Ρ < 0.01 
(c) Ρ < 0.05 (с) Ρ < 0.01 
(d) Ρ < 0.01 (d) Ρ > 0.1 
(e) Ρ < 0.01 (e) 0.01 < Ρ < 0.05 
Values represent means ± SEM of three experiments. Significance was determined by Student's t test. 
6.5. Discussion 
Intestinal and renal epithelium cells contain high concentrations of tissue 
specific vitamin D-dependent Ca2*-binding proteins (calbindins). These proteins 
facilitate the diffusion of Ca2* through the cytosol. At the present time there is no 
agreement whether calbindins activate the plasma membrane Ca2* pump. In this study 
we demonstrated that high concentrations of calbindins increase Ca2* pump activity in 
intestinal basolateral membranes and erythrocytes. It was necessary to use Ca2* ligand 
free solutions because EGTA stimulated the Ca2* pump in a similar way as calbindins. 
In the EGTA-free system, a submicromolar concentration of calmodulin stimulated 
the erythrocyte Ca2* pump but not the intestinal Ca2* pump. The reason for this 
difference is most likely the presence of endogenous calmodulin in the intestinal 
preparation (7,9). The prepared erythrocyte vesicles were essentially calmodulin free 
(10). 
At resting level the free Ca2* concentration in a cell is extreme low, 50-100 Nm. 
Consequently, the Ca2* pumps of various tissues exhibit only a part of their maximum 
capacity since the K„ for Ca2* varies around 100 Nm (13). Considering the maximum 
transcellular Ca2* absorption that has been measured in intact intestinal and renal 
epithelia and the available Ca2* pump capacity (1,5), it appears necessary to increase 
Ca2* pump activity. Calmodulin is not suitable for this function since association of 
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calmodulin with the Ca2* pump occurs at higher Ca1* concentrations and this effect 
may come into play after transient rises in cytosolic Ca2* during signal-transduction 
processes. For this reason only a moderate stimulation by calmodulin in erythrocyte 
vesicles was observed when EGTA-containing solutions were used. In this experiment 
the free Ca2* concentration was adjusted to 0.2 дМ. 
The presence of calbindins in Ca2* transporting tissues has been demonstrated 
long ago, but little is known about their physiological role. Calbindins may act as 
soluble Ca2* buffers which complex Ca2* entering the cell via the brush border mem­
brane, thereby maintaining the free Ca2* concentration around the resting level. Based 
on theoretical and experimental evidence it is assumed that calbindins facilitate the 
diffusion of Ca2* through the cytosol, which is believed to be the rate limiting step in 
transcellular Ca2* absorption (1-4). A direct stimulation of the Ca2*-pump by 
calbindins would then cooperate with increased Ca2* supply near the basolateral 
membrane. So far experimental problems prevented to demonstrate this effect. The 
primary reason is the similar stimulation produced by EGTA used as a Ca2* buffer. 
Recently a low affinity receptor for calbindin-D* has been identified on the 
erythrocyte Ca2* pump. This calbindin-D* receptor was identified as the calmodulin 
receptor, although the affinity for calbindin-D* was 5-10 times lower than for 
calmodulin (14). The work presented here has shown unambiguously that in the 
presence of a submicromolar concentration calmodulin, the Ca2* pump can be further 
stimulated by Ca2*-binding proteins. This observation suggests strongly that calmodulin 
and Ca2*-binding proteins affect two independent sites on the Ca2* pump. It has been 
proposed that the interaction of calbindins with the Caz* pump might occur through 
surfaces with complementary charges (15). Opposite charges would favor a close 
approach of the two proteins and a transfer of Ca2* from calbindin to the Ca2* pump. 
Probably, the Ca2* receptor on the Ca2* pump is the low affinity binding domain for 
Ca2*-binding proteins. The physiological importance of a low affinity binding site on 
the Ca2* pump is that during times of decreased Ca2* absorption the pump is not 
overstimulated. This situation occurs at a low vitamin D, status and hence low 
calbindin concentrations. 
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Chapter 7 
Calbmdin-Dgk and parvalbumin are exclusively 
located along basolateral membranes in rat distal 
nephron 
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7.1. Summary 
There is strong evidence, that vitamin D-dependent Ca2*-binding proteins, i.e. 
calbindin-D* and calbindin-D^, facilitate diffusion of Ca2* through the cytosolic 
compartment of renal and intestinal cells, which transport Ca2* transcellular. In the 
present study, parvalbumin, calbindin-D* and calbindin-D^ were localized precisely by 
immunocytochemistry in rat kidney. Antisera recognizing specifically the thick 
ascending loop of Henle, the connecting tubules and collecting ducts and the 
intercalated cells of the collecting ducts, were used to identify different cell types. In 
rat kidney cortex, parvalbumin and calbindin-D« colocalized in the thick ascending 
loop of Henle, the distal convoluted tubule, connecting tubule and in the intercalated 
cells of the collecting duct. Strikingly, in all responsive cells, parvalbumin and 
calbindin-D* were exclusively present in a thin layer along the basolateral membrane. 
In contrast, calbindin-D^ was only present in the distal convoluted and connecting 
tubule, where it was evenly distributed through the cytosol. 
In conclusion, the exclusive localization of parvalbumin and calbindin-D* at the 
basolateral membrane of immunopositive renal cells, implies their involvement in 
regulation of transport processes located in these membranes rather than a role as 
intracellular Ca2* buffer and Ca2* shuttle between the two opposing membranes. 
7.2. Introduction 
In the mammalian kidney, Ca2* is reabsorbed mainly passively in the proximal 
tubule and loop of Henle (1), whereas the distal nephron is the main site of active 
Ca2*-reabsorption. The fine regulation of Ca2*-excretion occurs primarily in these 
distal nephrons, where hormones such as PTH, calcitonin and l,25(OH)2 vitamin Dj, 
regulate the rate of active Ca2* reabsorption (1,2). The mechanisms by which these 
hormones function to regulate Ca2* absorption are still largely unknown (2), but 
1,25(ОН)2Оз has been described to act, at least in part, in the stimulation of 'de novo' 
synthesis of a specific Ca2*-binding protein (3). In turn, these Ca2*-binding proteins are 
involved in the regulation of transcellular Ca2* transport (4,5). 
In the intestine, it has been shown that calbindins, a class of vitamin D-
dependent Ca2*-binding protein, to which calbindin-D« and calbindin-Da* belong, play 
an important role in active transcellular Ca2* transport. The rate of active Ca2* 
absorption correlates well with the amount of calbindin over a wide variety of 
physiological conditions (4,5). In the intestine, calbindins function most likely as 
intracellular buffers and shuttle between the limiting membranes in which Ca2* influx 
and efflux mechanisms are located (4,5). 
There is no doubt that calbindins play a similar role in renal cells (6,7). 
Calbindin-Ds» has been localized immunohistologically in the distal convoluted and 
connecting tubule in several species by different groups (3,8,9). Calbindin-D* has until 
now only been localized in mouse (10, 11) and rat (12). Parvalbumin, a 12kD Ca2*-
binding protein in fast-twitch skeletal muscle, has also been reported to be present in 
rat kidney (13). Like calbindin, parvalbumin is able to facilitate Ca2* diffusion through 
an aqueous compartment (14). In contrast to the calbindins, the parvalbumin 
concentration in tissues is unaffected by the vitamin D, status of the animal (13). 
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The distal nephron is a heterogeneous structure containing several transport 
processes which are thought to be located in distinct cell types (15,16). Recent 
immunohistological studies, in which monoclonal antibodies to cell surface antigens 
have been developed, further substantiate this heterogeneity (17,18,19,20). Until now, 
the complexity of the distal nephron has impeded a detailed localization of Ca2*-
binding proteins in the kidney. 
Since precise immunohistochemical localization of calbindin-D* and 
parvalbumin may reveal hitherto unknown nephron segments involved in active Ca2* 
reabsorption, we reinvestigated their localization along the distal nephron using three 
additional antisera specific for (i) the thick ascending limb of Henle, (ii) principal and 
(iii) intercalated cells of the connecting tubule and cortical collecting duct. 
7.3. Materials and methods 
7.3.1. Preparation of antisera 
Calbindin-Dmc was isolated from chick duodenum (21), calbindin-D« purified 
from bovine intestine was kindly provided by Dr. S. Forsén (Lund, Sweden) and 
parvalbumin was purified from rabbit skeletal muscle (Sigma, St. Louis, MO). The 
purified Ca2t-binding proteins were used for immunization of New Zealand white 
rabbits. The produced antisera were tested for their specificity and cross-reactivity 
with an enzyme-linked immunosorbent assay (ELISA). Polystyrene plates were coated 
with 50 ng purified Ca2*-binding protein in a total volume of 100 μΐ of coating buffer 
containing 0.1 M NaHCO* 5 mM NaN, (pH 9.6), for 2 h at 37 0C. After several 
washings with 150 mM NaCl, 0.05 % (v/v) Tween-20, 10 mM Tris-HCl (pH 7.4), 100 
ді of diluted antiserum was added and the plate incubated overnight at 4 "C. After 
several washings, 100 ді/well peroxidase-labelled goat anti-rabbit IgG (H&L) (1:500) 
was added and incubated for 2 h at room temperature. Color was developed by 
adding 100 μΐ medium containing 0.5 mg/ml o-phenyldiamine in 23 mM citric acid, 66 
mM Na2HPO„ 0.01% (v/v) H 2 0 2 (pH 5.5). Antiserum against Tamm Horsfall was 
obtained from Organon Teknika (Oss, NL), monoclonal antibody St. 48 against 
principal cells of connecting tubule and collecting ducts was kindly provided by Drs. 
Fejes-Tóth and Náray-Fejes-Tóth (Detroit, MI) (17), and antiserum against human 
erythrocyte Band 3 protein was kindly provided by Dr. M. Kay (Temple, TX) (22). 
7.3.2. Immunocytochemistry 
Kidneys were obtained from 200 g male Wistar rats. The kidneys were cut into 
pieces, placed in 2% (w/v) periodate-lysine-paraformaldehyde fixative (23) for 2 hours, 
dehydrated, and embedded in paraffin. The staining was performed at room 
temperature on deparaffinized and rehydrated sections (5 μτη) of the fixed kidneys. 
For double immunofluorescent staining, sections were incubated with 10% (v/v) 
fetal bovine serum in PBS for 15 min, and subsequently covered with antiserum 
against one of the Ca2*-binding proteins (1:200), simultaneously with antiserum against 
Tamm Horsfall protein (1:250) or with Mab St. 48 (1:5) for 60 min. The sections were 
rinsed thoroughly and incubated either with FITC-ccnjugated swine antimouse IgG 
and TRITC-conjugated swine antigoat Ig or with TR iTC-conjugated goat antimouse 
Ig for 60 min. After incubating, the sections were rinsed twice, mounted in glycerol 
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and examined by fluorescence microscopy. 
For immunoperoxidase staining, serial sections were incubated with 10% v/v 
goat serum in PBS for 15 min and subsequently covered with antiserum against one of 
the Ca2+-binding proteins (1:200) for 60 min. After thorough washing with PBS, the 
sections were incubated with peroxidase-conjugated goat antirabbit Ig for 60 min 
(1:200). 
For staining of intercalated cells, sections were incubated with antiserum 
against the human erythrocyte Band 3 protein (1:100) for 60 min, washed and 
subsequently incubated with peroxidase-conjugated goat antimouse IgG (H&L) for 60 
min (1:200). The sections were then rinsed twice and peroxidase activity was revealed 
with 0.05% (w/v) diaminobenzidine and 0.03% (v/v) H202 in PBS for 10 min. The 
sections were counterstained with hematoxylin Gill 2 and mounted with gelatin. 
All controls, including sections treated with pre-immune rabbit serum, solely 
with conjugated antibodies or with antisera preabsorbed with their antigen, were 
devoid of any staining. Sections fixed with an alternative fixation method to avoid 
redistribution of protein during fixation, i.e. snap-frozen tissue Fixed by freeze 
substitution (24), provided similar results but with considerable less morphological 
detail and were therefore not included. All chemicals and conjugated antibodies were 
obtained from Sigma (St. Louis, MO). Data are expressed as mean ± SEM. 
7.4. Results 
Since parvalbumin and calbindin-D* are small, high affinity Ca2+-binding 
proteins, the obtained antisera were tested for cross-reactivity. In Fig. 1, ELISAs for 
both antisera are shown, proving the absence of cross-reactivity. We also found, as in 
the literature, that antisera against calbindin-D» do not exhibit cross-reactivity with 
parvalbumin and calbindin-D» (6) (data not shown). 
Absorbance 492nm 
100 1000 10000 
Serum dilution 
Absorbance 492nm 
100 1000 10000 
Serum dilution 
Fig. 1. Concentration-dependent binding of antisera io (A) rabbit parvalbumin and (B) bovine 
calbindin-D* in an ELISA system. Preimmune serum (open symbols), immune serum (closed symbols). 
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7.4.1. Cortical ascending limb of Henle's loop (cTALH) 
Immunofluorescence staining of serial sections of rat kidney cortex 
revealed co-localization of parvalbumin and calbindin-D9k in cTALH cells 
(Figs. 2A-D). In addition, parvalbumin and calbindin-D9k reactivity were 
mainly present along the basolateral plasma membrane. Calbindin-D^ 
was clearly absent in cTALH cells (Figs. 2E,F). During examination of 
multiple preparations, we found one section through a juxta glomerular 
apparatus in which staining for parvalbumin was absent in macula densa 
cells, but clearly present in cTALH cells (Fig. 3). 
7.4.2. Distal convoluted tubule (DCT) 
The distal convoluted tubule of rat kidney contains most of renal 
calbindin-D^ (8,9,11,12) and we confirm these earlier observations in Fig. 
4C. In the present study, parvalbumin and calbindin-D9K co-localized in 
calbindin-D^-positive cells (Figs. 4B,C). Again, as in cTALH cells, 
parvalbumin and calbindin-D^ were exclusively present in a thin layer 
along the basolateral membrane (Figs. 4B,C). In contrast, calbindin-D^ 
was clearly present throughout the cytosol. 
7.4.3. Connecting tubule (CNT) 
In rat kidney, calbindin-D^ was also abundantly present in the 
connecting tubule, although not in all cells (Fig. 5C; Fig. 6; Fig. 7). These 
cells lacking calbindin-DjgK are most likely intercalated cells (see under 
CCD). Parvalbumin and calbindin-D9k co-localize with calbindin-D^-
positive CNT cells, except for their conspicuous presence along 
basolateral membranes (Figs. 5A,B). In addition, calbindin-D9k and 
parvalbumin were also present in those cells lacking calbindin-D^ (see 
under CCD). 
7.4.4. Cortical collecting duct (CCD) 
In Fig. 6, the sudden transition of connecting tubule into cortical 
collecting duct is shown. Calbindin-D28k was clearly absent in CCD cells. 
In addition, fluorescence staining of serial sections demonstrated the 
absence of calbindin-D^ in CCD but its presence in CNT cells (Figs. 
7E,F). The presence of calbindin-D9k and parvalbumin in CCD cells was 
restricted to a minority of cells (—30%). The CCD cells lacking these 
Ca2+-binding proteins were identified with Mab St48 as principal cells 
(Figs. 7A,B,C,D). The calbindin-D9k- and parvalbumin- positive CCD cells 
could be identified as intercalated cells. This is shown in Fig. 8, where in 
serial sections, antisera against Band 3 protein and against parvalbumin 
stained cells in similar positions. Figs. 7B,D and Fig. 8 reveal again the 
typical localization of calbindin-D9k and parvalbumin along the basolateral 
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membrane. 
In Fig. 9, the immunohistochemical localization of the two 
calbindins and of parvalbumin is summarized. The distal convoluted and 
connecting tubule contains all three Ca2+-binding proteins, but only 
calbindin-D^ is homogeneously distributed throughout the cytosol. 
Calbindin-D9k and parvalbumin were also present in the thick ascending 
loop of Henle and intercalated cells in the cortical collecting duct, but 
their distribution was exclusively along the basolateral membrane. 
86 
Fig. 2. Double immunofluorescent staining of paraffin-embedded sections of rat kidney, showing on the 
left, staining for cortical thick ascending loop of Henle (cTALH) (A.C,E) and on the right, distribution 
of parvalbumin (B) , calbindin-D^ (D) and calbindin-D^ (F). Asterix indicate intercalated cells (1С) of 
collecting duct (lOOOx). 
S7 
í¿iSS^ 
Fig. 3. Immunoperoxidase staining of paraffin-embedded section of rat kidney, showing distribution of 
parvalbumin in cortical thick ascending loop of Henle (cTALH). Notice lack of staining for 
parvalbumin in the macula densa (asterix) (1200x). 
Fig. 4. Immunoperoxidase staining of serial paraffin-embedded sections of rat kidney, showing 
distribution of parvalbumin (A), calbindin-D» (B) and calbindin-Dj» (C) in a transition of cortical 
thick ascending loop of Henle (cTALH) to distal convoluted tubule (OCT) (lOOOx). 
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Fig. 5. Immunoperoxidase staining of serial paraffin-embedded sections of rat kidney, showing 
distribution of parvalbumin (A), calbindin-D% (B) and calbindin-D^ (C) in distal convoluted and 
connecting tubules. Asterix indicate cells of the distal tubule negative for calbindin-Dg* (lOOOx). 
Fig. 6. Immunoperoxidase staining of paraffin-embedded section of rat kidney, showing distribution of 
calbindin-D^» in transition of connecting tubule (CNT) to cortical collecting duct (CCD). Asterix 
indicate cells of the connecting tubule, presumably intercalated cells, negative for calbindin-D^ 
(1200x). 
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Fig. 7. Double immunofluorescent staining of paraffin-embedded sections of rat kidney, showing on the 
left, staining for principal cells of connecting tubule (CNT) and cortical collecting duct (CCD) (A,C,E) 
and on the right, distribution of parvalbumin (B), calbindin-D« (D) and calbindin-D^ (F). Asterix 
indicate intercalated cells (1С) of collecting ducts (1400x). 
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Fig. 8. Immunoperoxidase staining of serial paraffin-embedded sections of rat kidney, showing 
distribution of Band 3-like antigen (A) and parvalbumin (B) in cortical collecting ducts (CCD). Asterix 
indicate intercalated cells (1С) of collecting ducts (500x). 
Lalbindin 1) :Sk 
ι .ilbindm I) 9k Parvalbumin 
Fig. 9. Model of rat distal nephron showing distribution of calbindin-D^, calbindin-D^ and 
parvalbumin. 
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7.5. Discussion 
The present study confirms previous observations on the localization of 
calbindin-Dat in rat kidney (8,9). The exclusive localization of calbindin-D^ in distal 
convoluted and connecting tubules is in line with the contention that these segments 
are the main sites of active transcellular Саг* reabsorption in the nephron (1,25). The 
uniform distribution throughout the cytosol is also in accordance with the physiological 
role assigned to calbindin-D^. It has been postulated that calbindin-D^ acts both as a 
cytosolic Ca2* buffer and as a shuttle mechanism between the luminal influx and the 
basolateral efflux sites (4,5). Theoretical and experimental models to substantiate 
facilitated diffusion of Ca2+ by calbindin-D^ have been published (5,14,26). 
In addition, our study provides new insights into the localization of calbindin-
D* and parvalbumin in rat kidney cortex. The localization of these smaller Ca2+-
binding proteins is wider than that of calbindin-D», as it is found not only in the distal 
convoluted tubule and connecting tubule, but also in the thick ascending loop of 
Henle and collecting duct. This observation adds further evidence to the hypothesis 
that calbindin-D» and parvalbumin have different functions in renal tubules than 
calbindin-Dja. Firstly, the conspicuous localization along the basolateral membrane 
excludes a shuttle-type role in facilitating Ca2+ diffusion through the cytosol. Secondly, 
the presence of calbindin-D* and parvalbumin in different nephron segments with a 
variety of specialized ion transport mechanisms suggests that both Ca2*-binding 
proteins may have a regulatory role in these different transport processes. Their 
precise function, however, can only be speculated at present, since for several 
abundant Ca2+-binding proteins, a specific interaction with another protein has not yet 
been shown (27). 
Several Ca2+-binding proteins, e.g. parvalbumin and calbindin, have been found 
in high concentrations in the central and peripheral nervous system where many 
processes depend on intracellular Ca2* (28). Parvalbumin is particularly found in fast-
firing, metabolically active neurons and in fast-twitch skeletal muscle (28). It has been 
speculated that parvalbumin could act as a slow but high-affinity "Ca2* sink" during 
intense spiking activity in these cells (27). An analogous function may be postulated 
for parvalbumin in renal cells, implying that basolateral membranes of thick ascending 
limbs of Henle, distal convoluted and connecting tubules, and of intercalated cells in 
collecting ducts are sites of heavy Ca2* traffic. In neurons, a different function was 
postulated for calbindin than for parvalbumin. Calbindins could bind and release Ca2* 
more quickly than parvalbumin and, therefore, aid to its redistribution in the cell (27). 
In our study, calbindin-D* and parvalbumin were always co-localized along basolateral 
membranes. Therefore, calbindin-DÄ could help distribute Ca2* quickly along the 
basolateral membrane after influx through a few scattered channels. In line with this 
hypothesis, one recent investigation reported activation by PTH of dihydropyridine-
sensitive Ca2* channels in renal cells from distal origin in primary culture (29). In 
general, however, information on Ca2* signalling in renal cells is very scarce and future 
work is awaited. 
The calmodulin-dependent Ca2* pump of the plasma membrane in duodenum 
has been claimed to be stimulated by calbindin-Dw and parvalbumin (29). Since Ca2*-
ATPase (31) as well as Na*/Ca2* exchange (32) have been demonstrated in distal 
tubules to be present in basolateral membranes, the preferred localization of 
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parvalbumin and calbindin-D« may suggest a close association with the Ca2*-pump 
and the Na7Ca2+ exchanger. 
The restricted localization of calbindin-D» and parvalbumin along basolateral 
membranes implies that binding-proteins for parvalbumin and calbindin-D« must be 
present on cytoskeletal elements. In trying to identify these binding-proteins, it may be 
worthwhile to attempt a gel-overlay technique, which has been successful in the 
identification of calmodulin-dependent proteins (33). This requires the development of 
methods for isolation of specific cell types in the distal nephron. Development of the 
immunodissection technique makes these studies feasible (34). 
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Chapter 8 
Quantification of Ca2+-ATPases in erythrocytes 
from subjects with essential hypertension or 
Raynaud's phenomenon 
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8.1. Summary 
Ca2* pump activity and Ca2* pumps densities were measured in erythrocyte 
membranes from healthy volunteers and subjects with essential hypertension or with 
Raynaud's phenomenon, in order to detect possible changes in the Ca2+ e-itrusion 
capacity. In addition to Ca2*-ATPase activity determinations, we measured the number 
of pump sites in erythrocyte membranes with an ELISA system. We found no 
significant differences between the three groups in the Ca2*-ATPase activity and in the 
number of pump sites per erythrocyte. Sex and age appeared to be of no influence on 
these parameters. It was calculated that each erythrocyte contains about 1,400 pump 
sites that equals a total Ca2+ pump activity that is sufficient to remove the free Ca2* 
pool 30 times per minute. We conclude that the Ca2* extrusion capacity of the 
erythrocytes is not changed in essential hypertension and in Raynaud's phenomenon. 
8.2. Introduction 
Cytosolic free Ca2* is crucial for vascular smooth muscle cell (VSMC) 
contraction and is likely to determine vascular tone (1,2). Membrane handling of Ca2* 
has been shown to be abnormal in spontaneously hypertensive rats and also in human 
hypertension (2,3). This has led to the hypothesis that the control of intracellular Ca2* 
in VSMC of patients with essential hypertension is impaired. This abnormal 
membrane handling of Ca2* in essential hypertension is not limited to contractile cells 
but has mostly been demonstrated in erythrocytes, adipocytes and nerve cells (3), 
platelet membranes (4,6) and erythrocytes (7-12). 
As a consequence a number of studies in essential hypertensive patients has 
focussed on Ca2* extrusion mechanisms. Intracellular Ca2* might be increased 
secondarily to a decreased (Na*,K*)-ATPase activity and the resulting increased 
intracellular Na* concentration reduces the Ca2* extrusion via the Na*/Ca2* exchanger 
(13). Studies have been carried out to measure (Na*,K*)-ATPase activity in 
hypertensives and the occurrence of a 'circulating inhibitor' of the (Na*,K*)-ATPase in 
plasma has been described (14-25). On the other hand a decreased Ca2*-ATPase 
activity in the plasma membrane directly elevates intracellular Ca2*. Studies on 
Ca2*-ATPase activities in erythrocytes and platelet membranes from hypertensive 
patients have been reported (7-12,26). These studies did not provide a clear answer to 
the question whether Ca2*-ATPase activity is decreased or increased in hypertensive 
patients. Ca2*-ATPase activity is influenced by several environmental factors and 
conditions. Therefore, we also measured pump densities in erythrocytes with an 
immunological assay. With specific antibodies against purified human erythrocyte 
Ca2*-ATPase a competitive ELISA was developed for this purpose. 
Additionally to essential hypertensives we also studied patients suffering from 
Raynaud's phenomenon. Vasoconstriction of VSMC is thought to be responsible for 
an inadequate blood flow in this disease (27). It has been demonstrated that 
treatment with Ca2* entry blockers, nifedipine or nicardipine, resulted in an increased 
finger blood flow (28-30). This suggests that an abnormal high Ca2* influx into VSMC 
might be a factor in Raynaud's phenomenon. Since this can partly be compensated by 
increased Ca2* pumping via the Ca2*-ATPase we also studied Ca2* pump densities in 
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erythrocytes from patients with Raynaud's phenomenon. 
8.3. Subjects 
Thirty-five subjects were selected. Eleven healthy volunteers, who were all 
normotensive (blood pressure below 140/90 mm Hg and had a normal body mass 
index (below 25 kg/cm2). Fourteen subjects had a hypertension considered as essential 
according to well accepted criteria. Blood pressure was above 140 systosolic and 
above 90 mm Hg diastolic, mean of three control visits, each consisting of three 
readings after 10 min of supine rest. The hypertensives had an increased body mass 
index, mean 28.3 ± 4.9 (SD), range 22.2-34.8 kg/cm2. They all had a normal renal 
function. Fourteen subjects had a Raynaud's phenomenon, diagnosed on clinical and 
serological grounds according to the well defined criteria of Allen & Brown (31) 
(primary Raynaud's phenomenon) and of the American Rheumatism Association for 
secondary Raynaud's phenomenon (32). Blood pressure was measured with a 
sphygmomanometer and a cuff of 30x13 cm and phase V was used for the diastolic 
blood pressure. Hypertension was mild (diastolic < 105 mm Hg) in five, moderate 
(105-115) in four and severe (> 115) in one subject. All 35 subjects were without 
medication for at least two weeks, except for oral contraceptives. 
8.4. Materials and methods 
8.4.1. Preparation of erythrocyte membranes 
Erythrocyte membranes were prepared essentially as described by Niggli et al. 
(33). Briefly, venous blood collected in heparinized tubes was centrifuged at 2,000 g 
for 10 min at 4 °C. The erythrocytes were washed 3 times in 5 volumes of 130 mM 
KCl, 20 mM Tris-HCl (pH 7.4). The erythrocytes were hemolyzed in 5 volumes of 1 
mM EDTA, 10 mM Tris-HCl (pH 7.4) and centrifuged at 20,000 g for 10 min. The 
ghosts were then washed 5 times in the hemolysis buffer and 4 times in 10 mM 
Hepes-Tris pH 7.4, without EDTA. The hemoglobin- and calmodulin free ghosts were 
finally resuspended in 130 mM KCl, 20 mM Hepes-Tris (pH 7.4), frozen in liquid N2 
and stored at -80 °C. 
8.4.2. Isolation of erythrocyte Ca2+-ATPase and production of antiserum 
See chapter 2. 
8.4.3. Competitive ELISA for Ca^-ATPase 
See chapter 2. 
8.4.4. Caz*-ATPase activity determinations 
The Ca2*-ATPase activity was measured in a final volume of 0.5 ml, containing 
150 mM KCl, 20 mM Hepes-Tris , 0.2 mM ouabain. 0.5 mM EGTA, 0.5 mM 
HEDTA, 2 mM free Mg2+ and 1 μΜ free Ca2% 3 mM ATP, 1 μΜ calmodulin , 50 μg 
erythrocyte membranes (pH 7.4). Total Mg2* and Ca2* were calculated using a routine 
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described by van Heeswijk et al. (34). Calmodulin was isolated according to 
Gopalakrishna and Anderson (35). The reaction was initiated by addition of 
membranes and incubated for 30 min at 37 °C. The reaction was stopped by adding to 
each tube 0.5 ml 5% (w/v) TCA The released phosphate was measured 
spectrofotometrically at 690 nM, 30 min after addition of 1 ml reagent containing 1% 
(w/v) ammoniumheptamolybdate, 40 mg/ml FeSO, and 1.15 N HjS04 to each tube. 
The difference between Ca2* containing and Ca2* free medium was taken as 
Ca2*-ATPase activity. 
8.4.5. Protein 
Protein was determined using a Coomassie Blue reagent (Biorad, Richmond, 
USA) using gamma-globulin as standard. Gamma-globulin was used as standard. 
Membranes were solubilized with 0.1% (v/v) Triton X-100 for 5 min prior to the 
addition of the reagent. 
8.4.6. Statistical analysis 
Values were expressed as means ± SEM. Differences in mean values were 
tested using Student's t test for unpaired groups. 
8.4.7. Chemicals 
Mg-ATP, was from Sigma (St. Louis, USA). DTT was from Boehringer (Mannheim, 
FRG) 
All other chemicals were of the purest grade. 
8.5. Results 
Ca2* dependent ATP-hydrolysis was measured with erythrocyte membrane 
preparations that had been isolated under exactly the same conditions, frozen in liquid 
N2 and stored at -80 "C for no longer than two days 
The competitive ELISA was very sensitive and ng amounts of solubilized 
Ca2*-ATPase could easily be detected (Fig. 1A). The detection limit was determined 
as the smallest amount of Ca2*-ATPase producing a statistically significant (P<0.05) 
reduction in absorbance at 492 nm compared to the absorbance value in the absence 
of competing antigen. The detection limit was 11 ng/ 50 μ,Ι Ca2*-ATPase. The amount 
of solubilized erythrocyte membranes applied in the assay was plotted against the 
amount of Ca2*-ATPase detected and a linear relationship was found (Fig IB). 
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Fig. 1. Competitive ELISA: (A) Calibration curve with purified human erythrocyte Ca2*-ATPase (B) 
typical curve with solubilized human erythrocyte membranes. Linear regression yields: y= 2.19%. 
(r=0.99). 
Table 1 gives the clinical and biochemical data of the three subgroups. There 
were no significant differences in the Ca2* pump activities and in the number of Ca2+ 
pumps per erythrocyte. Since there were important age and sex differences between 
the three groups, we looked for a correlation between age and the biochemical 
parameters. No such correlation was found. Within the group of healthy volunteers 
and of essential hypertension the biochemical parameters were not different between 
males and females. Within the hypertensive group there was no relation between 
blood pressure or body mass index and the biochemical parameters. We also looked 
for differences of the biochemical parameters within the Raynaud's group between 
subjects with primary and with secondary Raynaud's phenomenon. There was no 
difference between these two. 
Table 1. Ca** pump activities and Ca?* pump densities m erythrocytes from healthy 
volunteers and subjects suffering from essential hypertension or Raynaud's phenomenon. 
Number 
Male/female 
Age 
Means ± S.E.M 
Range 
Healthy 
controls 
10 
6/4 
34 ± 3 
23 10 47 
Bloodpressure (mm Hg) 115.5/60.5 ± 10.6^ 7.8 
Specific activity 
(дтоіе ATP/hour, mg prot.) 
Mg Ca:*-ATPase/mg protein 
0.34 ± 0.03 
3.01 ± 0.09 
Essential 
hypertension 
10 
5/5 
40± 7 
26 to 71 
162.7/102.2 ± 20.8/11.5 
0.40 ± 0.05 
2.89 ± 0.14 
Raynaud's 
phenomenon 
15 
14/1 
44 ± 4 
23 to 78 
127.3'68.0 ± 15.0/8.0 
0.31 ± 0.01 
3.39 ± 0.19 
100 
8.6. Discussion 
This study demonstrates that the Ca2*-ATPase activity and the number of Ca2*-
pumps in erythrocytes is not abnormal in essential hypertension and Raynaud's 
phenomenon. Therefore, it is unlikely that anticipated increases in intracellular Ca2* 
concentration are due to reduced Ca2+ extrusion capacities nor that increased 
intracellular Ca2+ concentration leads to increased pump capacity. We determined for 
the first time the number of Ca2* pumps in erythrocytes using an ELISA system. The 
advantage of an immunological quantification of Ca2* pumps is that inactivation of 
Ca2* pumps during cell preparation is of no importance. 
The obtained values enable us to calculate the Ca2* transport capacity per 
erythrocyte. It was determined that 1 mg erythrocyte membrane stems from 9.2 . 10' 
± 1.8 . 10' cells (n=8). By combining the data in Table 1 we calculate that each cell 
contains roughly 1,400 pump sites with an apparent turnover number of about 250 
ATP molecules/pump site per min at 37 "С. Since the stoichiometry of the plasma 
membrane Ca2*-ATPase is 1 mole Ca2* transported per mole ATP hydrolyzed (36), it 
follows that each cell transports 3.5 . 105 Ca2* ions per min at 37 °C. With a half 
maximum velocity around ΙΟ'7 M Ca2* , it is estimated that with an intracellular space 
of 87 μπι1 for human erythrocytes the free Ca2* pool can be pumped out 30 times per 
minute. This should be sufficient to compensate for a small leak in a healthy cell. 
Apparently cells have ample Ca2* extrusion capacity as was found previously for 
porcine small intestine (37). 
It is thought that minor elevations in intracellular Ca2* of VSMC have severe 
implications for vasoconstriction (13,38). Furthermore it has been demonstrated that 
there is an impaired membrane handling of Ca2* in cells of hypertensives (2,3). When 
there is increased Ca2* influx in cells from subjects with essential hypertension or 
Raynaud's phenomenon, as has been demonstrated in erythrocytes from 
spontaneously hypertensive rats (39), it might be possible that the Ca2* extrusion 
mechanisms are not capable to maintain the desired basic level within a very narrow 
range. Then the origin of higher basal levels of intracellular Ca2* is most likely an 
increased Ca2* influx rather than a decreased Ca2* extrusion. 
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9.1. Ca2+ homeostasis of epithelial cells 
With respect to Ca2*, intestinal and renal epithelial cells are more alike than 
unlike other cells. The intracellular Ca2* is maintained at low resting values around 
50-100 Nm. The regulation of intracellular Ca2* is a concerted action of various 
membrane transport systems, and is a complex phenomenon. Neurohumoral 
substances induce a rapid but transient rise in cytosolic Ca2* either by Ca1* influx via 
receptor operated Ca2* channels in the basolateral cell membrane and/or via release 
of Ca2* from intracellular stores whose pathway is activated by cleavage of 
phosphatidylinositol 4,5 -bisphosphate (1-3). The restoration of cytosolic Ca2* to 
resting level during a transient rise, is accomplished by Ca2* accumulation in 
mitochondrial and non-mitochondrial Ca2* stores and by Ca2* extrusion out of the cell. 
The mitochondria accumulate large amounts of Ca2*, providing that the cytosolic 
concentration reaches values of 0.3 μΜ Ca2* or higher. High affinity 
non-mitochondrial Ca2* stores have been demonstrated in endoplasmic reticulum- and 
golgi-enriched membranes of several cell types, among them enterocytes and renal 
epithelial cells (4-7). The non-mitochondrial Ca2* stores of intestinal and renal cells 
contain a Ca2* pump that shares many characteristics with the sarcoplasmic reticulum 
Ca2* pump from fast twitch muscles (8,9). Ca2* might be extruded out of the cell by a 
second type of Ca2* pump which is stimulated by calmodulin and a Na*/Ca2* exchange 
mechanism, both located in the basolateral membrane. The latter is of minor 
importance in the intestine (10,11). For both epithelial cell types it is clear that the 
Ca2* pumps in the plasma membranes and in the non-mitochondrial Ca2* stores have 
almost identical capacities. Since the affinities for Ca2* are also identical, K,. — 0.1 μΜ 
Ca2*, both systems are, from a kinetically point of view, of equal importance to 
maintain intracellular Ca2* around a resting value of 0.1 μΜ. Mitochondria have no 
role in maintaining a low intracellular Ca2* concentration. However, increases in 
cytosolic free Ca2* between 0.3 and 1.0 μΜ Ca2*, also increases mitochondrial Ca2* 
uptake which then results in increased activities of Ca2*-dependent mitochondrial 
enzymes which are essential in the regulation of ATP production (12). 
9.2. Effect of 1,25(ОН)2Вз on transcellular Ca2+ transport of 
porcine intestine and cultured Caco-2 cells 
Transcellular Ca2* transport is closely related with the presence of vitamin 
D-dependent Ca2*-binding proteins (calbindins). Calbindins are typically found in cells 
which are specialized in transcellular Ca2* transport; such as enterocytes and distal 
convoluted tubule cells. Most likely their function is enhancement of Ca2* diffusion 
through the cytosol, which is believed to be the rate limiting step (13,14). The active 
vitamin-D metabolite 1,25(ОН)ДЭэ stimulates the synthesis of calbindins and there is 
evidence that in epithelial cells, the hormone stimulates the Ca2* influx at the level of 
the brush border membrane (13,15-19). It is unknown whether the hormone affects 
the extrusion of Ca2* via the basolateral membrane as well. Previous results indicated 
that 1,25(ОН)2Оз stimulated Ca2* pump activity in rat duodenal basolateral membrane 
(20-22). However, these effects were due to the cell isolation method which 
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specifically damaged the Ca2* pumps in preparations of vitamin D-deficient animals 
while incubated at 37 "C (23). We studied the effect of 1,25(ΟΗ)Α on the number of 
Ca2* pumps and on the Ca2* pump activities in subcellular fractions from porcine 
duodenal enterocytes. Basolateral membrane vesicles and microsomes were prepared 
from normal pigs and from pigs suffering from an inherited defect of renal 
l,25(OH)2Dj synthesis. Additionally to Ca2* uptake studies, we measured the number 
of Ca2* pumps with calmodulin overlay and immunological techniques. We calculate 
about 95,000 plasma membrane Ca2* pump sites/enterocyte. We found no effect of 
1,25(ОН)2Оз on the activity and on the number of Ca2* pumps in both subcellular 
fractions. It was calculated that there is ample Ca2*- pump capacity to prevent the 
enterocyte from being flooded with Ca2* entering the cell via the brush border 
membrane, under the influence of l,25(OH)2D,. Apparently, there is no need to 
increase the Ca2* extrusion capacity in these cells. We found that the concentration of 
calbindin-D* in duodenal enterocytes from vitamin D-deficient pigs was reduced with 
58%. This reduction might explain the reduced Ca2* absorption in vitamin-D-deficient 
pigs leading to severe rickets. 
We found a stimulation of the transcellular Ca2* transport in cultured Caco-2 
cells by 1,25(ОН)
г
оз. These cells did not contain calbindin-D» in detectable amounts, 
which might be the reason for the low transcellular Ca2* transport that was found. 
Surprisingly, l,25(OH)2Dj also stimulated the paracellular transport route for Ca2*. In 
some way, that is not yet understood, the hormone presumable affects the tight 
junctions of cultured Caco-2 cells. 
9.3. Ca2+-bmdmg proteins 
Ca2*-binding proteins have been demonstrated in a wide variety of tissues such 
as intestine, kidney, brain, retina and testes (24). Their widespread occurrence and the 
subcellular localization in some cells, which was demonstrated for parvalbumin and for 
calbindin-D« in rat collecting duct, suggests more specialized functions for calbindins. 
This suggestion is consolidated by the strong evolutionary conservation of calbindins, 
since for Ca2* binding alone a high degree of conservation is not required (24,25). In a 
search for functions during the last decade, no effect of calbindins on a large number 
of cellular processes, beside the already mentioned facilitated Ca2* diffusion, was 
found (26). It has been proposed that calbindins activate the plasma membrane Ca2* 
pump (27). Since the Ca2* supply near the basolateral membrane increases as a result 
of high concentration of calbindins, stimulation of the plasma membrane Ca2* pump 
by calbindins might enhance the rate of transcellular Ca2* transport. 
We demonstrated that calbindins stimulated the Ca2* pump from porcine 
erythrocytes and from rat duodenal basolateral membranes when EGTA free 
solutions were used. In the presence of EGTA, there was no effect of calbindins on 
the Ca2* pump activity in both preparations. This is in line with earlier findings that 
EGTA mimics the effect of calbindins (28,29). Calmodulin, on the other hand, binds 
with high affinity and is therefore a potent stimulator that activates the plasma 
membrane Ca2* pump via a calmodulin binding domain on the pump. 
At resting level around ΙΟ"7 M Ca2*, calmodulin is dissociated from the plasma 
membrane Ca2* pump and consequently the pump reaches only part of its maximum 
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activity (30). However, in the presence of calbindins there is an increased Ca2* pump 
activity during transcellular Ca2* transport. Calbindins may have a double role in 
transcellular Ca2* transport. Firstly, enhancement of Ca2* diffusion and at the same 
time maintaining intracellular Ca2* around 10 '7 M. Secondly, the plasma membrane 
Ca2* pumps are activated by enhanced Ca2* delivery via calbindins. 
Taking into consideration that a change of surface charges on calbindin affects 
its affinity for Ca2*, it can be anticipated that the Ca2* receptor of the pump is the site 
were calbindins associate. The importance of three negatively charged side chains in 
the binding of Ca2* to bovine calbindin-D* was investigated by Linse et al. (31). Each 
of these charges were found to contribute to the binding of two Ca2* ions. As there is 
no evidence for any hydrophobic surface patches on calbindin, the interaction with the 
Ca2* pump might occur through surfaces with complementary charges and have a 
double role. First, the proteins would be docked into a favorable position for Ca2* 
ions to be transferred from calbindin to the Ca2* pump. Second, the surface charges 
of both proteins would be partially neutralized as a result of the close approach of 
opposite charges. The Ca2* affinity of calbindin would then decrease and that of the 
Ca2*-pump might increase. The net effect would favor Ca2* transport from calbindin 
to the Ca2* pump. 
9.4. Ca2+-bmdmg proteins and intracellular Ca2+ homeostasis 
An important question is how cells which contain large amounts Ca2*-binding 
proteins are able to trigger cellular events by fluctuations in cytosolic Ca2* 
concentrations. Speculations about this problem should take the following arguments 
into consideration. At a Ca2* concentration of ΙΟ'7 M and physiological Mg2* 
concentrations, calbindins are to a high degree saturated with Ca2* (32). Because of 
the enormous gradient in free Ca2* that exists between the intra- and extracellular 
milieu, and the massive influx when Ca2* channels are open, it is likely that a transient 
rise in cytosolic Ca2* can be realized within a short period of time. 
It is interesting to mention that parvalbumin has been demonstrated in so 
called 'fast spiking' cells, such as metabolic active, GABA-containing neurons (33). 
These cells are characterized by very fast alterations in cellular Ca2*. Very fast 
transient alterations in cytosolic Ca2* might be difficult to accomplish with the 
available Ca2* stores. In these cells parvalbumin could be a slow but high-affinity 
'Ca2* sink', taking up the Ca2* that enters the cytosol during intense neural activity. 
During a fast transient rise in cellular Ca2*, the Ca2* concentration will then overshoot 
for a short period of time before it is bound to parvalbumin. In contrast to 
parvalbumin, calbindins could bind and release Ca2* more quickly, acting as a 
'diffusion catalyst' to redistribute it in the cell (25). 
9.5. Subcellular localization of Ca2+-bindmg proteins 
At the moment, information about the subcellular localization of parvalbumin 
and calbindins is very scarce. The restricted localization of parvalbumin and 
calbindin-D* along basolateral membranes of the collecting duct implies that binding 
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proteins for parvalbumin and calbindin-D* must be present on cytoskeletal elements. 
At the moment there is no information available about "binding-proteins' in the 
collecting duct. However, it might be one explanation for the strong evolutionary 
conservation of Ca2+-binding proteins. The restricted localization of Ca2*-binding 
proteins favors more localized transport and functions. Calbindin-D* could help 
distribute Ca2" quickly along the basolateral membrane after influx through a few 
scattered channels. The presence of both parvalbumin and calbindin-D* along the 
basolateral membrane of rat collecting duct is difficult to explain in terms of their 
physiological function, since a 'slow rate' and a 'high rate' Ca2* sink co-localize. It can 
be anticipated that anchored parvalbumin and calbindins have altered affinities for 
Ca2* and/or altered Ca2* binding rates than free solubilized proteins, since it has been 
demonstrated that surface charges affect the Ca2* binding on calbindin-D» (31). It 
might depend on the type of binding-protein, in what way the dynamic parameters 
change. If this is true then the physiological functions of parvalbumin and calbindins 
are broader then previously anticipated. 
9.6. Ca2+-ATPase densities in erythrocytes from persons 
suffering from essential hypertension or Raynaud's 
phenomenon 
It is generally accepted that increased constriction of vascular smooth muscles 
in essential hypertension is caused by raised cytosolic levels of Ca2*. A number of 
studies on Ca2* pump activities in erythrocytes and platelet membranes in essential 
hypertensives have been reported (34-40). However, there is no agreement concerning 
the nature of the Ca2* pump abnormality, whether Ca2* pump activity is decreased or 
increased. A key factor here is the variability of the pump activity in different human 
erythrocyte preparations and its peculiar sensitivity to environmental factors. 
Therefore we measured the number of Ca2* pumps with an ELISA technique. We 
calculate about 1,400 pump sites/erythrocyte. We found no difference in the number 
of Ca2* pumps or Ca2* pump activity in erythrocytes from healthy persons and persons 
suffering from essential hypertension or Raynaud's phenomenon. We conclude that 
raised Ca2* influx might explain the increased intracellular Ca2* concentration, as has 
been demonstrated in spontaneously hypertensive rats (41). 
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I l l 
Summary 
Molecular Identification of Calcium Binding Proteins and Ca2+-
ATPases in Small Intestine and Kidney 
The mechanisms by which intestinal and renal epithelia absorb Ca2* has been 
studied in detail during the last few decades and is still a topic of interest. The 
anatomical features of intestinal and renal epithelia are such that two routes are 
available for Ca2* to cross these tissues. The paracellular or junctional route has a 
variable permeability along the intestinal tract and along the nephron. Passive 
movements of Ca2* can occur in both directions and are driven by favorable 
electrochemical gradients or by solvent drag. The transcellular route consists of a 
passive influx from lumen to the cell and a active extrusion of Ca2* out of the cell into 
the circulation. Since mechanisms for active Ca2* extrusion, Na*/Ca2* exchange and 
ATP-dependent Ca2* transport are exclusively located in the basolateral membrane of 
the cell, the transcellular route provides for active Ca2* absorption. Transcellular Ca2"-
absorption is closely related with the presence of soluble Ca2*-binding proteins, the 
calbindins. In the mammalian intestine calbindin-D« has been demonstrated. The 
distal convoluted tubule cells contain calbindin-Da». There is strong evidence that 
calbindins facilitate the diffusion of Ca2* through the cytosol, which is believed to be 
the rate limiting step in transcellular Ca2* absorption. 
Like in all cells, the intracellular Ca2* concentration of intestinal and renal 
epithelial cells is kept at low resting values between 50-100 nM. Many cellular 
processes are regulated by fluctuations in cytosolic Ca2* concentrations, mainly 
brought about by receptor activation at the cell surface. Transient rises in cytosolic 
Ca2* can be accomplished by Ca2* influx through scattered channels at the cell surface 
and/or via Ca2* release from intracellular Ca2* stores. Like many other cells, intestinal 
and renal epithelial cells contain two types of Ca2* ATPases. The basolateral 
membrane contains a Ca2*-ATPase with a molecular weight around 140 kDa and is 
calmodulin dependent. A second type of Ca2*-ATPase is located in the intracellular 
Ca2* store, it has a molecular weight around 115 kDa and is not stimulated by 
calmodulin. Both types of Ca2* pumps are responsible to maintain cytosolic Ca2* at 
low resting levels around 10' M, either by Ca2* extrusion out of the cell or by 
re-uptake in the intracellular Ca2* store. 
The intracellular Ca2* homeostasis of intestinal and renal epithelial cells is 
continually challenged by large and variable rates of transcellular Ca2* transport. The 
mechanisms by which these cells transport Ca2* transcellular and at the same time 
maintain cytosolic Ca2* at low resting levels, is a topic of interest. 
In chapter 2 the Ca2*-ATPases from erythrocytes, sarcoplasmic reticulum and 
porcine duodenum were characterized by ^I-calmodulin overlay and by "P-phosphory-
lation studies on acidic gels. The Ca2* pumps from erythrocytes and porcine duodenal 
basolateral membranes showed common characteristics, i.e.; a molecular weight 
around 140 kDa, binding of "I-calmodulin and increased amounts of phosphoiylated 
intermediate in the presence of La3*. Also the Ca2* pumps from porcine enterocyte 
microsomes and sarcoplasmic reticulum shared similar characteristics, i.e.; a molecular 
weight around 115 kDa, no bincng of 125I-calmodulin and decreased amounts of the 
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phosphorylated intermediate in the presence of La3*. Since attempts to isolate 
enterocyte Ca2+ pumps were unsuccessful, we used isolated Ca2* pumps from 
erythrocyte and sarcoplasmic reticulum for the production of polyclonal antisera and 
for the development of competitive and non-competitive ELISA 's. The antisera were 
specific and showed no cross-reactivity with the other type of Ca2* pump. It turned out 
that anti-Ca2* pump from porcine erythrocytes cross-reacted for less then 4% with 
erythrocytes from other species, whereas anti-Ca2* pump from rat sarcoplasmic 
reticulum cross-reacted for almost 100% with sarcoplasmic reticulum from other 
species and showed even cross-reactivity with the intracellular Ca2* pump from 
porcine duodenal enterocytes. Calbindins and parvalbumin were isolated and used for 
the production of polyclonal antisera. With competitive ELISA's we showed that 
anti-calbindin-D» from bovine kidney cross-reacted with calbindin-D» from rabbit 
kidney and chicken intestine. Anti-parvalbumin from rabbit muscle cross-reacted with 
parvalbumin from chicken muscle. On the other hand we found that anti-calbindin-D* 
from bovine intestine cross-reacted for less then 1% with porcine calbindin-D*. 
The active vitamin-D metabolite l,25(OH)2Dj, is known to regulate 
transcellular Ca2* absorption by the intestine. It has been demonstrated that the 
hormone stimulates the synthesis of calbindin-D», and it increases the Ca2* influx via 
the brush border membrane of enterocytes. In chapter 3 we investigated the effect of 
1,25(0^20, on the Ca2* uptake rates and on the number of Ca2* pumps in 
subcellular fractions of porcine duodenal enterocytes. Duodenal basolateral membrane 
vesicles and microsomes were isolated from healthy piglets and from piglets suffering 
from an inherited defect in renal 1,25(ОН)2оз synthesis. We found no significant 
differences in the Ca2* uptake rates and in the number of Ca2* pumps between 
healthy and l,25(OH)2D3-deficient piglets for both subcellular fractions. It was 
calculated that there are about 95,000 pump sites/enterocyte and that there is ample 
Ca2* pump capacity to prevent the enterocyte from being flooded with Ca2* entering 
the cell via the brush border membrane, under the influence of 1,25(ОН)2Оз. 
Apparently, there is no need to increase the number of Ca2* pumps in these cells. 
In chapter 4 we describe ATP-dependent Ca2* transport in plasma membranes, 
microsomes and mitochondria from intestinal and renal epithelial cells. For both 
epithelial cell types it is clear that the Ca2* pumps in plasma membranes and in the 
non-mitochondrial intracellular store have almost identical capacities. Since the 
affinities for Ca2* are also identical, K„ ~ 0.1 μΜ Ca2*, both pumps are, from a 
kinetic point of view of equal importance to maintain intracellular Ca2* around a 
resting value of 0.1 μΜ. Mitochondria have no role in maintaining a low intracellular 
Ca2* concentration. However, increases in cytosolic free Ca2* between 0.3 and 1.0 μΜ, 
also increases mitochondrial Ca2* uptake which then results in increased activities of 
Ca2*-dependent mitochondrial enzymes which are essential in the regulation of ATP 
production. 
In chapter 5 we investigated the effect of l,25(OH)2Dj on the Ca2*-uptake rate 
and on the transepithelial Ca2* flux in cultured human colon carcinoma cells, Caco-2. 
Preincubation for 24 h with 10"" - 10"7 1,25(ОН)2Оз, increased the Ca2* uptake rate in 
Caco-2 cells significantly. Preincubation with l,25(OH)2D, for 48h, resulted in further 
augmentation of Ca2* uptake. Confluent monolayers of Caco-2 cells grown on 
permeable supports were also placed in modified Ussing chambers. J„ and J
m
 fluxes 
of Ca2* increased significantly after 48 h preincubation with ΙΟ"7 M 1,25(ОН)2оз, 
without a significant effect on the net Ca2* flux. The transepithelial Ca2* flux across 
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l,25(OH)2Dj treated Caco-2 cells was 50-fold lower than was found in cultured rabbit 
collecting tubular cells. This might be due to the high concentration of calbindin-D» 
present in cultured collecting tubular cells. Calbindin-D* could not be demonstrated in 
Caco-2 cells with monoclonal antibodies against human calbindin-D*. 
Calbindins belong to the troponin-C superfamily of high affinity Ca2*-binding 
proteins to which also calmodulin and parvalbumin belong. They are present in a 
number of Ca2* transporting tissues such as the intestine and the distal tubule of the 
kidney. There is strong evidence that calbindins facilitate the Ca2+ diffusion through 
the cytosol, thereby increasing the rate of intestinal and renal Ca2* absorption. 
Recently calbindins and also parvalbumin have been demonstrated in several other 
tissues such as the brain, pancreas, parathyroid gland and bone. Calbindins and 
parvalbumin possess a high degree of evolutionary conservation. Since for the sole 
purpose of Ca2* binding, a strong selective pressure against mutations is not required, 
it has been postulated that there might be more physiological functions for these 
proteins than simply enhancement of Ca2* diffusion. In chapter 6 we investigated the 
effect of calbindin-Dak and parvalbumin on the ATP-dependent Ca2* uptake rates in 
inside-out orientated vesicles from porcine erythrocytes and rat duodenal basolateral 
membranes. We found that 6-40 дМ calbindin-D^ or parvalbumin increased Ca2* 
pump activities in both preparations when Ca2* uptake was performed in EGTA free 
solutions. In EGTA containing solutions we found no effect of calbindin-D» and 
parvalbumin on the Ca2* pump activities, which is in line with earlier observations that 
Ca2* chelating agents like EGTA mimic the effect of Ca2*-binding proteins. In the 
presence of 200 nM calmodulin, the Ca2* pump activity could be further stimulated 
with parvalbumin. This suggests that the calmodulin binding domain is not the 
receptor for Ca2*-binding proteins since calmodulin binds with a K^  in the nanomolar 
range to the plasma membrane Ca2* pump. It is proposed that calbindins associate 
with the Ca2* receptor on the pump. Complementary charges would favor binding and 
transfer of Ca2* from calbindin to the Ca2* pump. In chapter 7 the precise localization 
of parvalbumin, calbindin-D» and calbindin-DÄ was studied by immunocytochemistry 
in rat kidney. Antisera recognizing specifically the thick ascending loop of Henle, the 
connecting tubules and collecting ducts and the intercalated cells of the collecting 
duct, were used to identify different cell types. In rat kidney cortex, parvalbumin and 
calbindin-D« colocalized in the thick ascending loop of Henle, the distal convoluted 
tubule and in the intercalated cells of the collecting duct. Strikingly, in all responsive 
cells, parvalbumin and calbindin-D* were exclusively present in a thin layer along the 
basolateral membrane. In contrast, calbindin-D» was only present in the distal 
convoluted and connecting tubule, where it was evenly distributed through the cytosol. 
Calbindin-D^ may act as a soluble Ca2* shuttle between the two opposing 
membranes. The exclusive localization of parvalbumin and calbindin-D* along the 
basolateral membrane of immuno-positive cells favors more localized transport and 
functions. Since Ca2*-binding proteins are highly soluble, the restricted localization of 
parvalbumin and calbindin-D* along the basolateral membrane implies that binding 
proteins must be present on cytoskeletal elements. 
It is generally accepted that increased constriction of vascular smooth muscles 
in essential hypertension is caused by raised levels of cytosolic Ca2*. Most investigators 
have used blood cells, especially erythrocytes and platelet membranes, to identify or to 
gain insight into abnormalities of cellular Ca2* regulation in essential hypertension. 
Measurements of Ca2* pump activities are hampered by the instability of the Ca2* 
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pump and its peculiar sensitivity to environmental factors. In Raynaud's phenomenon 
vasoconstriction of extremities is thought to be responsible for an inadequate blood 
flow. It has been demonstrated that treatment with Ca2+ entry blockers resulted in an 
increased finger blood flow. Therefore an abnormal high Ca2*- influx into vascular 
smooth muscle cells may be a factor in Raynaud's phenomenon. Since, a high Ca2* 
influx can be partly compensated by increased Ca2* pumping, Ca2* pump densities in 
patients with Raynaud's phenomenon is a parameter of interest. In chapter 8 we 
determined the number of Ca2* pumps in erythrocytes from essential hypertensives 
and persons suffering from Raynaud's phenomenon by an ELISA technique. Specific 
antisera were raised against purified human erythrocyte Ca2* pump and a competitive 
ELISA was developed. Additionally, Ca2*-dependent ATP-hydrolysis were studied in 
the same erythrocyte membrane preparations. We found no significant differences in 
Ca2* pump densities and in Ca2* pump activities between healthy persons and persons 
suffering from essential hypertension or Raynaud's phenomenon. Furthermore, we 
found no influence of sex and age on these parameters. It was calculated that each 
erythrocyte contains about 1,400 pump sites, that equals a transport capacity large 
enough to extrude the free Ca2* pool 30 times per min. It was concluded, that active 
Ca2* transport is not a parameter of interest in both diseases. Raised levels of 
intracellular Ca2* that leads to contraction of vascular smooth muscle cells, might be 
caused by increased Ca2* influx. 
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Samenvatting 
Moleculaire Identificatie van Calcium Bindende Eiwitten en 
Ca2+-ATPases in de Dunne Darm en de Nier 
De mechanismen waarbij darm- en nierepitheel Ca2* absorberen is 
gedetailleerd onderzocht in de afgelopen decennia, en is tot op de dag van vandaag 
een onderwerp dat de aandacht vraagt. De anatomische bouw van darm- en 
nierepitheel is zodanig dat er twee wegen beschikbaar zijn voor Ca2* om deze weefsels 
te passeren. De paracellulaire ofwel junctionele weg heeft een variabele permeabiliteit 
langs het darmkanaal en het nefron. Passief Ca2* transport kan optreden in beide 
richtingen en wordt gedreven door geschikte electrochemische gradiënten of door 
translocatie van vloeistoffen. De transcellulaire weg bestaat uit een passieve influx van 
Ca2* van lumen naar de cel en een actieve extrusie uit de cel naar de circulatie. 
Aangezien de mechanismen voor actieve Ca2* extrusie, de Na*/Ca2* uitwisseling en het 
ATP-afhankelijke Ca2* transport, uitsluitend gelokaliseerd zijn in het basolaterale 
membraan van de cel, voorziet de transcellulaire weg in de actieve Ca2* absorptie. De 
transcellulaire Ca2* absorptie is nauw verbonden met de aanwezigheid van oplosbare 
Ca2*-bindende eiwitten, de calbindinen. In de darm van zoogdieren is calbindine-D» 
aangetoond. De distale convoluut cellen van het nefron bevatten calbindine-D^. 
Calbindinen versnellen waarschijnlijk de Ca2*-diffusie door het cytosol. Er wordt 
aangenomen dat de Ca2* diffusie de snelheidsbeperkende factor is bij de transcellulai-
re Ca2* absorptie. 
Zoals in alle cellen wordt de cytosolische Ca2* concentratie in darm- en 
nierepitheel cellen laag gehouden op een rustniveau van ongeveer 50-100 nM. 
Verschillende cellulaire processen worden gereguleerd door fluctuaties in de 
cytosolische Ca2* concentratie, voornamelijk teweeg gebracht door receptoractivatie 
aan het celoppervlak. Transiente stijgingen in de cytosolische Ca2* concentratie 
kunnen tot stand komen door Ca2* influx via geactiveerde kanalen aan het 
celoppervlak en/of via het vrijmaken van Ca2* uit intracellulaire Ca2* opslagplaatsen. 
Zoals vele celtypen bevatten darm- en nierepitheelcellen twee typen Ca2* pompen. 
Het basolaterale membraan bevat een Ca2* pomp met een moleculair gewicht van 
ongeveer 140 kDa en wordt aanzienlijk gestimuleerd door calmoduline. Een tweede 
type Ca2* pomp is gelokaliseerd in de intracellulaire Ca2* opslagplaats, heeft een 
moleculair gewicht van ongeveer 115 kDa en wordt niet gestimuleerd door 
calmoduline. Beide Ca2* pompen zijn verantwoordelijk voor het laag houden van de 
cytosolische Ca2* concentratie rond 10'7 M. 
De intracellulaire Ca2* huishouding van darm- en nierepitheel cellen wordt 
bedreigt door het transcellulaire Ca2* transport. De mechanismen waarbij deze cellen 
Ca2* transcellulair kunnen transporteren en tegelijkertijd de cytosolische Ca1* 
concentratie rond het rustniveau kunnen handhaven, is een relevant onderwerp. 
In hoofdstuk 2 worden de Ca2* pompen van erythrocyten en van het sarcoplasma-
tisch reticulum gekarakteriseerd met 125I-calmoduline binding, 32P fosforylatie op zure 
gels, en vergeleken met duodenumenterocyten van varkens. De Ca2* pompen van 
erythrocyten en van varkensduodenum basolaterale membranen vertonen 
overeenkomstige eigenschappen: een moleculairgewicht van ongeveer 140 kDa, 
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binding van l25I-calmoduline en een toename van de hoeveelheid gefosforyleerd 
intermediair in aanwezigheid van La3+. Aan de andere kant vertonen de Ca2* pompen 
van het sarcoplasmatisch reticulum en microsomen van varkens duodenum 
overeenkomstige eigenschappen; een moleculair gewicht van ongeveer 115 kDa, geen 
binding van 125I-calmoduline en een afname van de hoeveelheid gefosforyleerd 
intermediair in aanwezigheid van La3*. Omdat isolatie van enterocytaire Ca2* pompen 
niet is gelukt, werden de geïsoleerde Ca2* pompen van erythrocyten en 
sarcoplasmatisch reticulum gebruikt voor de produktie van polyclonale antisera en 
voor de ontwikkeling van competitieve en niet-competitieve ELISA's. Ieder antiserum 
bleek specifiek en vertoonde geen kruisreactie met het andere type Ca2* pomp. 
Gebleken is dat anti-Ca2* pomp van varkens erythrocyten een kruisreactie van minder 
dan 4% vertoonde met erythrocyten van andere species, terwijl anti-Ca2* pomp van de 
rat sarcoplasmatisch reticulum een kruisreactie van bijna 100% vertoonde met 
sarcoplasmatisch reticulum van andere species. Calbindinen en parvalbumine werden 
geïsoleerd en gebruikt voor de produktie van polyclonale antisera. Met behulp van 
competitieve ELISA's werd aangetoond dat anti-calbindine-D» uit de rundemier een 
kruisreactie vertoonde met calbindine-Dz» uit de konijnenier en de kippedarm. 
Anti-parvalbumine uit de konijnespier vertoonde een kruisreactie met parvalbumine 
uit de kippespier. Echter het anti-calbindine-D» uit runderdarm vertoonde een 
kruisreactiviteit van minder dan 1% met calbindin-D% uit de varkensdarm. 
De actieve vitamine D metaboliet l,25(OH)2Dj reguleert de transcellulaire 
Ca2*- absorptie in de darm. Er is aangetoond dat het hormoon de synthese van 
calbindine-D» stimuleert en verhoogt de Ca2* influx via de borstelzoom membraan 
van de enterocyt. In hoofdstuk 3 werd het effect van l,25(OH)2Dj op de Ca2* 
opnamesnelheid en op de Ca2* pomp dichtheden in subcellulaire fracties van het 
varkensduodenum onderzocht. Basolaterale membraanblaasjes en microsomen werden 
geïsoleerd uit duodena van gezonde varkens en uit duodena van varkens die een 
genetisch defect vertonen in de l,25(OH)2Dj synthese. Er werden geen significante 
verschillen gevonden in de Ca2* opnamesnelheid en in de Ca2* pompdichtheden tussen 
gezonde en l,25(OH)2D, deficiënte varkens voor beide subcellulaire fracties. Uit 
berekeningen bleek dat enterocyten ongeveer 95.000 Ca2* pomp moleculen/enterocyt 
bevatten en over voldoende Ca2* pompcapaciteit beschikken om te verhinderen dat de 
enterocyt volloopt met Ca2* dat via de borstelzoommembraan binnenstroomt in een 
1,25(0^20, gestimuleerde cel. Blijkbaar is er geen noodzaak voor een toename van 
de hoeveelheid Ca2* pompen in een door 1,25(ОН)2Оз gestimuleerde cel. 
In hoofdstuk 4 staat het ATP-afhankelijke Ca2* transport in plasmamembr • nen, 
microsomen en mitochondrion van darm- en nierepitheel cellen beschreven, oor 
beide celtypen is duidelijk dat de Ca2* pompen in de plasma membranen en de niet-
mitochondriële intracellulaire Ca2* opslagplaatsen, vergelijkbare capaciteiten hebben. 
Aangezien de affiniteiten voor Ca2* ook hetzelfde zijn, K„ ~ 0.1 μΜ Ca2*, zijn beide 
Ca2* pompen, vanuit kinetisch oogpunt van evengroot belang bij het handhaven van 
intracellulair Ca2* rond een rustniveau van ongeveer 0.1 μΜ. Mitochondriën spelen 
geen rol in de handhaving van een lage intracellulaire Ca2* concentratie. Echter een 
toename van de vrije cytosolische Ca2* concentratie vanaf 0.3 μΜ leidt tot een 
verhoogde mitochondriële Ca2* opname, hetgeen resulteert in een toename van de 
activiteit van Ca2*-afhankelijke mitochondriële enzymen welke verantwoordelijk zijn 
voor de regulatie van de ATP produktie. 
In hoofdstuk 5 werd het effect van 1,25(ОН)
г
Оз op de Ca2* opnamesnelheid en 
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op de transepitheliale Ca2* flux in gekweekte humane colonkankercellen, Caco-2, 
onderzocht. Preïncubatie van de cellen met IfrMO"7 M 1,25(ОН)гОз gedurende 24 
uur, verhoogde significant de Ca2* opnamesnelheid in Caco-2 cellen. Preïncubatie van 
de cellen met 1,25(ОН)
г
Оз gedurende 48 uur resulteerde in een verdere toename van 
de Ca2* opnamesnelheid. Confluente monolagen van Caco-2 cellen op permeabele 
filters werden in gemodificeerde Ussing kamers geplaatst om de transepitheliale Ca2* 
fluxen te meten (J„ en J„). Ca2* fluxen waren significant verhoogd na 48 uur 
preïncubatie met Ш7 M l,25(OH)2Dj. Er werd echter geen effect waargenomen op de 
netto Ca2* flux. De transepitheliale Ca2* flux in 1,25(ОН)2Оз behandelde Caco-2 cellen 
was 50 maal lager dan in gekweekte konijneverzamelbuiscellen. Dit kan veroorzaakt 
zijn door de hoge concentratie calbindine-Dja dat aanwezig is in gekweekte konijne 
verzamelbuiscellen. Calbindine-D* kon in gekweekte Caco-2 cellen niet worden 
aangetoond met monoclonale antilichamen tegen humaan calbindine-D*. 
Calbindinen behoren tot de troponine-C superfamilie van Ca2*-bindende 
eiwitten met een hoge affiniteit voor Ca2*, waartoe ook calmoduline en parvalbumine 
behoren. Calbindinen komen voor in Ca2* transporterende weefsels zoals darm- en 
nierepitheel. Calbindinen verhogen waarschijnlijk de Ca2* diffusie door het cytosol, 
waardoor de snelheid van de actieve Ca2* absorptie in darm- en nierepitheel 
toeneemt. Recentelijk zijn calbindinen en parvalbumine ook aangetoond in 
verschillende andere organen zoals de hersenen, de alvleesklier, de schildklier en het 
bot. Calbindinen en parvalbumine bezitten een hoge mate van evolutionaire 
conservatie. Omdat voor Ca2* binding alleen een sterke selectie tegen mutaties niet 
vereist is, wordt gedacht dat er voor deze eiwitten waarschijnlijk andere fysiologische 
functies zijn dan eenvoudig het versnellen van de Ca2* diffusie. In hoofdstuk 6 staat 
het effect van calbindine-D» en parvalbumine op de ATP-afhankelijk Ca2* 
opnamesnelheid in membraanblaasjes van varkenserythrocyten en ratteduodenum 
beschreven. Aangetoond werd dat 6 tot 40 цЫ calbindine-D» of parvalbumine de 
Ca2* pomp activiteit in beide preparaten significant verhoogden indien de Ca2* 
opnamen werden verricht in EGTA vrije media. In aanwezigheid van EGTA werd 
geen effect gevonden van calbindine-D^ of parvalbumine op de Ca2* pomp, hetgeen 
in overeenstemming is met eerdere waarnemingen dat EGTA het effect van Ca2*-
bindende eiwitten nabootst. In aanwezigheid van 200 nM calmoduline kon de Ca2* 
pomp activiteit van varkenserythrocyten verder worden gestimuleerd door Ca2*-
bindende eiwitten. Dit veronderstelt dat de calmoduline receptor niet de plaats is 
waar Ca2*-bindende eiwitten associëren met de Ca2* pomp, aangezien calmoduline 
met een K,, in het nanomolaire concentratiegebied bindt aan de 
calmodulinebindingsplaats van de Ca2* pomp. Verondersteld werd dat de Ca2* 
receptor de plaats is waar Ca2*-bindende eiwitten associëren met de Ca1* pomp. 
Complementaire ladingen zouden binding en overdracht van Ca2* mogelijk maken. In 
hoofdstuk 7 werden calbindine-Da», calbindine-D* en parvalbumine met behulp van 
immunocytochemische technieken nauwkeurig gelokaliseerd in de rattenier. Antisera 
die specifiek de verbindingsbuizen, de verzamelbuizen en de tussenliggende cellen van 
de verzamelbuizen herkennen, werden gebruikt om de verschillende celtypen te 
identificeren. Gevonden werd dat calbindine-D* en parvalbumine op dezelfde plaats 
voorkomen in het dikke stijgende deel van de lis van Henle, het distale convoluut en 
de tussenliggende cellen van de verzamelbuis. In al deze celtypen bevinden 
calbindine-D% en parvalbumine zich als een dunne laag aan de binnenzijde langs het 
basolaterale membraan. Calbindine-Da, werd uitsluitend aangetoond in het distale 
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convoluut en in de verbindingsbuis, waar het homogeen in het cytosol verspreid is. 
Calbindine-Dak zou mogelijk als een oplosbare Ca2* transporteur tussen twee 
tegenover elkaar liggende membranen kunnen fungeren. De lokalisatie van 
calbindine-D* en parvalbumine als een dunne laag langs het basolaterale membraan 
in alle immuno-positieve cellen, zou meer gelokaliseerd Ca2* transport en Ca2* 
afhankelijke processen mogelijk maken. Aangezien de Ca2*-bindende eiwitten 
oplosbaar zijn, is het waarschijnlijk dat zij aan de binnenzijde van het basolaterale 
membraan op hun plaats worden gehouden door Ъіпаепае eiwitten' die zich aan 
elementen van het cytoskelet bevinden. 
In het algemeen wordt aangenomen dat de toegenomen vasoconstrictie bij 
essentiële hypertensie veroorzaakt wordt door een verhoogde cytosolische Ca2* 
concentratie. De meeste onderzoekers hebben gebruik gemaakt van bloedcellen, 
vooral erythrocyten en bloedplaatjes, om inzicht te krijgen in de verstoring van de 
Ca2* regulatie bij essentiële hypertensie. Activiteitsmetingen van de Ca2* pomp worden 
bemoeilijkt door de instabiliteit en de uitgesproken gevoeligheid van de Ca2* pomp 
voor externe omstandigheden. Bij het fenomeen van Raynaud wordt verondersteld dat 
vasoconstrictie van extremiteiten de oorzaak is voor een onvoldoende bloedcirculatie. 
Het is aangetoond dat een behandeling met Ca2* instroomremmers een toenemende 
bloedcirculatie in de vingers tot gevolg heeft. Daarom zou een abnormaal toegenomen 
Ca2* instroom in vasculaire gladde spiercellen van belang kunnen zijn bij het 
fenomeen van Raynaud. Aangezien een verhoogde Ca2* instroom kan worden 
gecompenseerd door een toegenomen Ca2* uitstroom, kunnen Ca2* pomp dichtheden 
een belangrijke factor zijn. in hoofdstuk 8 werden de Ca2* pomp dichtheden in 
erythrocyten van patiënten, die leiden aan essentiële hypertensie of aan het fenomeen 
van Raynaud, bepaald door middel van een ELISA techniek. Tevens werden de Ca2* 
afhankelijke ATP-hydrolyse activiteiten gemeten in dezelfde erythrocyte membranen. 
Er werden geen significante verschillen gevonden in Ca2* pomp dichtheden en Ca2* 
pomp activiteiten in erythrocyten van gezonde personen en patiënten welke leiden 
aan essentiële hypertensie of aan het fenomeen van Raynaud. Berekend werd dat 
iedere erythrocyt ongeveer 1400 Ca2* pompen bevat, wat overeenkomt met een 
transport capaciteit die voldoende is om de hoeveelheid vrij cytosolisch Ca2* 30 maal 
per minuut de cel uit te pompen. Geconcludeerd werd dat het actieve Ca2* transport 
geen belangrijke parameter is bij beide ziektebeelden. Verhoogde intracellulaire Ca2* 
concentraties zouden mogelijk veroorzaakt kunnen worden door een toegenomen Ca2* 
instroom. 
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